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This PhD work describes the development of different Michael and Michael 
type processes employing different bifunctional organocatalysts. All the 
processes studied involved a non-covalent activation of the substrates 
provided by the organic promoters.  
An asymmetric epoxidation of electron-poor trisubstituted olefins has been 
developed by employing the commercially available diphenyl prolinol 
which afforded the epoxides in high yield, complete diastereocontrol and 
good enantioselectivity. Diaryl prolinols were found to promote a Michael 
addition of -ketoesters to nitroalkenes. An unexpected high efficiency and 
stereocontrol was observed with hexafluorobenzene as unconventional 
solvent, but also employed as an additive. A convenient tandem double 
Michael addition process was developed to access symmetrically and 
unsymmetrically 3,5-diaryl substituted cyclohexanones by using quinine 
as catalyst. An aziridination reaction of terminal electron-poor olefins has 
been disclosed by using a commercially available aminothiourea catalyst. 
The desired aziridines, bearing a quaternary stereocenter, were isolated in 
good yield and enantiocontrol. These compounds, were regioselectively 
ring-opened to access valuable ,-disubstituted -amino ester 
derivatives. Finally, an asymmetric Fischer indolization to produce helical 
molecules was investigated employing a chiral phosphoric acid as 
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1.1 Why Chirality? 
 
Chirality, which concerns a rigid object not superimposable to its mirror 
image (Figure 1.1), is at the basis of the life.  
 
Figure 1.1 Human hands and amino acids are classical examples of chiral 
objects. 
 
Most of the biological systems interacts recognizing an enantiomer better 
than the other (molecules with a chemically identical structure) and are 
able to synthesize optically active compounds in an enantiopure form. 
Amino acids, sugars, nucleotides are all small chiral components whose 
chiral information can affect an entire macroscopic environment. Effects 
in the macroscopic world can have their origin at the molecular level, such 
as the common phenomena of perception of odours and tastes by human 
brain. Signals interpreted as a perception of sense come from the 
interaction and the specific fitting of a molecule, for example an odorant, 
in its complementary chiral receptor or ensemble of receptors, giving 
different responses in dependence on its absolute configuration. As an 
example, amino acids belonging to different stereochemical series (Figure 
1.1) taste different: D-aminoacids tend to have a sweet taste, while those 
belonging to the L-series are generally tasteless. D-carvone and L-carvone, 
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shown in Figure 1.2, have a different odour since they interact with 
different ensembles of receptors assigned to the sense of smell. The D-
carvone is responsible for the odour of caraway while its enantiomer 
smells like spearmint. 1 
 
Figure 1.2 D and L-carvone. 
 
In 2003 a review on flagrances and flavours reported that 285 couples of 
enantiomers exhibited different odour qualities and intensities.2 
Even more important is the role of chirality in regulating enantiomerically 
specific bioactivity in drugs, agrochemicals or the way the nature 
communicates, such as the power of a signal depending on the 
stereoisomer of a given pheromone.  
The concept of chirality was introduced after the middle of the 19th 
century by Pasteur, vant’Hoff and LeBel describing for the first time a 
carbon with four different substituents as a chiral unit.3  Nevertheless 
until the end of the 20th century synthetic drugs were produced almost 
exclusively in racemic form although enantiomerically pure natural 
compounds have been employed as drugs since ancient times.4  
                                                          
1 T. J. Leitereg, D. G. Guadagni, J. Harris, T. R. Mon, R. Teranishi, J. Agric. Food. Chem. 
1971, 19, 785. 
2 E. Brenna, C. Fuganti, S. Serra, Tetrahedron: Asymmetry 2003, 14, 1. 
3 a) L. Pasteur, Compt. Rend. Acad. Sci. 1848, 34, 535; b) J. H. van’t Hoff, Arch. Neerl. Sci. 
Exactes Nat. 1874, 9, 445; c) J. A. Le Bel, Bull. Soc. Chim. France 1874, 22, 331. 
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It is dramatically known the effect of the “wrong” enantiomer of the 
thalidomide, a drug introduced to treat morning sickness and to aid sleep 
although soon one of the two enantiomers was proved to be teratogen. 
Since then a particular effort has been invested by pharmaceutical 
companies and research groups to obtain enantiopure active compounds 
or at least to study the effects of the separate stereoisomers. From this 
and similar episodes and a growing awareness of the different activity of 
some enantiomer pairs, in the 90s FDA (Food and Drug Administration) 
and other international regulatory agencies fixed some guidelines in the 
synthesis and in the tests of optically active drugs.5 
Given the appeal of enantiopure compounds, the traditional methods such 
as resolution or diastereoselective chemical synthesis soon revealed to be 
insufficient to meet the demand. Therefore both stoichiometric and 
catalytic asymmetric synthesis was increasingly exploited. In asymmetric 
catalysis, a small amount of enantiopure catalyst can transfer the 
asymmetric information to many optically active molecules of product 
from a chiral or a non-chiral precursor, by being continuously regenerated 
during the process.6 In the past, metal and enzymatic catalysis were the 
most widespread strategies in asymmetric catalysis. In recent years a 
third pillar has joined this fundamental field, organocatalysis, the 
acceleration of chemical reactions with chiral organic molecules employed 
in a substoichiometric amount to obtain enantioenriched products. 7  
A number of advantages can be recognised in the absence of transition-
metals and the feasible lack of toxic wastes. Moreover these catalysts are 
generally easily accessible and reactions can be run under air and without 
restrictive precautions since they usually are not air and moisture-
sensitive compounds. As a substantially different approach, this third 
                                                          
5 FDA’s Policy Statement for the Development of New Stereoisomeric Drugs, Chirality 1992, 
4, 338. 
6 K. C. Nicolaou, E. J. Sorensen, Classics in Total Synthesis: Targets, Strategies, Methods, 
Wiley-VCH, Weinheim, 1996. 
7 D. W. C. MacMillan, Nature 2008, 455, 304. 
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pillar provides a complement to the other two in order to achieve 
asymmetric induction in catalytic reactions. Indeed, some processes, not 
compatible with metal- or biocatalysis have been successfully addressed 
by organocatalysis and vice versa.8 
In the field of natural products and drug synthesis the organocatalysis is 
becoming more represented, as witnessed by the several reviews 
concerning this argument.9    
 
1.2 Historical Development 
 
The first “traces” of reactions promoted by organic molecules can be dated 
back to the 1800s when pioneering studies of van Liebig showed that the 
cyanogen in the presence of acetaldehyde furnished the oxalamide  
(Scheme 1.1).10 
 
Scheme 1.1 Oxamide synthesis by Liebig. 
 
Afterwards, an investigation on the catalytic activity of cinchona alkaloids 
was conducted by Bredig, who reported in 1912 the addition of hydrogen 
cyanide to benzaldehyde promoted by quinine 1 (Scheme 1.2).11  
                                                          
8 B. List, Adv. Synth. Catal. 2004, 346, 1021. 
9 For reviews on the organocatalytic synthesis of drugs and of bioactive natural products, 
see: a) R. M. de Figueiredo, M. Christmann, Eur. J. Org. Chem. 2007, 2575; b) C. Grondal, 
M. Jeanty, D. Enders, Nature Chem. 2010, 2, 167;  c) E.  Marqués-López, R. P. Herrera, M. 
Christmann, Nat. Prod. Rep. 2010, 27, 1138.  
10 J. von Liebig, Annalen der Chemie und Pharmacie 1860, 113, 246. 
11 G. Breding, P. S. Fiske, Biochem. Z. 1912, 46, 7. 
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Scheme 1.2 Addition of hydrogen cyanide to benzaldehyde promoted by 
quinine 1.  
 
Although the enantiocontrol of the reaction was low, it is important to 
consider this process as an ancestor of asymmetric organocatalytic 
reactions despite at that time it was not further investigated. In the 60s 
another example of process promoted by the cinchona alkaloid derivative 
2 was reported by Pracejus: the addition of methanol to ketenes furnished 
the corresponding ester with good enantiocontrol (Scheme 1.3).12 
 
Scheme 1.3 Addition of methanol to a ketene catalysed by the cinchona 
alkaloid derivative 2. 
Enantiocontrol above 90% was achieved in the asymmetric version of the 
Robinson annulation, developed at the end of the 70s by Hajos and 
Parrish13 and Eder, Sauer, Wiechert.14 They disclosed that a catalytic 
                                                          
12 H. Pracejus, Justus Liebigs Ann. Chem. 1960, 634, 9. 
13 Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1973, 38, 3239; J. Org. Chem. 1974, 39, 1615. 




- 6 - 
 
amount of the amino acid proline (3) could promote the formation of a 
bicyclic product with 93% ee (Scheme 1.4). 
 
Scheme 1.4 Asymmetric Robinson annulation. 
 
Despite these promising few examples of reactions catalysed by small 
organic molecules, only at the beginning of the new century the full 
potential of organocatalysis was realised with the discovery of List and 
Barbas that proline 3 could catalyse the direct intermolecular aldol 
reaction with good enantiocontrol (Scheme 1.5).15  
 
Scheme 1.5 Direct aldol reaction promoted by L-proline. 
 
At the same time an enantioselective Diels-Alder reaction was developed 
by MacMillan and co-workers exploiting the imidazolinone salt 4 to 
activate the reagents (Scheme 1.6).16 
                                                          
15 B. List, R. A. Lerner, C. F. Barbas, J. Am. Chem. Soc. 2000, 122, 2395. 
16 K. A. Ahrendt, C. J. Borths, D. W. C. MacMillan, J. Am. Chem. Soc. 2000, 122, 4243. 
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Scheme 1.6 Enantioselective Diels-Alder. 
 
Both the publications reported mechanistic insights and the generality of 
this activation mode could give a reason for the rapid growth of the field in 
the last 12 years. The increasing annual number of publications found in 
a research on scifinder database with “organocatalysis” as key word is 
shown in the diagram in figure 1.3.17 
 
Figure 1.3 Number of publications per year with the key concept 
“organocatalysis”.  
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1.3 Different Activation Modes 
 
The exponential growth of reports in the field of the organocatalysis has 
been likely due to the individuation of generic activation modes that could 
be broadly applied to different systems. In the wide spectrum of 
organocatalysed reactions several kinds of classifications can help in their 
rationalization. Most of the reactions can be divided into four classes 
depending on the activation strategy of the substrates by the catalyst and 
on its chemical nature: Lewis base, Lewis acid, Brønsted base and 
Brønsted acid.18 The general simplified mechanisms for the four classes of 
catalysts are shown in Scheme 1.7. 
 
Scheme 1.7 Simplified mechanism for the four classes of organocatalytic 
activation (S = substrate, P = product, B = base, A = acid). 
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According to the traditional definition of Lewis base and acid this catalysis 
is based on the donation of an electron pair from the catalyst to the 
substrate or vice versa. Covalent intermediates, i.e. Lewis adducts, are 
formed and afterwards break yielding the product and regenerating the 
catalyst. The Brønsted activation exploits complete or partial transfer of 
protons, although there is not a sharp border between the above 
mentioned regimes since there could be synergistic effects. As an example, 
in order for the reaction to proceed, Lewis base catalysts often require a 
Brønsted acid co-catalyst. The possibility to form covalent intermediates 
or non-covalent interactions is another interesting and broader 
classification in the organocatalytic activation.19 The formation of covalent 
intermediates usually involves bond energies exceeding 15 kcal/mol, while 
H-bonding, ion pairs, van der Waals forces, -stacking are the most 
exploited non-covalent interactions characterized by an energy that 
usually does not overcome 4 Kcal/mol. 
 
1.3.1 Covalent Activation Mode 
Amino-acids, peptides, alkaloids and synthetic nitrogen-containing 
compounds received particular attention as catalysts in the covalent 
strategy. It involves a reaction between an amine-catalyst with carbonyl 
compounds to give enamines and/or iminium ions which are more 
reactive towards respectively electrophiles and nucleophiles.20 Scheme 1.8 
displays how these species are correlated to each other. 
 
                                                          
19 A. Berkessel, H. Gröger, Asymmetric Organocatalysis, Wiley‐VCH: Weinheim, 2005. 
20 For reviews about iminium-enamine catalysis, see: a) B. List, Chem. Commun. 2006, 
819; b) S. Mukherjee, J. W. Yang, S. Hoffmann, B. List, Chem. Rev. 2007, 107, 5471; c) A. 




- 10 - 
 
 
Scheme 1.8 Equilibrium between iminium ion and enamine generated 
from a carbonyl compound and an amine catalyst. 
 
A carbonyl compound with a secondary amine can form an iminium ion 
(intermediate A), thereby decreasing the energy of the LUMO (Lower 
Unoccupied Molecular Orbital) of the substrate, which results in an 
increase in electrophilicity and in the acidity of the -position (Figure 1.4, 
a). The deprotonation of the intermediate A leads to the enamine B, 
whose HOMO (Highest Occupied Molecular Orbital) is raised in energy, 
gaining a more nucleophilic character (Figure 1.4, b). 
 
Figure 1.4 Activation of a carbonyl compound as iminium ion (a) or as 
enamine (b). 
 
The classical paradigm iminium/enamine has been recently extended to 
, and to ,,, unsaturated carbonyl compound to form dienamine (C) 
and trienamine (D) (Figure 1.5).21  
                                                          
21 a) S. Bertelsen, M. Marigo, S. Brandes, P. Diner, K. A. Jørgensen, J. Am. Chem. Soc. 
2006, 128, 12973; b) G. Bergonzini, S. Vera, P. Melchiorre, Angew. Chem. Int. Ed. 2010, 
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Figure 1.5  Dienamine and trienamine intermediates. 
 
Another novelty in terms of the covalent activation mode has been 
introduced by MacMillan in 2006. He exploited the concept that an 
electron-rich enamine can undergo one-electron oxidation generating a 
reactive radical cation (E, Figure 1.6) characterized by a SOMO (Singly 
Occupied Molecular Orbital). The generated intermediate is able to 
interact with weakly nucleophilic and previously difficult to combine 
species, such as radicals, halides and -nucleophiles.7, 22 
 
 
                                                                                                                                                                 
49, 9685; c) J. Stiller, E. Marques-Lopez, R. P. Herrera, R. Fröhlich, C. Strohmann, M. 
Christmann, Org. Lett. 2011, 13, 70; d) Ł. Albrecht, G. Dickmeiss, F. C. Acosta, C. 
Rodríguez-Escrich, R. L. Davis, K. A. Jørgensen, J. Am. Chem. Soc. 2012, 134, 2543; e) Z.-
J. Jia, H. Jiang, J.-L. Li, B. Gschwend, Q.-Z. Li, X. Yin, J. Grouleff, Y.-C. Chen, K. A. 
Jørgensen, J. Am. Chem. Soc. 2011, 133, 5053; f) Y. Liu, M. Nappi, E. Arceo, S. Vera, P. 
Melchiorre, J. Am. Chem. Soc. 2011, 133, 15212; g) K. S. Halskov, T. K. Johansen, R. L. 
Davis, M. Steurer, F. Jensen, K. A. Jørgensen J. Am. Chem. Soc. 2012, 134, 12943. 
22 For selected examples on SOMO-based catalysis, see: a) T. D. Beeson, A. Mastracchio, J. 
B. Hong, K. Ashton, D. W. C. MacMillan, Science 2007, 316, 582; b) K. C. Nicolaou, R. 
Reingruber, D. Sarlah, S. Brase, J. Am. Chem. Soc. 2009, 131, 2086; c) R. Sebastian, D. W. 
C. MacMillan, J. Am. Chem. Soc. 2010, 132, 5027; d) R. Beel, S. Kobialka, M. L. Schmidt, 
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Figure 1.6 Radical cation which reacts with its SOMO. 
 
The wide applicability of these activation modes is witnessed by the high 
number of possible reactions performable exploiting enamine (aldol 
reaction with a wide range of reactants, Michael and Mannich reactions 
and -functionalization of carbonyl compounds),20b or iminium catalysis 
(nucleophilic 1,2 and 1,4-addition, cycloaddition, trans-amination, Diels-
Alder reactions).20c 
The enantioselectivity is addressed through the controlled approach of the 
other reactant to the covalent intermediate formed between the catalyst 
and the substrate. Mainly one face of the pro-chiral reactive site is 
accessible. The steric hindrance offered by the catalyst itself or another  
active site of the catalyst interact and guide the second partner of the 
reaction. 
Primary amines as catalysts have late entered in the literature because of 
their lower reactivity due to the unfavourable iminium/enamine 
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Figure 1.7 Unfavourable equilibrium iminium/enamine for primary amine 
catalyst 
 
Recently primary amine catalysis has been rediscovered in the activation 
of particularly hindered and more challenging substrates which are not 
able to form covalent intermediates with secondary amine.23 
9-Amine-9-deoxy derivatives of the cinchona alkaloids 5, diamines with 
different chiral scaffolds, such as compound 6, thioureas derivatives, such 
as species 7, amino-acids 8 are only few examples of the primary amine 
catalysts exploited in the last years (Figure 1.8).  
 





                                                          
23 For some reviews on primary amine catalysts, see: a) G. Bartoli, P. Melchiorre, Synlett 
2008, 12, 1579; b) L.-W. Xu, Y. Lu, Org. Biomol. Chem. 2008, 6, 2047; c) L. W. Xu, J. Luo, 
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1.3.2 Non-covalent Activation Mode 
Organic molecules with a framework able to establish non-covalent 
interactions can be responsible of a different type of activation mode of the 
substrates. H-bonding are particularly important but also ion pair 
formation,- stacking, cation- interaction, van der Waals forces. The 
synergistic effect of weak interactions among the catalyst and the 
reactants leads the reaction to proceed with some extent of enantiocontrol. 
The cooperation among the active sites of a catalyst reminds the action of 
the enzymes. Indeed, some specific portions of the enzyme activate the 
substrate through attractive non-covalent interactions stabilizing the 
transition state.24 
In the 80s cinchona alkaloids mediated reactions were found to proceed 
through a non-covalent complex involving a well-defined network of 
hydrogen bonding and ion pair, as demonstrated by Wynberg and 
Hiemstra for the addition of thiols to cyclic enones (Scheme 1.9).25  
 
Scheme 1.9 Asymmetric addition of phenyl thiols to cyclohexanone 
promoted by quinine. 
                                                          
24 R. R. Knowles, E. N. Jacobsen, Proc Natl Acad Sci USA, 2010, 107, 20678. 
25 H. Hiemstra, H. Wynberg, J. Am. Chem. Soc. 1981, 103, 417. 
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Cinchona alkaloids are today widely exploited both in their natural form 
and as their chemical derivatives. For example their salts are often 
implicated in PTC (Phase Transfer Catalysis), which involves not only the 
activation of the substrates but also their transfer from a phase to 
another. Ureas and thioureas, and other derivatives modified on the 
skeleton are other representatives of the class.26   
Chiral urea and thioureas were subsequently developed as double 
hydrogen bonding donors, first employed by Sigman and Jacobsen in the 
asymmetric Strecker  reaction of HCN to aldimines (Scheme 1.10). 27  
 
Scheme 1.10 Strecker reaction promoted by a urea catalyst. 
 
Thioureas became more popular than the corresponding ureas because of 
the weaker intermolecular hydrogen bonds that play an important role on 
the solubility and the NH acidity. For this reason thioureas seem to be 
more suitable in catalysis because of their higher reactivity and solubility 
                                                          
26 a) K. Kacprzak, J. Gawronski, Synthesis 2001, 961; b) T. Marcelli, J. H. van 
Maarseveen, H. Hiemstra, Angew. Chem., Int. Ed. 2006, 45, 7496; c) S. J. Connon, Chem. 
Commun. 2008, 2499; d) C. E. Song, Cinchona alkaloids in synthesis and catalysis, Wiley-
VCH, Weinheim, 2009; e) S. S. Jew, H. G. Park, Chem. Commun. 2009, 7090; f) T. 
Marcelli, H. Hiemstra, Synthesis 2010, 1229. 
27 M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 4901. 
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(in non-polar solvents ureas often form aggregates which render difficult 
the catalysis).28 
Thioureas are known to be able to form cooperative hydrogen bonds not 
only with carbonyl compounds, but also with nitro groups and dicarbonyl 
compounds (Figure 1.9) and for this reason they have been employed in a 
variety of reactions. 26c, 29 
 
Figure 1.9 Different hydrogen bond patterns with different substrates. 
 
Based on the observation that hetero Diels-Alder reactions were 
accelerated in alcoholic solvents, Rawal’s group investigated the use of the 
TADDOL derivative 9 as promoter for the asymmetric version of the hetero 
Diels-Alder reaction (Scheme 1.11).30  
 
Scheme 1.11 Hetero Diels-Alder catalysed by the diol 9. 
 
                                                          
28 A. Berkessel, F. Cleemann, S. Mukherjee, T. N. Müller, J. Lex, Angew. Chem., Int. Ed. 
2005, 44, 807. 
29 a) S. J. Connon, Chem. Eur. J. 2006, 12, 5418; b) M. Kotke, P.R. Schreiner, (Thio)urea 
organocatalysts in Hydrogen bonding in organic synthesis, Wiley-VCH, Weinheim, 2009. 
30 Y. Huang, A. K. Unni, A. N. Thadani, V. H. Rawal, Nature 2003, 424, 146. 
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Different catalysts are able to activate the substrates via hydrogen 
bonding and many research groups have given their contributions 
exploiting chiral squaramides, thioureas derivatives, guanidinium, 
amidinium and many others.31 
Catalysts mentioned until now mainly work under general Brønsted acid 
catalysis, but when the catalyst pKa (in DMSO) decreases to <4 it is more 
appropriate to refer to specific Brønsted acid catalysis. 
Strong acidic catalysts have been recently developed and widely employed 
in the field of organocatalyzed reactions. In 2004, the groups of Akiyama 
and Terada independently disclosed that the BINOL derivative of 
phosphoric acid (10a) could promote a Mannich addition in quantitative 
yield and excellent enantioselectivity.32 Afterwards many different 
phosphoric acid derivatives have been designed,  with BINOL, TADDOL 
(11),33 VAPOL (12),34 and recently SPINOL (13) skeletons35 (Figure 1.10).  
Figure 1.10 Different phosphoric acid-based catalysts. 
 
                                                          
31 For some reviews, see: a) T. Akiyama, J. Itoh, K. Fuchibe, Adv. Synth. Cat. 2006, 348, 
999; b) A. G. Doyle, E. N. Jacobsen, Chem. Rev. 2007, 107, 5713; c) J. Alemán, A. Parra, 
H. Jiang, K. A. Jørgensen, Chem. Eur. J. 2011, 17, 6890. 
32 a) T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem., Int Ed. 2004, 43, 1566; b) 
D. Uraguchi, M. Terada, J. Am. Chem. Soc. 2004, 126, 5356. 
33 T. Akiyama, Y. Saitoh, H. Morita, K. Fuchibe, Adv. Synth. Catal. 2005, 347, 1523. 
34 G. B. Rowland, H. Zhang, E. B. Rowland, S. Chennamadhavuni, Y. Wang, J. C. Antilla, 
J. Am. Chem. Soc. 2005, 127, 15696. 
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These are only few examples of the wide class of strong Brønsted acid 
catalysts which include also phosphorodiamidic acids, phosphoramides, 
dicarboxylic acids.36 This class emerged as versatile ensemble of catalysts 
whose acidity can be finely modulated by choosing the active moieties and 
modifying substituents on the aromatic rings. They can promote several 
different asymmetric processes, among the others Mannich, Friedel Craft, 
cycloaddition, oxidation, Pictet-Spengler and reductive amination 
reactions.37  
 
1.4 Bifunctional organocatalysts 
 
Most of the reported organocatalysts incorporates two complementary 
functionalities able to synergistically activate the electrophile and the 
nucleophile.  
The formation of new bonds and the creation of new stereocenter(s) are 
fundamental issues to address in a asymmetric synthetic process.  The 
simultaneous activation of both the partners positioned in an opportune 
geometry is necessary to achieve a certain degree of stereocontrol.38 Both 
covalent and non covalent interactions can be responsible for the 
activation and the achievement of the optimized transition state. In the 
contest of the “non-covalent catalysis”, diaryl prolinols, cinchona alkaloids 
and their derivatives, such as thioureas, represent clear examples of 
bifunctionality (Figure 1.11). 
                                                          
36 For selected examples, see: a) M. Terada, K. Sorimachi, D. Uraguchi, Synlett 2006, 133; 
b) D. Nakashima, H. Yamamoto, J. Am. Chem. Soc. 2006, 128, 9626; c) T. Hashimoto, K. 
Maruoka, J. Am. Chem. Soc. 2007, 129, 10054. 
37 For reviews on strong chiral Brønsted acid catalysis, see: a) T. Akiyama, Chem. Rev. 
2007, 107, 5744; b) D. Kampen, C. M. Reisinger, B. List, Top. Curr. Chem. 2009, 291, 395; 
c) M. Terada, Synthesis 2010, 1929. 
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Figure 1.11 Concurrent activation of electrophile and nucleophile 
 
The amine moiety (secondary for the prolinols, tertiary for the cinchona 
alkaloids and the Takemoto catalyst) activates the nucleophile through 
(partial) deprotonation and possibly forming an ion pair while the 
hydrogen bond donor activates the electrophile. This double activation 
provides a ternary complex where the approach between the two reactants 
occurs in a highly preferential manner.24, 39  
 
1.5 Tandem Reactions 
 
Organocatalysts have been recently employed in tandem or domino 
reaction, a new field which allows to perform subsequent transformations 
in a single pot.40 The possibility to create in the reactants functionalities 
that in the same reaction environment can undergo to further 
modifications can be addressed to build complex molecular structures 
with a simple experimental procedure. Thus, multiple C-C and C-
                                                          
39 a) E. Marqués-López, R. P. Herrera, Current Organic Chemistry 2011, 15, 2311; b) A. 
Lattanzi, Chem. Commun. 2009, 1452; c) J.L. Zhu, Y. Zhang, C. Liu, A. Zheng, W. Wang, J. 
Org. Chem. 2012, 21, 9813; d) C. S. Cucinotta, M. Kosa, P. Melchiorre, A. Cavalli, F. L. 
Gervasio, Chem. Eur. J. 2009, 15, 7913. 
40 For some reviews, see: a) H. Guo, J. Ma, Angew. Chem., Int. Ed. 2006, 45, 354; b) A. 
Dondoni, A. Massi, Angew. Chem. Int. Ed. 2008, 47, 4638. 
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heteroatom bonds can be consecutively formed to give multifunctionalized 
products, often with several stereogenic centers. The new bonds can be 
formed in a single mechanistic cycle or can derive from different and 
independent catalytic cycles. Moreover the catalyst can be involved in the 
first transformation or can participate in all the reactions that occur in the 
pot. In this case, the complexity and the stereochemistry of the final 
product is dependent on each step where the catalyst operates.41 
Combinig more synthetic steps, while avoiding intermediate purifications 
and separations is a highly appealing strategy. The atom economy, the 
high efficiency, the reduced times and costs of cascade processes render 
them very advantageous also in the synthesis of natural products. 
Towards this direction stereocontrolled construction of carbon- or 
heterocycles with one or more fused rings has being developed.42   
In the young area of organocatalyzed cascade processes, covalent 
catalysis, based on enamine/iminium ion formation from primary or 
secondary amines as catalysts, is widely represented (Scheme 1.12, a).43  
In contrast, just few examples of non-covalent activation mode can be 
found, mostly involving chiral phosphoric acid,44 cinchona-based and 
Takemoto thioureas45 (Scheme 1.12, b). 
 
                                                          
41 For a clear review on the different types of one-pot reaction, see: N. Shindoh, Y. 
Takemoto, K. Takasu, Chem. Eur. J. 2009, 15, 12168. 
42 For a review on organocatalyzed cyclization reaction see: A. Moyano, R. Rios Chem.Rev. 
2011, 111, 4703. 
43 For selected examples, see: a) Y. Huang, A. M. Walji, C. H. Larsen, D. W. C. MacMillan, 
J. Am. Chem. Soc. 2005, 127, 15051; b) T. Urushima, D. Sakamoto, H. Ishikawa, Y. 
Hayashi, Org. Lett. 2010, 12, 4588; c) X. Wu,  L. Nie, H. Fang, J. Chen, W. Cao, G. Zhao, 
Eur. J. Org. Chem. 2011, 33, 6755.  
44 For selected examples, see: a) M. Rueping, A. P. Antonchick, T. Theissmann, Angew. 
Chem., Int. Ed. 2006, 45, 3683; b) M. Terada, K. Machioka, K. Sorimachi, J. Am. Chem. 
Soc. 2007, 129, 10336; c) M. Rueping, A. P. Antonchick, Angew. Chem., Int. Ed. 2008, 47, 
5836.  
45 For selected examples, see: a) Y.-K. Liu, H. Liu, W. Du, L. Yue, Y.-C. Chen, Chem. Eur. J. 








Scheme 1.12 Examples of covalent (a) and non-covalent (b) cascade 
organocatalyzed reactions.   
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1.6 Research Objectives 
 
Chiral bifunctional organocatalysts have a huge potential to promote, via 
non-covalent activation, a plethora of organic reactions for the 
construction of carbon-carbon and carbon-heteroatom bonds in a 
stereocontrolled fashion. Over the last years, we have assisted to an 
increasing number of novel transformations catalysed by these promoters 
coupled with the design of new chiral organocatalysts bearing more 
effective acid and basic groups. 
Among the different reactions available to study, the Michael addition 
reaction occupies a special place. It offers a great variety of combinations 
between Michael donors and acceptors to produce highly functionalised 
chiral molecules. Moreover, tandem processes can be exploited as in 
Michael initiated ring closure reactions (MIRC) to prepare important chiral 
cyclic compounds of different nature and sizes such as epoxides, 
cyclopropanes, aziridines and more. 
The main target of this present doctoral work is to develop novel 
stereoselective methodologies in the area of Michael type reactions and in 
MIRC approaches by using easily available bifunctional organocatalysts. 
First of all, commercially available promoters based on classical scaffolds 
such as L-proline, cinchona alkaloids, amino thioureas will be checked in 
some selected processes. The synthesis of modified bifunctional 
organocatalysts is also envisaged by tuning the stereoelectronic features 
or modifying the chiral backbone and eventually the basic and acidic sites 
involved in the catalysis. Another goal of the study is working on further 
derivatization of the chiral products obtained in the asymmetric processes 
to demonstrate their potential synthetic applications. Finally, being 
relatively few the reports on the detailed mechanism of the organocatalytic 
reactions, efforts into clarification of the pathway will be carried out by the 
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aid of spectroscopic detection or characterization of intermediates and by 
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The asymmetric synthesis of epoxides is an important goal, gaining 
attention by many scientists in the last decades.46 The asymmetric 
epoxidation reaction has been intensively investigated due to the 
importance of epoxides as compounds of biological and pharmaceutical 
interest. Moreover they are desirable targets in organic chemistry because 
of their high synthetic potential as intermediates and precursors of a wide 
range of chiral compounds. The asymmetric epoxidation and the further 
epoxide manipulation frequently constitute the key steps of natural 
products total synthesis such as (+)-scuteflorin and polyrhacitide A, a 
polyol obtained through iterative epoxidation, or more recently in the 
synthesis of heronapyrrole C.47  
Optically active epoxides can be accessed through a variety of reactions 
such as the epoxidation of olefins, alkylidenation of carbonyl compounds 
by ylides, Darzens condensation and they can also be regio- and 
stereoselectively opened with different carbon and heteroatom based 
nucleophiles to furnish a great variety of functionalised derivatives.48   
The importance of the epoxidation reaction is demonstrated by the Nobel 
prize awarded to Sharpless for his contribution in this area, with the 
asymmetric epoxidation of allylic alcohols mediated by titanium/tartrate 
                                                          
46 For some reviews on the asymmetric epoxidation, see: a) J. E. Bäckvall, Modern 
Oxidation Methods, Wiley-VCH, Weinheim, 2004; b) Q.H. Xia, H.Q. Ge, C.P. Ye, Z.M. Liu, 
K.X. Su, Chem. Rev. 2005, 105, 1603; c) O. A. Wong, Y. Shi Chem. Rev. 2008, 108, 3958; 
d) K. M. Weiß, S. B. Tsogoeva, The Chemical Record 2011, 11, 18. 
47 a) C. J. Bartlett, D. P. Day, Y. Chan, S. M. Allin, M. J. McKenzie, A. M. Z. Slawin, P.C. B. 
Page J. Org. Chem 2012, 77, 772; b) G. Kumaraswamy, A. N. Murthy, K. Sadaiah 
Tetrahedron 2012, 68, 3179; c) J. Schmidt, C. B. W. Stark Org. Lett. 2012, 14, 4042. 
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system and with tert-butyl hydroperoxide (TBHP) as the oxygen source 
(Scheme 2.1 a).49 Several metal-based asymmetric epoxidation reactions 
have been successively developed, the Jacobsen and Katsuki’s epoxidation 
of unfunctionalized alkenes with Mn-Salen complexes represents just one 
of the most relevant examples (Scheme 2.1 b).50 
 
Scheme 2.1 Early stages of the metal-based asymmetric epoxidation of 
alkenes. 
 
Among the structurally different accessible epoxides, epoxy carbonyl 
derivatives are an important class of versatile compounds, due to the 
possible transformations of the epoxide and carbonyl moieties. Indeed, 
carbonyl compounds and the epoxide ring can be selectively manipulated 
leading to a wide variety of optically active compounds possibly containing 
polyoxygenated groups, such as allylic epoxy alcohols, - or - hydroxyl 
ketones, ,-epoxy esters.51 
 
                                                          
49 a) Y. Gao, R. M. Hanson, J. M. Klunder, S. Y. Ko, H. Masamune, K. B. Sharpless, J. Am. 
Chem. Soc. 1987, 109, 5765; b) K. B. Sharpless, Angew. Chem., Int. Ed. 2002, 41, 2024. 
50 a) W. Zhang, J. L. Loebach, S. R. Wilson, E. N. Jacobsen, J. Am. Chem. Soc. 1990, 112, 
2801; b) R. Irie, K. Noda, Y. Ito, N. Matsumoto, T. Katsuki, Tetrahedron Lett. 1990, 31, 
7345; c) R. Irie, K. Noda, Y. Ito, T. Katsuki, Tetrahedron Lett. 1991, 32, 1055. 
51 C. Lauret, Tetrahedron: Asymmetry 2001, 12, 2359. 
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2.1.1 Weitz-Scheffer Metal-Catalysed Epoxidation 
The epoxidation of ,-unsaturated carbonyl compounds and more 
generally the epoxidation of electron-poor olefins follows the mechanism 
proposed by Weitz and Scheffer in 1921 for the epoxidation of the ,-
unsaturated ketone 15 with basic hydrogen peroxide under basic 
conditions (Scheme 2.2).52  
 
Scheme 2.2 Proposed mechanism for the Weitz-Scheffer epoxidation 
 
It involves a conjugate addition of the hydroperoxide anion to substrate 15 
forming the-peroxyenolate intermediate F. The following intramolecular 
ring closure with the elimination of the hydroxyl group allows the epoxy 
ketone 16 to be formed. This mechanism is different from the concerted 
addition of a peracid, such as m-CPBA, to simple olefins since, in contrast 
with the concerted addition, the Weitz-Scheffer reaction is not 
stereospecific. Indeed a trans/cis mixture of isomers can be found, proving 
the existence of intermediate F where rotation around the C-C bond, 
before the ring-closure, can occur. 
Although its lack of stereospecificity, this reaction has been exploited in 
several asymmetric variants, where both the diastereo- and the 
enantioselectivity issues were addressed, relying on the activation of the 
substrate and/or the peroxide reagent by the catalyst. 
The metal-catalysed asymmetric epoxidation of electron-poor alkenes has 
been widely investigated and a number of methodologies have been 
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developed from the 90s up to now. The most relevant based on Lewis acid-
chiral ligand systems are summarized in Figure 2.1.53  
 
Figure 2.1 Typical Lewis acids with chiral ligands employed in the Weitz-
Scheffer epoxidation. 
 
They include zinc-aminoalcohol complexes with molecular oxygen as the 
oxidant firstly reported by Enders (a), magnesium-L-diethyl tartrate 
complexes investigated by Jackson (b), 1,1’‐bi‐naphthol (BINOL) used as 
ligand both for zinc (c), as investigated by Dötz, and lanthanum systems 
developed by Shibasaki (d, e). Another variant as the gallium-BINOL 
system was reported, while the supported-BINOL ligands are employed 
with ytterbium and lanthanum complexes.54 Challenging epoxidation 
reactions of poorly electrophilic ,-unsaturated amides and esters has 
                                                          
53 a) D. Enders, J. Zhu, G. Raabe, Angew. Chem., Int. Ed. 1996, 35, 1725; b) C. L. Elston, 
R. F. W. Jackson, S. J. F. MacDonald, P. J. Murray, Angew. Chem., Int. Ed. 1997, 36, 410; 
c) A. Minatti, K. H. Dötz, Synlett 2004, 1634; d) M. Bougauchi, S. Watanabe, T. Arai, H. 
Sasai, M. Shibasaki, J. Am. Chem. Soc. 1997, 119, 2329; e) T. Nemoto, H. Kakei, V. 
Ganadesikan, S.-Y. Tosaki, T. Ohshima, M. Shibasaki, J. Am. Chem. Soc. 2001, 123, 2725.  
54 a) R. Chen, C. Qian, J. G. de Vries, Tetrahedron 2001, 57, 9837; b) D. Jayaprakash, Y. 
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been developed by using modified BINOL-samarium or other yttrium 
complexes.55 
 
2.1.2 Organocatalyzed Epoxidation of ,-Unsaturated Carbonyl 
Compounds 
Among the first examples of metal-free methods, the epoxidation of 
unsaturated carbonyl compounds under phase transfer catalysis (PTC) 
was introduced by Wynberg in the 70s and afterwards widely investigated. 
The most representative results obtained with PTC are summarized in 
Scheme 2.3. Wynberg pioneered the use of quaternary ammonium salt 17 
derived from cinchona alkaloids using hydrogen peroxide, alkyl 




                                                          
55 a) T. Nemoto, H. Kakei, V. Gnanadesikan, S. Tosaki, T. Ohshima, M. Shibasaki, J. Am. 
Chem. Soc. 2002, 124, 14544; b) H. Kakei, R. Tsuji, T. Ohshima, M. Shibasaki, J. Am. 
Chem. Soc. 2005, 127, 8962. 
56 a) R. Helder, J. C. Hummelen, R. W. P. M. Laane, J. S. Wiering H. Wynberg, Tetrahedron 
Lett. 1976, 17, 1831; b) H. Wynberg, B. Greijdanus, J. Chem. Soc. Chem Commun. 1978, 
427; c) H. Wynberg, B. Marsman, J. Org. Chem. 1980, 45, 158; d) H. Plium, H. Wynberg, J. 
Org. Chem. 1980, 45, 2498. 
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Scheme 2.3 PTC in the asymmetric epoxidation of ,-unsaturated 
carbonyl compounds. 
 
Highly effective catalysts were developed during the last years including 
hindered derivatives of quaternized cinchona alkaloids (e.g. the 
anthracenyl derivative 18),57 the dimeric species 19,58 and the recently 
investigated axially chiral quaternary spiro ammonium salt 20 reported by 
Maruoka.59  
Chiral crown ethers and guanidinium/urea systems, such as derivative 
21 (figure 2.2, a) and C2-symmetric guanidinium salt 22 (figure 2.2, b),60  
have been investigated as efficient PTC promoters in the asymmetric 
epoxidation of ,-unsaturated carbonyl compounds.61 
                                                          
57 a) B. Lygo, P. G. Wainwright, Tetrahedron Lett. 1998, 39, 1599; b) E. J. Corey, F.-Y. 
Zhang, Org. Lett. 1999, 1, 1287. 
58 S. Jew, J.H. Lee, B.S. Jeong, M.S. Yoo, M.J. Kim, Y.J. Lee, J. Lee, S.H. Choi, K. Lee, M.S. 
Lah, H.G. Park, Angew. Chem. Int. Ed. 2005, 44, 1383. 
59 T. Ooi, D. Ohara, M. Tamura, K. Maruoka, J. Am. Chem. Soc. 2004, 126, 6844. 
60 M. T. Allingham, A. Howard-Jones, P. J. Murphy, D. A. Thomas, P. W. R. Caulkett, 
Tetrahedron Lett. 2003, 44, 8677. 
61 a) P. Bakó, T. Bakó, A. Mészáros, G. Keglevich, À. Szöllösy, S. Bodor, A. Makó, L. Töke, 
Synlett 2004, 643; b) K. Hori, M. Tamura, K. Tani, N. Nishiwaki, M. Ariga Y. Tohda, 
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Figure 2.2 Different guanidine catalysts employed in the asymmetric 
epoxidation of unsaturated ketones. 
 
Strong bases such as guanidine containing compounds have been also 
applied in the asymmetric epoxidation of ,-unsaturated ketones  with 
different hydroperoxides as the oxygen source, although inferior level of 
enantiocontrol was achieved. Compound 23 (figure 2.2, c)62 and the 
binaphthyl derivative 24 (figure 2.2, d)63 are the most representative 
examples.  
                                                          
62 T. Ishikawa, T. Isobe, Chem. Eur. J. 2002, 8, 552. 
63 M. Terada, M. Nakano, Heterocycles 2008, 76, 1049. 
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In the 80s Juliá and Colonna disclosed polyamino acids as catalysts for 
the asymmetric epoxidation of enones.64 Poly-L-Alanine (PLA) and Poly-L-
Leucine (PLL) provided good level of asymmetric induction when used in 
basic aqueous medium and with hydrogen peroxide as oxidant at room 
temperature (Scheme 2.4). The optimum efficiency was achieved with the 
optimized number of 30 amino acids in the chain. Subsequently modified 
versions of this system and the mechanism of the reaction have been 
investigated.46d, 65  
 
Scheme 2.4 Asymmetric epoxidation of enones promoted by poly amino 
acids. 
 
Recently rather challenging aliphatic enones and enals were converted 
into the corresponding epoxides by chincona derived primary amine 
catalysts exploiting a covalent regime. 
Cyclic enones were successfully epoxidized with the primary amine 5 or 
exploiting the ACDC tool (Asymmetric Counteranion Directed Catalysis) by 
means of the salt formed by diamine 6 and chiral phosphoric acid TRIP 
10b (Scheme 2.5).66 
                                                          
64 a) S. Juliá, J. Masana, J. C. Vega, Angew. Chem., Int. Ed. 1980, 19, 929; b) S. Juliá, J. 
Guixer, J. Masana, J. Rocas, S. Colonna, R. Annunziata, H. Molinari, J. Chem. Soc., Perkin 
Trans. 1 1982, 1317. 
65 a) S. Juliá, J. Masana, J. C. Vega, Angew. Chem., Int. Ed. 1980, 19, 929; b) S. Juliá, J. 
Guixer, J. Masana, J. Rocas, S. Colonna, R. Annunziata, H. Molinari, J. Chem. Soc., Perkin 
Trans. 1 1982, 1317. 
66 a) X. Wang, C. M. Reisinger, B. List, J. Am. Chem. Soc.,  2008, 130, 6070; b) A. Lee, C. 
M. Reisinger, B. List, Adv. Synth. Catal. 2012, 354, 1701. 
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Scheme 2.5 Asymmetric epoxidation of cyclic enones  
 
Moreover, List and co-workers developed a method based on  5/TFA/H2O2 
system which converted aliphatic acyclic ketones into peroxyhemiketals 
(Scheme 2.6).67  A basic treatment furnished the corresponding epoxides 
up to 99% ee. 
 
Scheme 2.6 Covalent catalysis in the asymmetric epoxidation of aliphatic 
enones. 
The issue concerning the organocatalytic asymmetric epoxidation of ,-
unsaturated aldehydes was faced only recently by Jørgensen and 
                                                          
67 C. M. Reisinger, X. Wang, B. List, Angew. Chem., Int. Ed.,  2008, 47, 8112. 
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coworkers. In 2005 they demonstrated that the O-TMS protected diaryl 
pyrrolidinemethanol derivative 25a furnished the corresponding epoxy 
aldehydes in good diastereoseletivity and high enantiocontrol using H2O2 
in dichloromethane at room temperature (Scheme 2.7, a).68 Córdova and 
co-workers exploited a similar approach using the O-silylated diphenyl 
prolinol 25b (Scheme 2.7, b).69 Instead MacMillan’s group performed the 
reaction with the imidazolidinone salt 26 and iodosobenzene as oxidant 
generated in situ from the reaction between [(N-Nosylimino)iodo]benzene 
(PhI=NNs) and acetic acid (Scheme 2.7, c).70 The fluoro derivative 27 
reported by Gilmour and co-workers proved to be an effective catalyst in 
the epoxidation of ,-unsaturated aldehyde with H2O2 as the oxidant 
(Scheme 2.7, d).71 
 
 
Scheme 2.7 Asymmetric epoxidation of enals by catalysts 25a, 25b, 26 
and 27. 
 
                                                          
68 M. Marigo, G. Franzén, T. B. Poulsen, W. Zhuang, K. A. Jørgensen, J. Am. Chem. Soc. 
2005, 127, 6964. 
69 (a) H. Sundén, I. Ibrahem, A. Córdova, Tetrahedron Lett. 2006, 47, 99; (b) G. L. Zhao, I. 
Ibrahem, H. Sundén, A. Córdova, Adv. Synth. Catal. 2007, 349, 1210. 
70 S. Lee, D. W. C. MacMillan, Tetrahedron 2006, 62, 11413. 
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Recently, the asymmetric epoxidation of disactivated terminal olefins to 
terminal epoxides has been developed by using for the first time cinchona 
alkaloid based thioureas as promoters with TBHP as the oxidant. The 
corresponding synthetically useful epoxides, bearing a quaternary 
stereocenter, were obtained with excellent yield and enantioselectivity  
(Scheme 2.8).72 
 
Scheme 2.8 Asymmetric epoxidation of disubstituted terminal olefins 
promoted by cinchona alkaloid thioureas. 
 
2.1.3 Diaryl Prolinol Catalysed Epoxidation  
In 2005, Lattanzi disclosed that easily accessible diaryl prolinols could 
catalyse the asymmetric epoxidation of ,-unsaturated carbonyl 
compounds at 30 mol% loading with TBHP as oxidant in hexane as 
solvent.73 The commercially available diphenyl pyrrolidinemethanol 29a 
furnished the corresponding epoxy ketones with up to 80% ee (Scheme 
2.9, a). Further studies demonstrated that electron-donating groups in the 
aromatic ring of promoters 29b and 29c were beneficial for the catalyst 
activity as attested by the higher yield and enantioselectivity of the 
                                                          
72 A. Russo, G. Galdi, G. Croce, A. Lattanzi, Chem. Eur. J. 2012, 18, 6152. 
73 A. Lattanzi, Org. Lett. 2005, 7, 2579. 
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epoxides achieved when working with reduced catalyst loading (Scheme 
2.9, b and c).74 
 
Scheme 2.9 Asymmetric epoxidation of enones by diarylprolinols. 
 
Trisubstituted electron-poor olefins were also investigated as substrates 
for the epoxidation reaction mediated by diarylprolinols, such as the 
acyclic and cyclic 2-arylidene-1,3-diketones, obtaining the epoxides with 






                                                          
74 a) A. Lattanzi, Adv. Synth. Catal. 2006, 348, 339; b) A. Lattanzi, A. Russo, Tetrahedron 
2006, 62, 12264. 








Scheme 2.10 Asymmetric epoxidation of some trisubstituted electron-
poor olefins. 
 
The mechanism of the nucleophilic epoxidation of simple enones was 
recently investigated by DFT calculations. From an experimental point of 
view, the catalytic activity dramatically decreased when passing from 
hexane to polar and protic solvents. Furthermore, the presence of acidic 
co-catalysts, which are known to increase the reaction rate when iminium 
or enamine intermediates are formed, prevented the reaction to occur. A 
non-covalent mechanism, where the catalyst activates the reagents under 
general acid and base catalysis was then suggested. Two energetically 
similar pathways (red and blue in figure 2.3) were calculated with L-
diphenyl prolinol 29a and a trans-enone. They show similar features and 
energetics only differing in the hydrogen bonding coordination pattern of 
the reagents with the organocatalyst. 
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Figure 2.3 Two possible pathways for the asymmetric epoxidation of 
enones by diphenyl prolinol 29a. 
 
The ternary complexes evolve via an oxa-Michael addition into the adduct. 
This process was found to be the rate- and stereoselectivity determining-
step. Ring closure of the peroxy adduct was calculated to proceed almost 
without energetic barrier. This fast ring closure is in agreement with 
complete control of the diastereoselectivity, as experimentally observed. 
The most energetically affordable transition state for the oxa-Michael 
addition would lead, after ring-closure, to the 2R,3S-configured epoxide as 
the preferentially formed epoxide, in line with the experimental data.  
The feasibility of the non-covalent pathway would be also supported by 
calculations on the binary hydrogen-bonded complex G and the first 
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intermediate along the covalent pathway such as the hemiaminal H, 
which was found to be 14 kcal/mol higher in energy (Figure 2.4).76 
 
Figure 2.4 Non-covalent binary complex vs hemiaminal.  
     
Other groups reported modified diaryl pyrrolidinemethanol derivatives, 
such as the 4-O-benzyl derivative 30 and catalyst 31 with an alkyl 
fluorinated chain as substituent on the aromatic ring. They were used in 
the asymmetric epoxidation of enones furnishing the epoxides in some 
examples with slightly improved enantioselectivity (Scheme 2.11).77  
 
Scheme 2.11 Two structurally similar catalysts for the asymmetric 
epoxidation of enones.  
   
                                                          
76 A. Capobianco, A. Russo, A. Lattanzi, A. Peluso, Adv. Synth. Cat 2012, 354, 2789. 
77 a) Y. Li, X. Liu, Y. Yang, G. Zhao, J. Org. Chem. 2007, 72, 288; b) H. Cui, Y. Li, C. Zheng, 
G. Zhao, S. Zhu, J. Fluor. Chem. 2008, 129, 45. 
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2.2 Results and Discussion78 
 
Although the asymmetric epoxidation is a very well-studied reaction, 
organocatalytic epoxidation of trisubstituted electron-poor olefins has 
been poorly explored. The introduction of a cyano group as a substituent 
on the alkene seemed to us particularly appealing owing to the possibility 
of obtaining diversely functionalized epoxides containing groups amenable 
to further transformations. Moreover, an ever-increasing number of 
nitrile-containing compounds can be found in natural products and 
pharmaceutically active species.79 
Ethyl -cyanophenylacrylate 32 was initially chosen as model substrate 
for the optimization of the epoxidation reaction with diarylprolinols as 
catalysts (Table 2.1). In the previously optimized conditions, catalysts 29b 
and 29e and TBHP as oxidant, the reaction proceeded smoothly with 
complete control of the diastereoselectivity, although epoxide 33 was 
isolated with only 23 and 16 % ee (entries 1 and 2). The use of more 
sterically demanding cumene hydroperoxide (CHP) as oxygen source 






                                                          
78 The results presented in this chapter are partially reported in the paper: C. De Fusco, C. 
Tedesco, A. Lattanzi, J. Org. Chem. 2011, 76, 676, 
79 a) T. Nagasawa, H. Yamada, Pure Appl. Chem. 1990, 62, 1441; b) F.F. Fleming, Nat. 
Prod. Rep. 1999, 597; c) V. J. Kukushkin, A. J. L. Pombeiro, Inorg. Chim. Acta, 2005, 358, 
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Table 2.1 Initial screening of the reaction conditions using model 
compound 32.a  
 
 
Entry Cat. t (h) yield (%)b ee (%)c 
1 29b  19 99 23 
2 29e  45 99 16 
3d 29b  68 12 37 
a Unless otherwise noted, reactions were carried with 32 (0.1 mmol), 
TBHP (1.2 equiv), 29 (30 mol%) in 0.5 mL of solvent. b Isolated yield 
after flash chromatography. c Determined by HPLC analysis on a 
chiral stationary phase. d CHP as the oxidant.   
 
Since compound 32 was found not to be a promising substrate for the 
reaction, 2-benzoyl-3-phenyl-acrylonitrile 34a was then tested. 
Differently substituted diarylprolinols were screened as catalysts in the 
epoxidation reaction of 2-benzoyl-3-phenyl-acrylonitrile 34a with TBHP as 
the oxygen source in methylcyclohexane at room temperature. As 
summarized in Table 2.2, all catalysts could smoothly promote the 
reaction to give product 35a as a single diastereoisomer, as judged by the 
1H-NMR of the crude mixture, in quantitative yield in most of the cases. As 
expected, the enantioselectivity was strongly influenced by the 
substituents on the aromatic rings of the catalysts. The ,-diphenyl 
prolinol 29a afforded the product with poor ee value (entry 1). The 
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dimethyl substituted diaryl prolinol 29b was confirmed to be the best 
catalyst in terms of reactivity and asymmetric induction, furnishing the 
product in 56 % ee (entry 2).  
Table 2.2. Screening of the catalysts in the asymmetric epoxidation of the 
model substrate 34a.a 
 
 
Entry cat t (h) yield (%)b ee (%)c 
1 29a 3 99 21 
2 29b 3 94 56 
3 29d 6 88 43 
4 29e 3 97 48 
5 29f 3 99 36 
6 36 4 99 2 
7 25b 4 99 rac 
a Unless otherwise noted, reactions were carried with 34a (0.1 mmol), TBHP 
(1.2 equiv), cat (30 mol%) in 0.5 mL of solvent. b Isolated yield. c Determined 
by HPLC analysis on a chiral stationary phase.  
 
The para-substituted derivatives 29d and 29f and the naphthyl derivative 
29e furnished the product in moderate enantioselectivity (entries 3-5), 
ASYMMETRIC EPOXIDATION 
 
- 42 - 
 
whereas the bicyclic derivative 36 proved to be completely unselective 
(entry 6). In order to prove that the hydroxyl group of the catalyst was 
fundamental for the reaction to proceed in a stereocontrolled fashion, the 
Hayashi-Jørgensen catalyst 25b was tested and the epoxide was isolated 
in quantitative yield although in racemic form (entry 7). 
A solvent screening was then performed with catalyst 29b (Table 2.3). 
Table 2.3 Solvent screening.a 
 
entry Solvent t (h) yield (%)b ee (%)c 
1 Hexane 3 99 54 
2 CHCl3 6 96 48 
3 Toluene 3 99 57 
4 ClC6H5 3 99 60 
5 CF3C6H5 3 99 58 
6 p-xylene 3 97 63 
7 m-xylene 3 99 64 
aUnless otherwise noted, reactions were carried with 34a (0.1 
mmol), TBHP (1.2 equiv), 29b (30 mol%) in 0.5 mL of solvent. 
bIsolated yield. cDetermined by HPLC analysis.  
 
The epoxide was always isolated in quantitative yield and, as expected for 
a non-covalent activation mode, non-polar solvents guaranteed higher 
enantioselectivity. Xylenes were found to be the best media (entries 6 and 
7) and m-xylene was chosen for further optimization studies.  
Other parameters were examined to optimise the reaction conditions as 
shown in Table 2.4. 
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Table 2.4 Optimization of reaction parameters.a  
 
entry T Conc. 
(M) 
29b 
(mol %)  
t (h) yield 
(%)b 
ee (%)c 
1d rt 0.2  30  17 69 47 
2 rt 0.1 30  5 99 63 
3 -20 °C 0.1 10  20 90 77 
4 -20 °C 0.05  10  18 99 78 
5 -20 °C 0.05 5  18 88 71 
6 -25 °C 0.05 10 24 99 76 
7 -30 °C 0.2 20 48 99 74 
8e -60 °C 0.2 10  60 99 73 
aUnless otherwise noted, reactions were carried with 34a (0.1 mmol), TBHP 
(1.2 equiv), 29b (30 mol%) solvent (0.5 mL). bIsolated yield after flash 
chromatography. cDetermined by HPLC analysis on a chiral stationary 
phase. dCHP employed as the oxidant. eThe reaction medium was a mixture 
of toluene/m-xylene 1/3. 
 
Cumene hydroperoxide (CHP) proved to be a poor alternative to TBHP  in 
terms of yield and enantioselectivity (entry 1). The reaction carried out 
under more diluted conditions did not improve the performance of the 
catalyst at room temperature (entry 2) but, pleasingly, the reaction 
performed at -20°C with reduced catalyst loading (10 mol%) and at 0.1 or 
0.05 M concentration, led to the formation of epoxide 35a in excellent 
yield and up to 78% ee (entries 3 and 4). Decreasing the catalyst amount 
to 5 mol% under similar conditions slightly affected the efficiency of the 
process (entry 5).  
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A small drop in the enantioselectivity was observed when working at -25° 
and -30°C, even increasing the catalyst loading and the concentration 
(entries 6-7). An experiment performed at -60 °C with a mixture of toluene 
and m-xylene allowed to obtain the product in quantitative yield but only 
in 73% ee (entry 8). 
Under the optimized conditions, the scope of the reaction of trans--
carbonyl--substituted acrylonitriles, easily synthesized via Knoevenagel 
condensation,80 was investigated. In all the examples, the trans-epoxide 
was formed exclusively in high to excellent yield and good enantiocontrol 
with both electron-rich and electron-poor phenyl substituted derivatives 
(Table 2.5).  
The ortho-substitution had a detrimental effect on the stereoselectivity 
(entry 3), while the introduction of a naphthyl ring led to the product 35f 
with 77% ee (entry 6). The heteroaromatic and trans-cinnamyl alkenes 
34g and 34h afforded the products in 81 and 84 % ee, respectively 
(entries 7 and 8). Alkenes bearing a -alkyl group such as compound 34l 
were epoxidized with lower enantiocontrol (entry 12). Interestingly, the -








                                                          
80 J. S. Yadav, B.V. Subba Reddy, A. K. Basak, B. Visali, A.V. Narsaiah, K. Nagaiah, Eur. J. 
Org. Chem. 2004, 546.  
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Table 2.5 Substrate scope of the epoxidation of trans--carbonyl--
substituted acrylonitriles. 
 
Entry Ar Ar’ 35 Yield(%)b ee (%)c 
1 Ph Ph a 99 (70) 78 (94) 
2 Ph 4-tBuC6H4 b 92 73 
3 Ph 2-CH3C6H4 c 77 57 
4 Ph 4-BrC6H4 d 99 (67) 76 (99) 
5 Ph 4-CNC6H4 e 99 70 
6 Ph 2-naphthyl f 96 77 
7 Ph 3-furyl g 99 81 
8 Ph trans-cinnamyl h 78 84 
9 3-ClC6H4 Ph i 99 73 
10 4-CH3OC6H4 Ph j 99 (60) 79 (>99) 
11 4-CH3OC6H4 4-BrC6H4 k 99 79 
12 Ph Cyclohexyl l 95 48 
13 Me Ph m 90 83 
a Conditions: 34 (0.2 mmol), TBHP (1.2 equiv), 29b (10 mol%) m-xylene (4 mL). 
b Isolated yield after flash chromatography; in parenthesis yield after 
crystallization. c Determined by HPLC analysis on a chiral stationary phase; in 
parenthesis ee after crystallization. 
 
A single crystallization performed by using hexane/isopropanol mixture 
allowed to obtain epoxides up to 99% ee. X-ray analysis performed on a 
single crystal of the bromo-derivative 35d led to the determination of the 
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absolute configuration as 2R,3S (Figure 2.5). The absolute configuration 
for all other compounds 35 was assigned by analogy. 
 
Figure 2.5 Crystallographic structure of the bromo derivative 35d 
determined by X-ray analysis. 
 
The stereochemical outcome of the reaction is consistent with that 
previously observed in the epoxidation of trans-disubstituted-,-enones 
mediated by the same system and supported by DFT calculations. 74,76 The 
proposed transition state for the oxa- Michael addition step of TBHP to 
trans--benzoyl--aryl-acrylonitriles promoted by the diaryl prolinol 29b is 
depicted in Figure 2.6.  
 
Figure 2.6 Proposed transition state for the oxa-Michael addition step of 
the epoxidation of trans--benzoyl--aryl-acrylonitriles. 
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To demonstrate the synthetic utility of epoxides 35, reduction of the 
carbonyl moiety of epoxide 35a was studied in order to obtain the 
corresponding ,-epoxy alcohol 37. This is a challenging product, not 
easily accessible by using the alternative approach based on the 
asymmetric Sharpless epoxidation of the corresponding electron-poor 
allylic alcohol. Indeed, few examples are reported in which cyano allylic 
alcohols have been epoxidized employing the system Ti(OiPr)4/(L)-
DET/TBHP under stoichiometric conditions.81 
Different reducing agents afforded the product with variable level of 
diastereoselectivity (Table 2.6). 
Table 2.6 Screening of the reducing agents.a 
 
entry reducing agent T (°C) t (min) drb 
1c NaBH4 0 40 1.5:1 
2 K-selectride -30 90 2.5:1 
3 K-selectride -78 90 4.5:1 
4 L-selectride -78 60 5.5:1 
5 DIBAL -78 24 h 3.5:1d 
a Unless otherwise noted, reactions were performed with 35a (0.1mmol) 
and the reducing agent (0.1 mmol) in dry THF (0.05M) at -78 °C. The 
data are given for full conversion monitored by TLC. b determined via 1H-
NMR analysis on the crude mixture. c reaction performed in Et2O/MeOH 
1:3 as solvent mixture. d low conversion. 
 
As expected less sterically demanding NaBH4 provided the product in low 
diastereocontrol (entry 1). A slight improvement of the diastereoisomeric 
                                                          
81 M. Aiai, A. Robert, M. Baudy-Floc’h, P. Le Grel, Tetrahedron: Asymmetry 1995, 6, 2249. 
ASYMMETRIC EPOXIDATION 
 
- 48 - 
 
ratio was achieved using K-selectride at -30 °C (entry 2). Decreasing the 
temperature to -78°C led to the product as a 4.5:1 isomeric mixture (entry 
3). Changing the counterion of the reducing agent from K+ to Li+ the 
product was isolated in 5.5/1 dr (entry 4). The reduction proceeded 
slugghishly when employing DIBAL (entry 5). The final reduction reaction 
was carried out with L-selectride in THF at -78 °C and the desired 
epoxyalcohol 37, containing three contiguous stereocentres, was obtained 
with 93% yield and good diastereoisomeric ratio (Scheme 2.12). 
 
Scheme 2.12 Diastereoseletive reduction of compound 35a. 
 
Both diastereoisomers were determined to have 99% ee. The anti-isomer 
was supposed to be preferentially obtained via a chelated cyclic transition 
state according to the Cram chelation model as previously reported in the 




The first stereoselective method for the epoxidation of trans--carbonyl--
substituted acrylonitriles has been developed by using the easily available 
diaryl prolinol/TBHP system. The functionalised epoxides, bearing two 
contiguous stereocentres, one being quaternary, were obtained in 
excellent yields, as a single diastereoisomer and up to 84% ee. 
Enantioselectivity up to 99% could be achieved by a single crystallization 
and the absolute configuration of epoxides was assigned by X-ray 
analysis. Reduction of the carbonyl group led to the desirable epoxy 
ASYMMETRIC EPOXIDATION 
 
- 49 - 
 




ASYMMETRIC NITRO-MICHAEL ADDITION 
 
- 50 - 
 
3. AN ASYMMETRIC NITRO MICHAEL ADDITION: A 




The Michael-type reaction is the conjugate addition of carbon or 
heteroatom based nucleophiles to electron-deficient olefins and it 
represents one of the most powerful strategies to form C-C and C-
heteroatom bonds. The impact of this reaction is evident by the huge 
number of examples in which it has been applied as strategic key-step in 
total synthesis.82 Asymmetric Michael and hetero-Michael reactions, 
promoted by a variety of organocatalysts, have been extensively exploit in 
one-step or multi-step reactions, creating stereogenic centres in 
compounds then possibly subjected to other transformations.83 Some 
carbon nucleophiles include -ketoesters, malonates, and -cyanoesters 
giving rise to products containing a highly useful 1,5-dioxygenated 
pattern, when using ,-unsaturated carbonyl compounds as the Michael 
acceptors. The first example of an organocatalytic Michael addition was 
performed by Långström and Bergson by using enantioenriched (57% ee) 
2-(hydroxymethyl)-quinuclidine which catalysed the reaction between -
                                                          
82 For selected examples, see: a) O. Andrey, A. Vidonne, A. Alexakis, Tetrahedron Letters 
2003, 44, 7901; b) P. Jakubec, D. M. Cockfield, D. J. Dixon, J. Am. Chem. Soc. 2009, 131, 
16632; c) H. Mitsunuma, M. Shibasaki, M. Kanai, S. Matsunaga, Angew. Chem., Int. Ed. 
2012, 51, 5217; d) K. L. Jensen, C. F. Weise, G. Dickmeiss, F. Morana, R. L. Davis, K. A. 
Jørgensen, Chem. Eur. J. 2012, 18, 11913; d) W. Zi, W. Xie, D. Ma, J. Am. Chem. Soc. 
2012, 134, 9126. 
83 For some general reviews on the asymmetric Michael reaction, see: a) M. P. Sibi, S. 
Manyem, Tetrahedron 2000, 56, 8033; b) N. Krause, A. Hoffmann-Roder, Synthesis 2001, 
171. For some reviews on organocatalyzed Michael addition, see: a) N. Yoshikawa, Chem. 
Rev. 2002, 102, 2187; b) J. Christoffers, A. Baro, Angew. Chem. Int. Ed. 2003, 42, 1688; c) 
J. L. Vicario, D. Badía, L. Carrillo, Synthesis 2007, 14, 2065; d) Catalytic Asymmetric 
Conjugate Reactions, ed. A. Córdova, Wiley-VCH, Weinheim, 2010.  
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ketoesters and -substituted acrolein furnishing an optically active 
compound (Scheme 3.1).84  
 
Scheme 3.1 First Michael addition, reported by Långström and Bergson. 
 
Given the large number of organocatalytic asymmetric Michael addition 
reactions reported, only some classes will afterwards be cited. 
 
3.1.1 Nitro-Michael Reaction 
One of the most studied Michael reactions is the addition of easily 
enolizable carbonyl compounds to nitroolefins, due to the high versatility 
of the nitro group in organic synthesis and the possibility to obtain 
enantioenriched, densely functionalized products (Scheme 3.2).85 
                                                          
84 B. Långström, G. Bergson, Acta Chem. Scand. 1973, 27, 3118. 
85 For general reviews on transformations of nitro functionality, see: a) A. G. M. Barrett, G. 
G. Graboski, Chem. Rev. 1986, 86, 751; b)  R. Ballini, A. Palmieri, P. Righi, Tetrahedron 
2007, 63, 12099; c) I. N. Ono, The Nitro Group in Organic Synthesis; Wiley-VCH, Weinheim, 
2001. 
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Scheme 3.2 Some examples of the transformations that the nitro group 
can undergo. 
 
A variety of nucleophiles was added to nitroolefins employing different 
organocatalysts, thus affording differently substituted nitroalkanes, as 
exemplified in Scheme 3.3.86 
 
Scheme 3.3 Generic scheme for the Michael addition to nitroalkenes 
 
Primary amine catalysts were employed in the nitro-Michael addition of 
ketones by Córdova and co-workers,87 and several pyrrolidine-derivatives, 
such as morpholinomethyl-pyrrolidine,88 pyrrolidine-pyridine89 or 
bipyrrolidine were also developed.90 Examples of amino thiourea 
                                                          
86 For some reviews on nitro-Michael addition, see: a) O. M. Berner, L. Tedeschi, D. Enders, 
Eur. J. Org. Chem. 2002, 1877; b) S. B. Tsogoeva, Eur. J. Org. Chem. 2007, 11, 1701; c) D. 
Roca-Lopez, D. Sadaba, I. Delso, R. P. Herrera, T. Tejero, P. Merino, Tetrahedron: 
Asymmetry 2010, 21, 2561. 
87
 Y. Xu, A. Córdova, Chem. Commun. 2006, 460. 
88 J. M. Betancort, C. F. Barbas, Org. Lett., 2001, 3, 3737. 
89 T. Ishii, S. Fujioka, Y. Sekiguchi, H. Kotsuki, J. Am. Chem. Soc. 2004, 126, 9558. 
90 O. Andrey, A. Alexakis, A. Tomassini, G. Bernardinelli, Adv. Synth. Catal. 2004, 346, 
1147. 
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derivatives can be found in the literature, installed on a BINOL scaffold,91 
on a cinchona alkaloid92 or on a cyclohexandiamine also known as 
Takemoto catalyst.93 Structural developments on the catalyst and reaction 
parameters for this process were intensively investigated. Barbas and co-
workers explored the possibility to perform the reaction in brine94 or chiral 
ionic-liquids were reported as effective organocatalysts.95 TMS-protected 
diphenyl prolinol 25b was employed by Hayashi and co-workers in the 
addition of acetaldehyde to different nitrostyrenes affording the products 
with good yield and high enantioselectivity.96  
In the past five years, many research groups studied the addition of cyclic 
-keto esters to nitroolefins using catalysts, such as amino thioureas, 
cinchona alkaloids and cinchona-based thioureas, imidazole derivatives 
and guanidines (Scheme 3.4).97  
                                                          
91 J. Wang, H. Li, W. Duan, L. Zu, W. Wang, Org. Lett., 2005, 7, 4713.  
92 J. Ye, D. J. Dixon, P. S. Hynes, Chem. Commun., 2005, 4481. 
93 T. Okino, Y. Hoashi, Y. Takemoto, J. Am. Chem. Soc., 2003, 125, 12672. 
94 N. Mase, K. Watanabe, H. Yoda, K. Takabe, F. Tanaka, C. F. Barbas, J. Am. Chem. Soc, 
2006, 128, 4966.  
95 S. Luo, X. Mi, L. Zhang, S. Liu, H. Xu, J.-P. Cheng, Angew. Chem., Int. Ed. 2006, 45, 
3093. 
96 Y. Hayashi, T. Itoh, M. Ohkubo, H. Ishikawa, Angew. Chem., Int. Ed., 2008, 47, 4722. 
97 a) H. Li, Y. Wang, L. Tang, F. Wu, X. Liu, C. Guo, B. M. Foxman, L. Deng, Angew. Chem. 
Int. Ed. 2005, 44, 105; b) Z. Zhang, X. Dong, D. Chen, C. Wang, Chem. Eur. J. 2008, 14, 
8780; c) X. Jiang, Y. Zhang, X. Liu, G. Zhang, L. Lai, L. Wu, J. Zhang, R. Wang, J. Org. 
Chem. 2009, 74, 5562; d) K. Murai, S. Fukushima, S. Hayashi, Y. Takahara, H. Fujioka, 
Org. Lett. 2010, 12, 964; e) Z. Yu, X. Liu, L. Zhou, L. Lin, X. Feng, Angew. Chem., Int. Ed. 
2009, 48, 5195. 
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Scheme 3.4 Addition of -ketoesters to nitroolefines promoted by different 
catalysts. 
 
In this contest, we became interested in studying the same reaction by 
using easily accessible or commercially available diaryl prolinols as 
catalysts. These bifunctional organocatalysts were found to be suitable 
catalyst for different Michael type and MIRC (Michael Initiated Ring 
Closure) reactions.98 According to the different carbon or oxygen-based 
nucleophiles and the Michael acceptor, epoxides, acyclic peroxides, 
                                                          
98 For a review on diaryl prolinols see: 39b 
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cyclopropanes, nitroalkanes and -substituted carbonyl compounds could 
be isolated with moderate to good enantiocontrol (Scheme 3.5).99 
 
Scheme 3.5 Michael addition reactions catalysed by diaryl prolinols. 
 
The authors suggested a non-covalent activation of the reagents provided 
by the secondary amine and the hydroxyl group of the diarylprolinol as 
general acid and base catalysis, which was in some examples99f supported 
by DFT calculations. 
The efficiency of a catalytic system is strongly dependent on the reaction 
medium, in particular when a non-covalent activation mode of the 
reagents is involved. Solvents able to preserve the network of non-covalent 
interactions established among the catalyst and the reagents (ion pairs 
and hydrogen bonding) are essential for the formation of conformationally 
rigid and more effective systems. Finding a systematic solvent effect or the 
individuation of a universal efficient solvent is unrealistic. Nevertheless, 
discovering and giving a rationale for solvent dependent enhancements on 
                                                          
99 a) A. Lattanzi, Tetrahedron: Asymmetry  2006, 17, 837; b) A. Russo, A. Lattanzi, Adv. 
Synth Cat. 2008, 350, 1991; c) A. Russo, A. Lattanzi, Synthesis 2009, 9, 1551; d) A. 
Russo, A. Lattanzi, Tetrahedron: Asymmetry 2010,  211155; e) A. Russo, S. Meninno, C. 
Tedesco, A. Lattanzi, Eur. J. Org. Chem. 2011, 5096; f) A. Russo, A. Capobianco, A. 
Perfetto, A. Lattanzi, A. Peluso, Eur. J. Org. Chem. 2011, 1922. 
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the reaction efficiency and stereoselectivity is a particularly important 
issue. Recently, some aromatic fluorinated solvents showed to positively 
affect the Ru-catalysed olefin metathesis in terms of rate enhancement 
and regiocontrol. In just one example the enantioselectivity was positively 
affected by the employment of the hexafluorobenzene.100 The origin of 
these effects was ascribed to - interactions between the solvent and the 
catalyst or direct fluorine-ruthenium interactions. 
 
3.2 Results and Discussion101 
 
A preliminary screening of commercially or easily available diaryl prolinols 
and derivatives as catalysts was carried out in the Michael addition of 
model -ketoester 39a to nitrostyrene 38a (Table 3.1). 
High yields, but only low to moderate diastereoselectivity and 
enantioselectivity for the major diastereoisomer were generally observed in 






                                                          
100 a) C. Samojlowicz, M. Bieniek, A. Zarecki, R. Kadyrov, K. Grela, Chem. Commun., 2008, 
6282; b) D. Rost, M. Porta, S. Gessler, S. Blechert, Tetrahedron Lett. 2008, 49, 5968; c) C. 
Samojlowicz, M. Bieniek, A. Pazio, A. Makal, K. Woźniak, A. Poater, L. Cavallo, J. Wójcik, 
K. Zdanowski, K. Grela, Chem. Eur. J. 2011, 17, 12981; d) C. Samojlowicz, E. Borré, M. 
Mauduit, K. Grela, Adv. Synth. Catal. 2011, 353, 1993; e) A. Grandbois, S. K. Collins, 
Chem. Eur. J. 2008, 14, 9323. 
101 The results presented in this chapter are partially reported in the paper: A. Lattanzi, C. 
De Fusco, A. Russo, A. Poater, L. Cavallo Chem. Commun. 2012, 48, 1650. 
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Entry cat. t (h) yield (%)b drc ee (M)d ee (m)d 
1 29a 18 91 3:1 28 54 
2 29b 16 80 4:1 12 50 
3 29d 32 95 5:1 6 38 
4 29e 17 >99 4.5:1 16 50 
5 29f 17 98 4:1 50 40 
6 36 55 87 3.5:1 60 42 
7 41 40 94 4.5:1 32 26 
8 42 3 99 4:1 4 14 
9 25b 36 - - - - 
a All reactions were performed at C 0.5 M in toluene at 0.2 mmol scale of 38a 
and 39a. b Yield of isolated product. c The diastereoisomeric ratio was 
determined by 1H NMR analysis on the crude reaction mixture. d Determined 
by HPLC analysis on a chiral stationary phase. 
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When employing the commercially available catalysts 29a, 29b and 29e 
the yields were good, but the enantioselectivity was only up to 30% ee for 
the major diastereoisomer (entries 1, 2 and 4). Lower stereoselectivity was 
observed with catalyst 29d (entry 3), whereas the product was obtained 
with promising 50% and 60 % ee, when using more hindered catalysts 29f 
and bicyclic derivative 36 (entries 5 and 6). NOBIN-prolinamide 41 could 
smoothly promote the reaction but without any improvement in the 
enantioselectivity (entry 7). Simple pyrrolidine methanol 42 led to a severe 
loss of stereoselectivity although the reactivity was preserved (entry 8). 
Interestingly, the Jørgensen-Hayashi catalyst 25b showed to be 
completely inactive, possibly due to the sterically hindered structure and 
the absence of the free OH group (entry 9). 
In order to improve the level of stereocontrol, a solvent screening using 
diphenyl prolinol 29a was then carried out (Table 3.2). 
All the solvents afforded the product in almost quantitative yield. Aromatic 
and/or apolar solvents such as benzene, chlorobenzene, m-xylene and n-
hexane were found to be similar to toluene in terms of stereocontrol 
(entries 1-5). Chloroform and acetonitrile proved to be unsuccessful 
(entries 6 and 7), whereas moving to ethereal solvents (THF, diethyl and 
di-n-butyl ether) a remarkable effect was noted since an improved 
enantioselectivity was found (entries 8-10). A surprising enhancement of 
diastereo- and enantioselectivity was observed when employing 
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Table 3.2 Solvent Optimization Study.a 
 
Entry Solvent t (h) yield (%)b drc ee (M)d ee (m)d 
1 Toluene 18 91 3:1 28 54 
2 Benzene 16 85 3:1 32 50 
3 m-xylene 24 95 4:1 24 54 
4 Cl-C6H5 25 92 4:1 28 51 
5 n-hexane 7 >99 4:1 32 26 
6 CHCl3 18 99 3:1 20 52 
7 CH3CN 16 98 5:1 14 10 
8 THF 23 85 5:1 54 30 
9 Et2O 16 97 4.5:1 58 40 
10 nBu2O 16 89 5:1 64 34 
11 C6F6 19 98 7:1 62 26 
12 CF3C6H5 16 98 5:1 52 28 
a All reactions were performed at C 0.5 M at 0.2 mmol scale of 38a and 39a 
and 30% mol of 29a. b Yield of isolated product. c The diastereoisomeric ratio 
was determined by 1H NMR analysis of the crude reaction mixture. d 
Determined by HPLC analysis on a chiral stationary phase. (M = major 
diastereoisomer, m = minor diastereoisomer) 
 
Since non-polar solvents are the most suitable to use in non-covalent 
catalysis, the hexafluorobenzene ( = 2.05) appeared to us a promising 
solvent for further investigation. Some of the already investigated catalysts 
were then screened in hexafluorobenzene (Table 3.3). 
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Table 3.3 Catalysts screen in hexafluorobenzene as solvent.a 
 
Entry cat. t (h) yield (%)b drc ee (M)d ee (m)d 
1 29a 19 98 7:1 62 26 
2 29b 19 94 8:1 70 26 
3 29e 19 99 13:1 83 1 
4 35 64 64 5:1 54 26 
5 41 16 10 5:1 14 n.d.e 
6 42 5 98 6:1 4 20 
aAll reactions were performed at C 0.5 M in hexafluorobenzene at 0.2 mmol 
scale of 38a and 39a. bYield of isolated product. cThe diastereoisomeric ratio 
was determined by 1H NMR analysis of the crude reaction mixture. 
dDetermined by HPLC analysis on a chiral stationary phase. (M = major 
diastereoisomer, m = minor diastereoisomer) eNot determined. 
 
Interestingly, commercially available catalysts 29a, 29b and 29e in 
hexafluorobenzene  afforded the product with higher stereocontrol than in 
toluene, with up to 83% ee obtained when using the naphthyl based-
prolinol 29e (entries 1-3). More or less sterically demanding catalysts 41 
and 42 showed poorer selectivity (entries 5 and 6).  
Fine tuning of the reaction conditions by modifying the reaction 
concentration and the amount of the catalyst 29e are reported in Table 
3.4. The reaction performed in benzene and diethyl ether with the same 
catalyst resulted in a significantly poorer stereocontrol when compared to 
the results obtained in C6F6 (entries 2 and 3 vs 1). 
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Table 3.4 Study of the reaction concentration and the amount of the 
















1 30% 0.5 20 99 13:1 83 1 
2e 30% 0.5 7 97 5:1 45 42 
3f 30% 0.5 16 98 6:1 30 21 
4 15% 0.5 6 93 19:1 84 4 
5 10% 0.5 21 94 19:1 85 7 
6 15% 0.4 7 98 19:1 90 12 
7 15% 0.2 24 85 16:1 81 2 
8g 15% 0.2 48 98 16:1 71 8 
9 15% 0.8 3 97 16:1 82 60 
10 15% Neat 6 94 5:1 35 19 
aAll reactions were performed in C6F6 at 0.2 mmol scale of 38a and 39a. 
bYield of isolated product. cThe diastereoisomeric ratio was determined 
by 1H NMR analysis of the crude reaction mixture. dDetermined by HPLC 
analysis on a chiral stationary phase. (M = major diastereoisomer, m = 
minor diastereoisomer) e Reaction conducted in benzene  f Reaction 
performed in Et2O. g reaction performed at 0°C. 
 
Pleasingly, the reaction carried out with 15 mol% loading of catalyst 
proceeded in a similar manner (entry 4), whereas further decrease of the 
catalyst loading resulted in slower reaction rate (entry 5). To our delight, 
under slightly more diluted conditions, product 40a was isolated after 7 
hours in excellent yield, almost as a single diastereoisomer with 90% ee 
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(entry 6). No further improvements were achieved under more diluted 
conditions or at lower temperature (entries 7 and 8). Under more 
concentrated or neat conditions, the product was isolated with reduced 
stereoselectivity (entries 9 and 10). All these findings showed that solvent 
effects governed the stereocontrol of the process. With the optimized 
conditions in hand, we examined the scope of the asymmetric Michael 
addition in C6F6 as medium (Table 3.5). 










drc eed (M) 
1 Ph (38a) Et (39a) 98 (40a) 24:1 90 
2 2-naphthyl (38b) Et (39a) 98 (40b) 19:1 88 
3 3-BrC6H4 (38c) Et (39a) 94 (40c) 19:1 90 
4 4-FC6H4 (38d) Et (39a) 98 (40d) 19:1 88 
5 2-ClC6H4 (38e) Et (39a) 92 (40e) 32:1 90 
6 2-furyl (38f) Et (39a) 89 (40f) 10:1 72 
7 2-thienyl (38g) Me (39b) 98 (40g) 16:1 84 
8 Ph (38a) Me (39b) 97 (40h) 16:1 88 
9 4-MeC6H4 (38h) Me (39b) 98 (40i) 13:1 66 
10 4-MeOC6H4 (38i) Me (39b) 95 (40j) 9:1 58 
11 Cyclohexyl (38j) Me (39b) 52 (40k) 24:1 62 
aAll reactions were performed in C6F6 with 0.2 mmol of 38 and 39. b Isolated 
yield. c Determined by 1H NMR analysis of the crude reaction mixture. 
dDetermined by HPLC analysis on a chiral stationary phase. 
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Almost quantitative yields and high diastereo- and enantio- selectivity 
were observed when the reaction was performed using ethyl -ketoester as 
Michael donor and differently substituted aryl nitroalkenes (entries 1-5). 
Heteroaromatic rings were tolerated in the Michael acceptor (38f-g) also 
when using methyl ketoester 39b as Michael donor (entries 6-7). 
Reactions performed on nitroalkenes bearing electron-donating groups on 
the phenyl ring furnished the product with slightly reduced enantiocontrol 
(entries 9 and 10). More challenging and less reactive aliphatic nitroalkene 
38j provided the product with satisfactory level of stereocontrol (entry 11). 
Other Michael donors and acceptors were investigated performing the 
reaction both in toluene and C6F6 for comparative purpose (Scheme 3.6). 
 
 
solvent t (h) yield (%) dr ee (M) ee (m) 
toluene 120 30 5:1 32 62 
C6F6 120 61 2:1 26 88 
 
 
solvent t (h) yield (%) dr ee (M) ee (m) 
toluene 79 24 1:1 44 62 
C6F6 72 28 2:1 62 36 
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Solvent t (h) yield (%) dr ee (M) ee (m) 
Toluene 18 90 1:1 8 10 
C6F6 7 98 1.5:1 22 44 
Scheme 3.6 Investigation of other Michael donors and acceptors. 
 
Michael donor 39c reacted sluggishly with model nitroolefin 38a, although 
in hexafluorobenzene the product was recovered in much better yield than 
in toluene. The minor diastereoisomer of the desired product 40l showed a 
higher enantiomeric excess in C6F6. When using the 7-membered ring 39d 
as nucleophile, the conversion was low in both solvent, although the 
stereocontrol was improved in C6F6. When the N-benzylmaleimide 43 was 
employed as Michael acceptor, both the reactivity and the stereocontrol 
were better in C6F6. The data suggested that the positive effect displayed 
by C6F6 as solvent might turn out to be more general, at least in Michael 
type addition reactions. 
The use of C6F6 as additive rather than as a solvent was also investigated 
in the model reaction (Table 3.6).  
When trans--nitrostyrene 38a was reacted in Et2O the major 
diastereoisomer of the compound 40a was isolated with 60 % ee (entry 1). 
Notably, the addition of 10 or 5 equivalents of C6F6 (entries 2 and 3) to the 
reaction mixture was sufficient to achieve the enantiocontrol found in the 
case of the reaction conducted in pure C6F6 (entry 1, Table 3.5). 
Interestingly, further reduction to only 3 equivalents of C6F6 afforded an 
acceptable result (entry 4), while decreasing the temperature caused a 
drop in the stereocontrol (entry 5).  As previously observed, the 
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concentration significantly affected the process, indeed both under more 
concentrated or diluted conditions using different amounts of C6F6, the 
product was recovered with lower enantioselectivity (up to 76 % ee) 
(entries 6-9). The reaction performed with n-butyl ether as solvent with 
C6F6 as additive (5 eq.) led to the product with a satisfying 
enantioselectivity (entry10).  
Table 3.6 Investigation of the optimized conditions for the use of C6F6 as 
additive for the model reaction.a 
 
 
Entry C (M) C6F6 (eq) Yield (%)b drc ee (M)d 
1 0.4 - 64 11:1 60 
2 0.25 10 74 19:1 89 
3 0.25 5 90 16:1 90 
4 0.25 3 98 24:1 86 
5e 0.25 3 99 32:1 77 
6 0.5 5 98 19:1 75 
7 f  0.5 3 99 19:1 76 
8 f 0.5 1 99 16:1 74 
9  0.1 3 96 16:1 68 
10 g 0.25 5 98 16:1 83 
a All reactions were performed in Et2O at 0.2 mmol scale of 38a and 39a. 
b Yield of isolated product. c The diastereoisomeric ratio was determined 
by 1H NMR analysis of the crude reaction mixture. d Determined by HPLC 
analysis on a chiral stationary phase. (M = major diastereoisomer) e 
reaction performed at -20 °C. f 30 mol% of catalyst was employed. g 
reaction conducted in di-n-butyl ether as solvent.  
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The optimized conditions reported in entry 3 proved not to be of general 
applicability to all the substrates, but reaction conditions need to be finely 
optimized for each different nitroalkene derivative. Reactions of 
representative nitroalkenes 38a, 38b, 38d carried out with the ethyl -
ketoester 39a in Et2O using 5 equivalents of C6F6 are illustrated in Table 
3.7. 
Table 3.7 Catalytic asymmetric Michael addition in Et2O with C6F6  as 
additive.a 
 
Entry R yield (%)b drc ee (M)d 
1 Ph (38a) 90 (40a) 16:1 90 
2e 2-naphthyl (38b) 98 (40b) 24:1 75 
3 4-FC6H4 (38d) 98 (40d) 12:1 77 
4f 4-FC6H4 (38d) 98 (40d) 16:1 86 
a All reactions were performed at C=0.25 M in Et2O, using 5 
equivalents of C6F6 at 0.2 mmol scale of 38 and 39a. b Yield of 
isolated product. c The diastereoisomeric ratio was determined by 1H 
NMR analysis of the crude reaction mixture. d Determined by HPLC 
analysis on a chiral stationary phase. (M = major diastereoisomer) e 
Reaction performed at C=0.4 M in Et2O. f reaction performed at C=0.5 
M in Et2O.  
 
In order to shed some light on the role of hexafluorobenzene, 1H-NMR 
experiments were conducted on dinaphthyl prolinol 29e in CDCl3 adding 
different amounts of hexafluorobenzene (Figure 3.1). Coalescence of the 
CH2NH proton resonances was observed when increasing the equivalents 
of C6F6. A plausible polar interaction of hexafluorobenzene with its 
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partially positively charged ring centre and the lone pair of nitrogen atom 
of pyrrolidine might account for the observed coalescence. 
 
Figure 3.1 1H-NMR spectra of the dinaphthyl prolinol 29e with different 
amounts of hexafluorobenzene. 
 
 
3.3 Computational Study 
 
In order to clarify the stereochemical outcome of the reaction in 
hexafluorobenzene, DFT calculations were performed by the group of 
Cavallo.102  
The originally proposed general acid-base catalysis provided by diaryl 
prolinols in Michael type reactions of acyclic -ketoesters with 
nitroalkenes99a was recently supported by Zhu and co-workers who 
demonstrated the unfeasibility of enamine intermediate formation between 
hindered diaryl prolinol and the carbonyl group of the substrate in the 
                                                          
102 Geometries were optimized at the BP86 level using the SVP basis set. The reported free 
energies correspond to in solvent M06/TZVP//BP86/SVP energies. BP86/SVP thermal 
corrections at 300 K are included. For more details, see the experimental part. 
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asymmetric -sulfenylation of -ketoesters catalysed by diaryl prolinols.103 
Indeed, the authors showed, through NMR NOE studies, the 
establishment of hydrogen bonding interactions between the catalyst and 
the enol form of the -ketoester.  
Being the C-C bond formation the rate limiting step, the transition state 
energies of this process were calculated for each of the four possible 
stereoisomers. The calculations indicated the (pro-R,S)104 transition state 
as the most energetically affordable, in agreement with the experimental 
data since the configuration of the major product was determined to be 
2R,3S by comparison with literature data.105  
Figure 3.2 shows the calculated transition states leading to the 
enantiomers of the major diastereoisomer in the absence and in the 
presence of one molecule of hexafluorobenzene. The (pro-R,S) transition 
state was favored by a higher number of H-bonds between the catalyst 
and the reagents. 
Similar results were obtained inserting two or three molecules of 
hexafluorobenzene in the calculation. Concerning the beneficial effect of 
hexafluorobenzene, it appeared that the C6F6 ring was found stacked over 
the enolate group. This can be explained considering that C6F6 is 
characterized by a quadrupole moment with the positive lobes above the 
aromatic ring, which optimizes electrostatic interaction with the electron 
density delocalized on the enolate -orbitals. The energy difference 
between the transition states was higher when hexafluorobenzene was 
included in the calculation (1.3 Kcal/mol with respect to 0.4 Kcal/mol 
calculated in toluene as solvent), in agreement with the experimental data. 
 
                                                          
103 L. Fang, A. Lin, H. Hu, C. Zhu, Chem. Eur. J. 2009, 15, 7039. 
104 Pro-R,S and pro-S,R indicate the configuration at the C2 and C3 atoms of the forming 
product. 
105 D. Almaşi, D. Alonso, E. Gómez-Bengoa, C. Nájera, J. Org. Chem. 2009, 74, 6163. 
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Pro-R,S:                                Pro-S,R: 











Figure 3.2 Comparison of transition states pro-R,S and pro-S,R, (a) and 
(b), respectively and the same TS in the presence of one molecule of 





These results showed for the first time that hexafluorobenzene, a non-
polar solvent ( = 2.05), could positively affect the reactivity and the 
stereocontrol of organocatalytic asymmetric Michael additions proceeding 
via non-covalent activation mode. Indeed, the conjugate addition of -
ketoesters to nitroolefins, conveniently catalyzed by a commercially 
available prolinol, was turned from scarcely to highly enantioselective 
process.  
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Moreover, the dramatic amplification of the stereoselectivity can be more 
conveniently observed when using hexafluorobenzene simply as additive. 
DFT calculations helped to suggest a reason for the stereoselectivity 
enhancement observed. 
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The Michael reaction, already discussed in chapter 3, is a 1,4-addition of a 
carbon nucleophile to ,-unsaturated carbonyl compounds. Its potential 
to form C-C bonds can be exploited in domino and multi step reactions 
(described in the paragraph 1.5) to construct cyclic skeletons through 
different cascade routes.  
Cyclic and polycyclic compounds are extremely important, since the 
majority of natural products and biologically and pharmaceutically active 
compounds contains complex skeletons characterized by one or more 
rings of different size. Michael-aldol, Michael-Mannich and Michael-
Michael are only some of the sequences exploited in the literature to 
construct complex molecules through tandem reactions,106, 43c and several 
are the organocatalysts able to promote them.107  
The synthesis of products featuring a cyclohexane unit has been an 
important research topic for a  long time. Among the other reasons, they 
are precursors of carbasugars or fundamental component in the skeleton 
of many natural products.108 Different synthetic pathways can be 
designed. A nucleophile bearing a Michael acceptor unit, reacting with 
enones, can be involved in a domino conjugate addition to afford highly 
                                                          
106 For selected examples, see; a) C. Schneider, O. Reese, Angew. Chem., Int. Ed. 2000, 39, 
2948; b) C. Schneider, O. Reese, Chem.–Eur. J. 2002, 8, 2585; c) D. Heber, E. V. Stoyanov, 
Synthesis 2003, 227; d) D. B. Ramachary, Y. V. Reddy, B. V. Prakash, Org. Biomol. Chem. 
2008, 6, 719.  
107 For a review, see: D. Enders, C. Grondal, M. R. M. Hüttl, Angew. Chem., Int. Ed. 2007, 
46, 1570. 
108 For selected examples, see: a) E. Maudru, G. Singh, R. H. Wightman, Chem. Comm. 
1998, 1505; b) S. L. Boulet, L. A. Paquette, Synthesis 2002, 895. 
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functionalized cyclohexanones (pathway a, Scheme 4.1).109 Similar 
products can be obtained reacting active methylene compounds and 
divinylketones 45, although this route has been less explored. The 
reaction consists of a double conjugated addition providing 
cyclohexanones bearing a quaternary stereogenic center (pathway b, 
Scheme 4.1).110 
 
Scheme 4.1 Construction of highly functionalized cyclohexanones 
through organocatalytic asymmetric conjugate addition. 
 
Melchiorre et al. reported, for example, the synthesis of 46 with the first 
double Michael approach promoted by the amino-deoxy-epi-hydroquinine 
and an acid co-catalyst, as shown in Scheme 4.2.111 
 
                                                          
109 For selected examples, see: a) H. Li, L. S. Zu, H. X. Xie, J. Wang, W. Jiang, W. Wang, 
Org. Lett. 2007, 9, 1833; b) A. Q. Ma, D. W. Ma, Org. Lett. 2010, 12, 3634. 
110 For a racemic process, see: D.  Zhang,  X. Xu,  J. Tan, Q. Liu, Synlett 2010, 6, 917.   
111 L.-Y. Wu, G. Bencivenni, M. Mancinelli, A. Mazzanti, G. Bartoli, P. Melchiorre,  Angew. 
Chem. Int. Ed. 2009, 48, 7196. 
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Scheme 4.2 Synthesis of derivative 46 reported by Melchiorre. 
 
Pioneering studies on double conjugated addition of cyclic 1,3-dicarbonyl 
compounds to divinylketones to access spirocyclohexanones promoted by 
quinine were conducted by Wynberg. The spiro-product was obtained in 
moderate yield (< 50%), as a mixture of trans/cis isomers (trans/cis ≥ 2:1) 
with an optical yield of 30 % in one specific case (Scheme 4.3).112 
 
 
Scheme 4.3 Double Michael addition to divinylketones pioneered by 
Wynberg. 
 
In the context of the Michael addition reaction to enals, enones, 
nitroalkenes, which represent the most common Michael acceptors, 
different donors were exploited, such as malonates, nitroalkanes and 1,3-
                                                          
112 W. ten Hoeve, H. Wynberg, J. Org. Chem. 1979, 44, 1508. 
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dicarbonyl compounds.113,86b Instead, only few example concerning the use 
of malononitrile addition appeared in the literature.114   
Recently, Lattanzi and co-workers reported a highly enantioselective 
Michael addition of malononitrile to ,-enones using quinine as a general 
acid base catalyst (Scheme 4.4).115 The same process was demonstrated to 
be promoted by diarylprolinols, although achieving lower enantiocontrol.99f  
 
Scheme 4.4 Addition of malononitrile to chalcones catalysed by quinine. 
 
With this background in mind and looking for the development of a simple 
stereoselective approach to cyclohexanone derivatives, the tandem 
Michael-Michael addition of commercially available malononitrile to easily 
available diaryl dienones 45 was investigated (Scheme 4.5). 
 
Scheme 4.5 Double Michael addition of malononitrile to dienones. 
                                                          
113 For reviews, see: a) D. Almaşi, D. A. Alonso, C. Nájera, Tetrahedron: Asymmetry 2007, 
18, 299; b) S. Sulzer-Mossé, A. Alexakis, Chem. Commun. 2007, 3123; c) A. Córdova (Ed.), 
Catalytic Asymmetric Conjugate Reactions, Wiley-VCH, Weinheim, 2010, 9419. For selected 
examples, see: a) J. Wang, H. Li, L. Zu, W. Jiang, H. Xie, W. Duan, W. Wang, J. Am. Chem. 
Soc. 2006, 128, 12652; b) C. G. Oliva, A. M. S. Silva, F. A. A. Paz, J. A. S. Cavaleiro, 
Synlett 2010, 7, 1123.  
114 For selected examples, see: a) T. Inokuma, Y. Hoashi, Y. J. Takemoto, J. Am. Chem. Soc. 
2006, 128, 9413; b) X.-F. Li, L.-F. Cun, C.-X. Lian, L. Zhong, Y.-C. Chen, J. Liao, J. Zhu, 
J.-G. Deng, Org. Biomol. Chem. 2008, 6, 349; c) Ren, Y.-J. Gao, J. Wang, Chem. Eur. J. 
2010, 16, 13594. 
115 a) A. Russo, A. Perfetto, A. Lattanzi, Adv. Synth. Catal., 2009, 351, 3067. 
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At the same time, a stereoselective access to cyclohexanones from 
dienones and malononitrile using 9-amino-9-deoxyepiquinine 5 and TFA 
as co-catalyst was developed by Yan and co-workers. In this example, the 
formation of an iminium-ion intermediate between the catalyst and the 
dienone was suggested to be involved.116  
 
4.2 Results and discussion117 
 
Malononitrile and model trans, trans-dibenzylideneacetone 45a were 
reacted in toluene with different cinchona based organocatalysts, to give 
2,5-diphenyl-1,1-dicyanocyclohexanone 47a/47’a in good to high 
diastereocontrol, together with the mono-adduct 48 in generally minor 
amount (Table 4.1). 
The reaction catalysed by quinine gave the product in 44% of yield with a 
good trans/cis ratio and 65% ee (entry 1). The starting material was 
almost completely consumed but the presence of a coloured solid was 
observed, which could be the oligomerization by-products. The process 
was found to be strongly dependent on the concentration. This was 
supported by higher yield and improved enantiocontrol (79% ee) obtained 
when performing the reaction under more diluted conditions (C = 0.04 M) 
(entry 4). Under these conditions a variety of catalysts were tested. 
Quinidine allowed to obtain the opposite enantiomer of diastereoisomer 
47a with 51 % ee (entry 5). Cinchonidine provided an effective 
stereocontrol but a poor reactivity, indeed the product was recovered in 
only 17% yield and the mono-adduct 48 was isolated in 46% yield and 
52% ee (entry 6).  
                                                          
116 X.-M. Li, B. Wang, J.-M. Zhang, M. Yan, Org. Lett. 2011, 13, 374. 
117 The results presented in this chapter are partially reported in the paper: C. De Fusco, 
A. Lattanzi, Eur. J. Org. Chem. 2011, 3728. 
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Table 4.1 Screen of reaction conditions and catalysts in the double 
conjugate addition of malononitrile to dibenzylideneacetone 45a.a 
 
 




47a [48]  
eed 
47a [48] 
1 QN 0.2 87 9/1 44 65 
2e QN 0.1 42 2/1 43 72 
3f QN 0.1 48 5/1 48 77 
4g QN 0.04 66 10/1 70 79 
5h QD 0.04 52 24/1 61 -51 
6 CD 0.04 54 30/1 17 [46] 80 [52] 
7 CPD 0.04 71 n.d.i - [37] - [45] 
8 eQNT 0.04 66 n.d. <5 [76] n.d. [86] 
9 eQDT 0.04 66 >30/1 15 [57] -86 [-76] 
a Reaction conditions: 45a (0.1 mmol)/malononitrile (0.12 mmol)/quinine 
(0.03 mmol). b Determined via 1H-NMR analysis on the crude mixture. c 
Yield of isolated product; yield of 48 in parenthesis. d Determined by HPLC 
analysis on a chiral stationary phase; ee of 48 in parenthesis. e 1 
equivalent of quinine was used. f 0.05 mmol of malononitrile was used. g 
0.1 mmol of malononitrile was used. h Negative ee is indicative of the 
formation of the opposite enantiomer. i Not determined. 
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Cupreidine was poorly active, indeed only the mono-adduct 48 was 
obtained in modest enantioselectivity (entry 7). Thioureas derivatives of 
the cinchona alkaloids demonstrated to be less reactive than their natural 
precursors affording the mono-adduct 48 as the most abundant product 
(entries 8 and 9).  
A screen of solvents was then carried out (Table 4.2). 
Table 4.2. Solvent effect and optimization study for the double conjugate 
addition of malononitrile to compound 45a with quinine.a 
 
Entry Solvent t [h] 47a/ 47’ab yield (%)c ee (%)d 
1 ClC6H5 36 14/1 66 72 
2e ClC6H5 47 >30/1 61 76 
3 m-xylene 70 20/1 66 80 
4 CHCl3 67 18/1 50 62 
5 THF 67 n.d.f < 5 n.d. 
6g toluene 91 >30/1 54 83 
7h toluene 74 >30/1 56 80 
8i toluene 103 >50/1 55 86 
a Reaction conditions: 45a (0.1 mmol)/malononitrile (0.1 mmol)/quinine 
(0.03 mmol) in 2.5 mL of solvent. b Determined via 1H-NMR analysis on 
the crude mixture. c Yield of isolated product. d Determined by HPLC 
analysis on a chiral stationary phase. e Reaction performed at -18 °C. f not 
determined. g Reaction performed at 4 °C. h 20 mol% of catalyst was used. 
i C = 0.02 M 
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Reaction performed in chlorobenzene gave the product with moderate yield 
but satisfactory enantiomeric excess (entry 1) and performing the reaction 
at lower temperature slightly improved the stereocontrol (entry 2). m-
Xylene was comparable with toluene (entry 3), while halogenated and 
ethereal solvents had a detrimental effect (entries 4 and 5). The reaction 
carried out in toluene at lower temperature or with a smaller amount of 
catalyst led to satisfactory level of stereoselectivity (entries 6 and 7). The 
product was obtained in excellent diastereoselectivity and 86% ee altought 
with longer reaction time, when working under more diluted conditions 
(entry 8).  
In order to better understand the stereochemical outcome of the entire 
process, the reaction of 45a and malononitrile with quinine was quenched 
at different times (Scheme 4.6). 
 
Scheme 4.6 Monitoring of the double Michael addition over time. 
 
After 28 hours, the product 47a was isolated in moderate yield, high 
enantiomeric excess (84% ee) and high diastereoisomeric ratio, whereas 
compound 48 was recovered in 30% yield and 69% ee. After 48 hours, the 
yield of the product 47a slightly increased but lower enantio- and 
diastereoselectivity were observed, whereas only traces of the reaction 
intermediate were detected. In both cases, starting compound 45a was not 
totally consumed. On the basis of the data illustrated in Scheme 4.6, it 
can be suggested that the second Michael addition step is influenced by 
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the chiral non racemic adduct 48. If the opposite were true, according to 
Horeau’s principle,118 compound 47a would be expected to achieve 92% ee 
and cis-47’a product formed in around 25% yield at full conversion. In 
order to shed light on the second step some experiments were performed 
on racemic and enantioenriched adduct 48 (Scheme 4.7).  
 
Scheme 4.7 Stereochemical outcome of the second Michael addition step 
 
The racemic Michael adduct 48 was reacted with QN in toluene and after 
15 hours the unreacted 48 was recovered with 11% ee, whereas the 
cyclized product 47a/47’a was isolated in 25% yield, 13/1 
                                                          
118 a) J. P. Vigneron, M. Dhaenens, A. Horeau, Tetrahedron 1973, 29, 1055; b) K. Soai, H. 
Hori, M. Kawahara, J. Chem. Soc. Chem. Commun. 1992, 106; c) S. E. Baba, K. Sartor, J.-
C. Poulin, H. B. Kagan, Bull. Chim. Soc. Fr. 1994, 131, 525. 
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diastereoisomeric ratio and 13% ee (Scheme 4.7, a). To evaluate matching 
and mismatching effects, the enantioenriched intermediate (74% ee) was 
reacted either with quinine 1 and with its pseudoenantiomer quinidine 50 
(Scheme 4.7, b and c). With  the quinine, results were comparable to those 
obtained in the model reaction (case b vs entry 4, Table 4.1). When using 
quinidine as the catalyst, a lower enantiomeric excess of compound 47a 
was observed along with a lower yield, showing a mismatching effect. 
These experiments indicate that the organocatalyst predominantly 
controls the stereochemical outcome of the process, although a minor 
substrate control is active in the second step. 
The procedure for the double asymmetric Michael addition with 
malononitrile was investigated using different substituted dienones, 
synthetized according to a known procedure (Table 4.3).119 Symmetrically 
substituted diaryl dienones 45a-c furnished the cyclized product in 
satisfactory yields, high diastereoselectivity and up to 86 % ee (entries 1-
3). Unsymmetrically disubstituted dienones 45d-f were also suitable 
substrates for the process (entries 4-6). The heteroaromatic derivative 
allowed to isolate the trans-product 47g in excellent diastereoisomeric 
ratio, 86% ee although with a modest yield (entry 7). A better yield of the 
product could be obtained quenching the reaction after a longer time 
(entry 8). Reactions carried out with methyl malonate and nitromethane 





                                                          
119 W. Tully, L. Main, B. K. Nicholson, Journal of Organometallic Chemistry 2001, 633, 162. 
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Table 4.3 Scope of the double Michael addition of malononitrile to 
dienones 45.a 
 





1 Ph Ph a 103 >50/1 55 86 
2 pMeC6H4 pMeC6H4 b 96 >50/1 54 85 
3 pCF3C6H4 pCF3C6H4 c 118 19/1 62 83 
4 pMeC6H4 Ph d 95 >30/1 68 82 
5 pMeOC6H4 Ph e 97 >40/1 48 85 
6 pClC6H4 Ph f 118 >40/1 53 80 
7 2-thienyl Ph g 99 >40/1 32 86 
8 2-thienyl Ph g 150 16/1 47 80 
a Reaction conditions: 45a (0.1 mmol)/malononitrile (0.1 mmol)/quinine (0.03 
mmol) in 5 mL of solvent. b Determined via 1H-NMR analysis. c Yield of isolated 
product. d Determined by HPLC analysis on a chiral stationary phase.  
 
The absolute configuration of the major enantiomer of the trans-product 
47a was supposed to be (2R, 6R), assuming product 48 to be S-configured 
as reported in the previous report on addition of malononitrile to 
chalcones.115a To confirm this hypothesis compound 45a was reacted with 
ethyl cyano malonate affording previously reported cyclic compound 46.  
A brief optimization study was conducted between dienone 45a and ethyl 
cyanoacetate as the nucleophile (Table 4.4).  
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Different solvents were evaluated as medium for the reaction, but as 
expected non polar, aromatic solvents proved to be the most effective 
(entries 1 and 3). 
Table 4.4 Optimization study for the addition of ethyl cyano malonate to 
dienone 45a. a 
 
Entry Solvent t (h) yield (%)b drc eed 
1 Toluene 93 92 >40: 1 60 
2 ClC6H5 64 95 >40: 1 47 
3 m-xylene 64 76 >40: 1 60 
4 CHCl3 72 74 >40: 1 44 
5 EtOAc 72 65 >40: 1 52 
6 Et2O 96 71 >40: 1 50 
a Reaction conditions: 45a (0.1 mmol), ethyl cyano malonate (0.1 
mmol), 0.3 M in toluene. b Yield of isolated product. c Determined via 
1H-NMR analysis. d Determined by HPLC analysis on a chiral 
stationary phase.  
 
The absolute configuration of compound 46 was determined to be (2R, 6R) 
by comparing HPLC retention times and optical rotation with those 
previously reported.111 This result confirmed that the stereochemical 
outcome of the first conjugate addition on compounds 45a, to give adduct 
48, was consistent with our previous findings. 
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In conclusion, a tandem Michael-Michael reaction to highly substituted 
cyclohexanones with high levels of diastereoselectivity and good 
enantiocontrol was developed using a low cost catalyst and easily available 
starting materials. It has been demonstrated that this non covalent 
organocatalytic approach can be considered an efficient alternative 
strategy to enamine-iminium cascade processes to stereoselectively obtain 
cyclohexane based scaffolds. 
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Aziridines are strained three-membered nitrogen-containing heterocycles. 
These small units are often contained in natural compounds showing 
biological and pharmaceutical activities. Moreover, they have also been 
object of attention for their potential use to access valuable nitrogen-
containing compounds such as lactams, amino acids, amino alcohols, 
after selective ring-opening.48  
Among the most important classes of aziridine-containing natural 
compounds, mitomycins, porfiromycins and azinomycins have to be 
remembered for being potent antitumor and antibiotic agents (Figure 
5.1).120 Their activity has been attributed to the aziridine ring, involved in 
the DNA alkylation process and in the cross-linking between the bases.  
 
Figure 5.1 Examples of aziridine-containing natural products. 
Aziridine containing compounds have mostly anticancer, antileukemic or 
antibiotic activities. These compounds, usually structurally different, only 
                                                          
120 a) M. Kasai, M. Kono, Synlett 1992, 778; b) Y. Na, S. Wang, H. Kohn, J. Am. Chem. Soc. 
2002, 124, 4666; c) T. J. Hodgkinson, M. Shipman, Tetrahedron 2001, 57, 4467. 
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share the aziridine moiety which is responsible for the activity (Figure 
5.2).121 
 
Figure 5.2 Compounds with pharmaceutical activities due to the aziridine 
ring.  
 
Chiral aziridines have also been employed as ligands in asymmetric metal 
catalysis. Tanner and co-workers used a ligand containing two aziridine 
rings, among the other, for the copper-mediated asymmetric hydroxylation 
of olefins, cyclopropanation and aziridination.122 Enantiopure aziridines 
bearing 2-carbinol moiety have been employed as ligands for boron and 
zinc in a number of asymmetric reaction.123 
Even though aziridines are less reactive than epoxides, due to the minor 
electronegativity of the nitrogen with respect to the oxygen, aziridine ring 
opening have also been deeply investigated. Optically active aziridines 
treated with different carbon or heteroatom based nucleophiles allowed to 
access a variety of enantioenriched nitrogen containing compounds, such 
as amino alcohols, amino thiols, diamines.124 Furthermore, electrophilic 
ring opening, ring expansion, rearrangements are only few of the possible 
transformations, as shown in Scheme 5.1. 
 
                                                          
121 G. S. Singh, M. D'Hooghe, N. De Kimpe, Chem. Rev. 2007, 107, 2080. 
122 D. Tanner, A. Harden, F. Johansson, P. Wyatt, P.G. Andersson, Acta Chem. Scand. 
1996, 50, 361. 
123 M. McCoull, F. A. Davis, Synthesis 2000, 1347. 
124 For a recent review on aziridine ring-opening, see: P. Lu, Tetrahedron 2010, 66, 2549.  
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Scheme 5.1 Overview of important transformations of aziridines 
 
The fate of the aziridine, the stereoselectivity of the resulting products are 
strongly influenced by steric and electronic features of the substituents on 
the aziridine ring, for example a nucleophile usually attacks the less 
substituted carbon but electronic effects can invert the 
regioselectivity.121,125 
For all these reasons, intensive investigations towards the development of 
asymmetric methodologies for the synthesis of aziridines have been 
developed in recent years. 
 
 
                                                          
125 For some reviews on transformations of aziridines, see: a) D. Tunner, Angew. Chem. Int. 
Ed. Engl. 1994, 33, 599; b) X. E. Hu, Tetrahedron 2004, 60, 2701. 
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5.1.1 Synthesis of Chiral Aziridines 
Different strategies to obtain aziridines can be employed: (a) cyclization 
reactions, (b) transfer of nitrogen to olefins or (c) carbenes to imines, (d) 
ring contraction, (e) transformation of functional groups (Scheme 5.2).126   
 
Scheme 5.2 General approaches to aziridines 
 
Diastereo- and enantiomerically enriched aziridines can be prepared either 
via chiral auxiliary approach or by using chiral ligands-metal based 
catalysis and by organocatalysis.127 
Concerning the chiral auxiliary approach, it is worth mentioning the 
employment of N-(p-toluenesulfonyl)-p-toluenesulfonimidamide with 
iodosylbenzene to afford the aziridinating agent in situ for a variety of 
alkenes with Cu-catalysis.128 The Aza-Darzens reaction, via generation of 
                                                          
126 For selected examples, see: a) W. Lwowsky, Angew. Chem., Int. Ed. Engl. 1967, 6, 897; 
b) L. Casarrubios, J. A. Perez, M. Brookhart, J. L. Templeton, J. Org. Chem. 1996, 61, 
8358; c) F. Palacios, A. M. Ochoa de Retana, E. Martinez de Marigorta, J. Manuel de los 
Santos, Eur. J. Org. Chem. 2001, 66, 2401; d) D. K. Wang, L. X. Dai, X. L. Hou, Chem. 
Commun. 1997, 1231; e) T. Satoh, T. Sato, T. Oahara, K. Yamakawa, J. Org. Chem. 1989, 
54, 3973; f) B. Olofsson, R. Wijtmans, P. Somfai, Tetrahedron 2002, 58, 5979; g) H. 
Pellisier, Tetrahedron 2010, 66, 1509. 
127 For some reviews, see: a) R. S. Atkinson, Tetrahedron 1999, 55, 1519; b) P. Müller, C. 
Fruit, Chem. Rev. 2003, 103, 2905. 
128 P. H. Di Chenna, F. Robert-Peillard, P. Dauban, R. H. Dodd, Org. Lett. 2004, 6, 4503. 
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chiral -halo or -sulfonio anions, has been exploited to access the 
aziridines in diastereoselective manner.129 
 
5.1.1.1 Metal-Catalyzed Enantioselective Methods 
In 1993, the group of Evans130 developed a Cu-catalysed method for the 
asymmetric aziridination of alkenes using [N-(p-
toluenesulfonyl)imino]phenyliodinane (PhI=NTs) as the nitrene source 
(Scheme 5.3).  
 
Scheme 5.3 Aziridination of styrene trough metal catalysis. 
 
Bisoxazoline 54 was found the most effective ligand, subsequently 
employed by Che,131 who introduced PhI(OAc)2 in the presence of 
sulphonamides to generate the nitrene precursor. Dauban132 and other 
groups improved this system and extended the scope of the aziridination. 
Other oxazoline-based ligands, such as cyclohexane or anthracene 
derivatives 55 and 56, were investigated in the Cu-catalysed aziridination 
                                                          
129 J. Sweeney, Eur. J. Org. Chem. 2009, 4911. 
130 D. A. Evans, M. M. Faul, M. T. Bilodeau, B. A. Anderson, D. M. Barnes, J. Am. Chem. 
Soc. 1993, 115, 5328. 
131 H. L. Kwong, D. Liu, K.-Y. Chan, C.-S. Lee, K.-H. Huang, C.-M. Che, Tetrahedron Lett. 
2004, 45, 3965.  
132 A. Esteoule, F. Duran, P. Retailleau, R. H. Dodd, P. Dauban, Synthesis 2007, 8, 1251. 
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of chalcones (Scheme 5.4, a). Instead the C2-symmetric diimine 57 was 
employed in the aziridination of ,-unsaturated esters (Scheme 5.4, b).133 
 
 
Scheme 5.4 Aziridination of ,-unsaturated ketones and esters with Cu-
catalysis. 
 
The group of Jacobsen found that a Cu-catalyst with a diimine ligand 
could promote the asymmetric aziridination of cis-olefines and imines.134 
In the field of the ruthenium catalysis, good results (up to 99% ee) were 
obtained in the aziridination of a wide range of monosubstituted alkenes 
with different azides. For example, Katsuki reported the enantioselective 
                                                          
133 a) L. Ma, D.-M. Du, J. Xu, J. Org. Chem. 2005, 70, 10155; b) J. Xu, L. Ma, P. Jiao, 
Chem. Comm., 2004, 1616; c) X. Wang, K. Ding, Chem. Eur. J. 2006, 12, 4568. 
134 a) Z. Li, R. W. Quan, E. N. Jacobsen, J. Am. Chem. Soc. 1995, 117, 5889; b) K. B. 
Hansen, N. S. Finney, N. Jacobsen, Angew. Chem., Int. Ed. Engl. 1995, 34, 676. 
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catalytic aziridination of terminal alkenes promoted by Ru-(Salen)(CO) 
complexes.135 Intramolecular rhodium-catalysis was often exploited by 
using an internal nucleophile, although the stereoselectivity was generally 
inferior to that obtained in the case of Cu-catalysis.136 Aggarwal and 
coworkers reported a Rh-catalysed aziridination reaction using catalytic 
quantities of a chiral sulphide and tosylhydrazone salt as the nitrogen 
source achieving up to 98% ee.137 Wulff and co-workers disclosed a 
catalytic enantioselective aziridination process reacting imines and 
diazoacetates with catalytic loadings of the chiral VANOL-borate complex 
(figure 5.3).138  
 
Figure 5.3 VANOL ligand for boron complexes.  
 
5.1.1.1 Aza-MIRC Approach and Organocatalyzed  Aziridination 
The Aza-MIRC (Michael Initiated Ring Closure) reaction is a two-step 
reaction: a nitrogen-based nucleophile attacks the substrate usually 
forming an anionic intermediate that trough intramolecular nucleophilic 
                                                          
135 a) K. Omura, T. Uchida, R. Irie, T. Katsuki, Chem. Commun. 2004, 2060; b) H. 
Kawabata, K. Omura, T. Uchida, T. Katsuki, Chem. Asian. J., 2007, 2, 248.  
136 a) J.-L. Liang, S.-X. Yuan, P. W. Hong Chan, C.-M. Che, Tetrahedron Lett. 2003, 44, 
5917; b) C. J. Hayes, P. W. Beavis, L. A. Humphries, Chem. Commun. 2006, 4501; c) M. 
Yamawaki, M. Tanaka, T. Abe, M. Anada, S. Hashimoto, Heterocycles 2007, 72, 709. 
137 V. K. Aggarwal, E. Alonso, G. Fang, M. Ferrara, G. Hynd, M. Porcelloni Angew. Chem. 
Int. Ed. 2001, 40, 1433. 
138 J. C. Antilla, W. D. Wulff, J. Am. Chem. Soc. 1999, 121, 5099. 
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substitution furnishes the aziridine. The stereoselectivity of the reaction is 
strongly dependent on the relative rate of the second step with respect to 
the speed of rotation around the C-C bond (Scheme 5.5).  
 
Scheme 5.5 Aza-MIRC aziridination mechanism. 
 
Diastereoselective aza-MIRC reactions to optically active aziridines have 
been performed, exploiting preformed chirality placed on nucleophile or 
substrate. Pellacani and coworkers developed both the strategies. 
Optically pure nitro alkenes were reacted with an alkyl nosyloxycarbamate 
under basic conditions to give the corresponding nitro aziridines in high 
yields and good diastereoselectivity (Scheme 5.6, a). Alternatively, a chiral 
nosyloxycarbamate was employed with electron-poor alkenes (Scheme 5.6, 
b).139 The diastereocontrol of the reactions was strongly influenced by the 
chiral residue used, more than by reaction conditions. 
 
                                                          
139 a) S. Fioravanti, F. Marchetti, L. Pellacani, L. Ranieri, P. Tardella Tetrahedron: 
Asymmetry 2008, 19, 231; b) S. Fioravanti, L. Pellacani, P. A. Tardella, Eur. J. Org. Chem. 
2003, 4549. 
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Scheme 5.6 Diastereoselective synthesis of aziridines by Pellacani. 
 
The same group developed an organocatalytic method based on the use of 
cinchona alkaloids derived quaternary salts in the aziridination of 2-
(phenyl-sulfanyl)-2-cycloalkenones (Scheme 5.7).140 This phase-transfer 
catalysed process provided the aziridines in satisfactory yields and 
moderate enantioselectivity strongly dependent on the nature of the 
substrates.  
                                                          
140 S. Fioravanti, M. Guni. Mascia, L. Pellacani, P. A. Tardella, Tetrahedron 2004, 60, 8073. 
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Scheme 5.7 Aziridination of 2-(phenylsulfanyl)-2-cycloalkenones 
mediated by cinchona alkaloids based quaternary salts. 
 
Different cinchona alkaloids were developed for phase-transfer catalysis in 
the asymmetric aziridination of electron-poor olefins. Murugan and Siva 
reported a methodology in which tosyl derivatives of cinchona alkaloids 
(catalyst 61a and b, Figure 5.4, a) were employed with N-acyl-N-aryl 
hydroxamic acids to furnish the corresponding aziridines with up to 95 % 
ee.141 Minakata et al. employed N-chloro-N-sodio carbamate with catalysts 
62a and b, respectively cinchonidine and cinchonine derivatives, achieving 
87% ee (Figure 5.4, b).142 
                                                          
141 E. Murugan, A. Siva, Synthesis 2005, 12, 2022. 
142 S. Minakata, Y. Murakami, R. Tsuruoka, S. Kitanaka, Chem. Commun. 2008, 6363. 
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Figure 5.4 Some cinchona alkaloid derivatives employed in phase-transfer 
catalysis for aziridination of electron-poor olefins.  
 
Armstrong and co-workers investigated the asymmetric aziridination of 
trans-chalcone with an aminimide generated in situ from O-
(diphenylphosphinyl)hydroxylamine with a tertiary amine, such as the 
quinine.143 A promising level of enantioselectivity was achieved using 
quinine (Scheme 5.8). 
 
Scheme 5.8 Aziridination of trans-chalcone promoted by quinine. 
 
A highly efficient methodology for asymmetric aziridination of ,-
unsaturated ketones with N-protected hydroxylamine bearing a potential 
leaving group (63a, b) was introduced by the group of Melchiorre (Scheme 
                                                          
143 A. Armstrong, C. A. Baxter, S. G. Lamont, A.R. Pape, R. Wincewicz, Org. Lett. 2007, 9, 
351. 
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5.9).144 The employed catalyst was the primary amine salt 64 obtained by 
combining easily available 9-amino(9-deoxy)epi-hydroquinine with D-N-
Boc Phenylglycine. 
 
Scheme 5.9 Asymmetric aziridination of enones mediated by catalyst 64.  
 
A highly efficient organocatalytic aziridination of ,-unsaturated 
aldehydes was disclosed by Córdova and co-workers to be promoted by 
the simple chiral pyrrolidine derivative 25b (Scheme 5.10). Both branched 
terminal and linear 1,2-disubstituted olefins were suitable substrates for 
this reaction furnishing the corresponding aziridines with quaternary or 
tertiary stereocentres with high enantioselectivity.145 The mechanism 
proposed by the authors involved the formation of an iminium ion 
intermediate between the aldehyde and the catalyst. 
                                                          
144 F. Pesciaioli, F. De Vincentiis, P. Galzerano, G. Bencivenni, G. Bartoli, A. Mazzanti, P. 
Melchiorre, Angew. Chem. Int. Ed. 2008, 47, 8703. 
145 a) J. Vasely, I. Ibrahem, G. L. Zhao, R. Rios, A. Còrdova Angew. Chem. Int. Ed. 2007, 
46, 778; b) L. Deiana, G. L. Zhao, S. Lin, P. Dziedzic, Q. Zhang, H. Leijonmarck, A. 
Còrdova, Adv. Synth. Catal. 2010, 352, 3201; d) A. Desmarchelier, D. Peirera de Sant’Ana, 
V. Terrasson, J. M. Campagne, X. Moreau, C. Greck, R. M. de Figueiredo, Eur. J. Org. 
Chem. 2011, 4046. 
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Scheme 5.10 Enantioselective aziridination promoted by catalyst 27. 
 
Terminal aziridines are prone to regioselective opening with a variety of 
nucleophiles. In substrats bearing a quaternary stereocenter, important -
substituted amino acid derivatives can be obtained.146 Indeed quaternary 
-amino-acids are gaining more importance because of their biological and 
chemical properties, activity and applicability in biochemical and drug 
discovery research. 
 
5.2 Results and Discussion147 
 
With this background in mind and taking into account the few methods 
available for the asymmetric synthesis of terminal aziridines bearing a 
                                                          
146 For some reviews, see: a) H. Vogdt, S. Bräse, Org. Biomol. Chem. 2007, 5, 406; b) C. 
Cativiela, M. D. Díaz-de-Villegas, Tetrahedron: Asymmetry 2007, 18, 569. 
147 The results presented in this chapter are partially reported in the paper: C. De Fusco, T. 
Fuoco, G. Croce, A. Lattanzi, Org. Lett. 2012, 14, 4078. 
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quaternary stereocenter, the aziridination reaction of a new class of 
electron-poor terminal olefins was investigated. Olefins 65 with N-
protected hydroxylamine derivatives as pro-nucleophile gave the terminal 
N-protected aziridines 66 (Scheme 5.11). We envisioned that bifunctional 
organocatalysts could promote the aza-MIRC reaction under general acid-
base catalysis. Indeed when hydrogen bonded to the catalyst, the thus- 
generated prochiral aza-Michael adduct could close in a preferential 
manner to afford enantioenriched aziridine. 
 
Scheme 5.11 General scheme for the synthesis of aziridines 66. 
 
5.2.1 Synthesis of Starting Materials 
The required methylene -ketoesters were prepared from the 
corresponding -ketoesters, which could be synthetized through two 
different strategies. Following a literature procedure148 methyl ketones 67 
were reacted with the proper carbonate (methyl or ethyl) with NaH as 
base, to give the condensation products 68 with good to excellent yields 
(Scheme 5.12).  
 
Scheme 5.12 Synthesis of -ketoesters from ketones and carbonate. 
                                                          
148 Y. Jiang, X. Chen, Y. Zheng, Z. Xuel, C. Shu, W. Yuan, X. Zhang, Angew. Chem., Int. 
Ed. 2011, 50, 7304. 
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This procedure could not be extended to tert-butyl and benzyl ketoesters 
to obtain the desired products 68l and 68m and a different approach was 
employed. Acyl halide 69 was added to a solution of the corresponding 
ester 70 with LDA to give the products in satisfactory yield (Scheme 5.13).  
 
Scheme 5.13 Synthesis of tBu and Bn -ketoesters. 
 
The -carbamoylester 68n was also synthetized via condensation between 
diethyl malonate and benzylamine in the presence of molecular sieves 
(Scheme 5.14). 
 
Scheme 5.14 Synthesis of the -carbamoylester 68n. 
 
The dicarbonyl compounds were subjected to a methylenation reaction, 
according a procedure reported in the literature,149 in which formaldehyde 
and diisopropylammonium trifluoroacetate 71 were employed (Scheme 
5.15). 
                                                          
149 A. Bugarin, K. D. Jones, B. T. Connell, Chem. Commun. 2010, 46, 1715. 
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Scheme 5.15 Synthesis of terminal olefins 65. 
 
Acrylates 65 were prone to polymerization reaction, so they have to be 
used freshly prepared. 
 
5.2.2 Asymmetric Aziridination Reaction  
First experiments were directed to select a good class of promoters for the 
aziridination reaction of model ethyl benzoyl acrylate 65a with Boc or Cbz 
N-protected O-tosyl hydroxylamines 63a and b, as summarized in Table 
5.1. For the first screening a stoichiometric amount of structurally 
different bifunctional organocatalysts was employed because in the 
process p-toluene sulfonic acid is released in the reaction mixture and 
could poison the organocatalyst.  
Quinine 1 furnished the aziridine 66a in high yield but almost as a 
racemate (entry 1), whereas with cinchona derived thioureas 72 a 
significant improvement of the enantioselectivity could be observed (entry 
2). Reagent 63b gave slightly inferior results in terms of stereocontrol with 
catalysts 72 and 28 (entries 3 and 4). Pleasingly, performing the reaction 
with the Takemoto thiourea 73a led to the product with 72% and 69% ee 
respectively for compound 63a and 63b (entry 5 and 6). Structurally 
similar thioureas 7 and 73b were tested, but the primary amine derivative 
7 gave a racemic product, whereas 73b, bearing longer alkyl chains at the 
nitrogen atom, afforded the product with 56 % ee (entries 7 and 8).  
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Table 5.1 Screening of the catalysts for the aziridination reaction between 
nitrogen nucleophiles 63 and acrylate 65a.a  
 
Entry 63 Promoter t (h) yield %b ee %c 
1d 63a 1 2 90 9  
2 63a 72 6 92 -51  
3 63b 72 6 40 -47  
4 63b 28 4 77  -45  
5 63a 73a 7 76 72  
6 63b 73a 5 59 69  
7 63a 7 5 42 Rac  
8 63a 73b 2 99 56  
9 63a 74 2 50 36 
10e 63a 75 2 43 14 
11 63a 76 24 96 10  
12 63a 77 21 71 -10  
13d 63a 29a 6 93 39  
14 63b 29a 6 75 46  
15 63a 29e 5 72 38  
16 63b 29e 15 84 48   
a Unless otherwise noted, reactions were carried out with 65a 
(0.1 mmol), 63(0.1 mmol), catalyst (0.1 mmol) in toluene (2 
mL). bIsolated yield after flash chromatography. cDetermined 
by HPLC analysis.d Reaction performed at C = 0.1 M e Reaction 
performed with 5 mol% of catalyst 75 with K2CO3 (0.1 mmol). 
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The diphenyl dimethyldiamine based thiourea 74 was less efficient than 
Takemoto catalyst 73a (entry 9). Squaramide 75, employed at catalytic 
loading due to its low solubility, revealed to be moderately active but less 
selective that the corresponding thiourea 73a (entry 10). Catalysts bearing 
a sulfonamide unit 76 and 77 proved to be active although poorly 
enantioselective compounds (entries 11 and 12). Finally, diaryl prolinols 
29a, e gave good conversion to the product, although a moderate level of 
enantiocontrol was observed (entries 13-16) These findings showed that 
catalyst being able to provide double hydrogen bonding interactions, such 
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as thiourea derivatives, proved to be the most efficient catalysts for this 
reaction. 
Phase transfer catalyst 60 was also tested, although it proved to be a 
poorly effective promoter (scheme 5.16).  
 
Scheme 5.16 Aziridination of alkene 65a with phase transfer catalysis. 
 
Different ambiphilic nitrogen sources were then investigated in the 
presence of the catalyst 73a,150 showing that the nature of N-protecting 
(PG) and leaving groups (LG) had a strong effect on the reactivity and the 
selectivity of the reaction (Table 5. 2). The Boc protected tosyl 
hydroxylamine 63a was confirmed to be the most effective nucleophile 
although the Cbz-protected 63b gave similar results (entries 1 and 2). The 
tosyl protecting group had a detrimental effect on the stereocontrol (entry 
3), as previously noted for the analogous reaction on the aldehyde.145a The 
acetate derivative did not react and only starting material was recovered 
(entry 4). The phosphinate protected compound  63f afforded a modest 
result in terms of enantiocontrol (entry 5).  
 
                                                          
150 For the synthesis of the protected amine, see: a) Ł. Albrecht, H. Jiang, G. Dickmeiss, B. 
Gschwend, S. G. Hansen, K. A. Jørgensen, J. Am. Chem. Soc., 2010, 132, 9188; b) L. 
Deiana, P. Dziedzic, G.-L. Zhao, J. Vesely, I. Ibrahem, R. Rios, J. Sun, A. Córdova, Chem. 
Eur. J. 2011, 17, 7904. 
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Table 5.2 Screen of protecting and leaving groups on the nitrogen source.a 
 
Entry 63 t (h) 66a yield (%)b ee (%)c 
1 63a 7 66aa 76 72 
2 63b 4.5 66ab 59 69 
3 63c 21 66ac 61 36 
4 63e 3 66aa / / 
5 63f 1 66aa 39 34 
a Unless otherwise noted, reactions were carried with 65a 
(0.1 mmol), 63 (0.1 mmol), catalyst (0.1 mmol) in toluene (2 
mL). b Isolated yield after flash chromatography. c 
Determined by HPLC analysis on a chiral stationary phase. 
 
In order to develop a catalytic aziridination reaction a variety of basic 
additives were tested as scavengers of p-toluene sulfonic acid. Organic 
and inorganic bases, at stoichiometric loading, were added under 
previously optimized conditions (Table 5.3). Organic bases appeared to 
compete with the organocatalyst, leading to loss of enantioselectivity 
(entries 1-2). Inorganic bases were more effective as illustrated when using 
NaHCO3,  AcONa, PhCO2Na, Na2CO3 and K2CO3 which provided the 
product with good level of enantioselectivity (entries 3-7). 
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Table 5.3 screening of the basic additive in the catalytic aziridination 
reaction. a 
 
Entry Base t(h) yield %b ee%c 
1 Et3N 0.5 40 46 
2 Proton-sponge 0.5 58 58 
3 NaHCO3 2 70 65 
4 AcONa 2 69 78 
5 PhCO2Na 1.5 48 78 
6 Na2CO3 3 68 76 
7 K2CO3 2 72 78 
8 K2CO3d 2 67 66 
9 K2CO3e 2 30 0 
a Reaction conditions: 65a (0.1 mmol), 63a (0.1 mmol), and 73a (0.03 
mmol) in 2mL of toluene. b Yield of isolated product. c Determined by 
HPLC analysis on a chiral stationary phase. d 3 eq of K2CO3 were 
employed. e Background reaction, performed in the absence of the 
catalyst. 
 
K2CO3 revealed to be the most suitable base furnishing the product with 
72% yield and 78% ee (entry 7). An excess of the base resulted in a drop of 
reactivity and enantiocontrol (entry 8). To check the relevance of 
background aziridination provided by K2CO3, the reaction was carried out 
without the organocatalyst (entry 9). The racemic route to aziridine was 
not found to be a negligible process. 
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Other reaction parameters were screened in the asymmetric catalytic 
aziridination (Table 5.4). 
Table 5.4 Optimization of reaction parameters.a 
 
Entry Solvent T(°C) t(h) yield %b ee %c 
1 m-xylene rt 2 63 72 
2 Diethyl ether rt 2.5 83 68 
3 Cl-benzene rt 2 39 58 
4 chloroform rt 2 69 54 
5 C6F6 rt 2 44 50 
6 toluene 0 2 98 74 
7 d toluene 0 3.5 95 78 
8d toluene -20 24 91 66 
a Unless otherwise noted, reactions were carried with 65a (0.1 
mmol), 63a(0.1 mmol), catalyst (0.03 mmol) in toluene (2 mL). 
bIsolated yield after flash chromatography. cDetermined by HPLC 
analysis on a chiral stationary phase. d  20 mol% of 73a. 
 
m-Xylene furnished the product in moderate yield and 72% ee (entry 1) 
and diethyl ether improved the conversion maintaining the level of 
enantioselectivity (entry 2). Halogenated solvents had a detrimental effect 
on the reactivity and the stereocontrol of the reaction (entries 3-5). 
Lowering the temperature helped to significantly improve the conversion 
to the product although without observing any enhancement of the 
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enantioselectivity (entry 6 and 8). Reduced catalyst loading to 20 mol%, 
when working at 0°C, enabled to achieve a satisfactory result (entry 7). 
With the optimised conditions in hands, we examined the scope of the 
aziridination reaction (Table 5.5). 
Table 5.5 Scope of the aziridination reaction.a  
 





1 Ph CO2Et 3.5 66a 95 78 
2 4-MeC6H4 CO2Et 8 66b 84 78 
3 3-MeC6H4 CO2Et 18 66c 80 82 
4 2-MeC6H4 CO2Et 8 66d 91 50 
5 4-MeOC6H4 CO2Et 29 66e 93 80 
6 4-ClC6H4 CO2Et 20 66f 98 78 
7 3-BrC6H4 CO2Et 16 66g 87 70 
8 2-naphthyl CO2Et 15 66h 93 74 
9 2-furyl CO2Et 19 66i 86 74 
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CO2Et 24 66j 67 74 
11 Ph CO2Me 6 66k 79 78 
12 Ph CO2tBu 5 66l 83 76 
13 Ph CO2Bn 4 66m 79 72 
14 Ph PO(OEt)2 15 66n 72 50 
15 NHBn CO2Et 18 66o 82 72 
a Reaction conditions: 65 (0.1 mmol), 63a (0.1 mmol), 73a (0.02 mmol), 
K2CO3 (0.1 mmol) in 2 mL of toluene. b Yield of isolated product.c 
Determined by HPLC analysis on a chiral stationary phase. 
 
Electron withdrawing and electron donating substituents on the aromatic 
ring were well tolerated at the para and meta positions, while the ortho 
methyl derivative 65d led to the corresponding aziridine in good yield but 
lower ee values (entries 2-7). The naphthyl and heteroaromatic derivatives 
65h, 65i afforded the corresponding aziridines in high yield and 74% ee 
(entries 8-9). The cyclohexenyl acrylate 65j was slightly less reactive but 
the reaction was regioselective and the product was obtained with 74% ee 
(entry 10). The bulkiness and the nature of the ester group in the acrylate 
65 slightly influenced the outcome of the reaction (entries 11-13). 
Different functionalities, such as phosphonate and amide groups were 
tolerated on the starting alkene, leading to the aziridines with slightly 
lower enantioselectivity (entries 14-15). 
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5.2.3 Determination of the Absolute Configuration 
The absolute configuration of the quaternary sterocenter of the aziridines 
66 was determined to be R by X-ray analysis on a single crystal of the 
naphthyl derivative 66h (Figure 5.5).  
           
Figure 5.5 Crystal structure of aziridine 66h. 
 
With the knowledge of the absolute configuration and reminding the 
transition state proposed by Takemoto in the Michael addition to imides 
with the catalyst 73a,114a we speculated on the origin of the enantiocontrol 
that occurred in the second step. The prochiral enolate, formed by attack 
of the nucleophile to the olefin, is involved in a hydrogen bonding network 
with the catalyst, so that the intramolecular SN2 displacement is assisted 
by the ammonium portion of the catalyst. Preferential Re-face closure 
would lead to the R enantiomer (Figure 5.6). 
 
Figure 5.6 Transition state proposal for the ring closure step. 
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5.2.4 Regioselective Opening of the Aziridine 66a 
Enantiomerically enriched terminal aziridines are interesting 
intermediates for the synthesis of highly desirable amino acid derivatives. 
A preliminary investigation demonstrated the synthetic potential of 
aziridine 66a to obtain ,-disubstituted -amino acid esters with a 
quaternary center (Scheme 5.17).  
 
Scheme 5.17 Access to ,-disubstituted -amino acid esters from 
aziridine 66a. 
 
Enantioenriched aziridine 66a was deprotected with tetrabutyl ammonium 
fluoride (TBAF) to furnish the aziridine 78 in excellent yield. Ring opening 
of the aziridine with an ethereal solution of HCl was found to give 
regioselectively the expected -aminoacid ester 79 with 95% yield. No 
racemization occurred as proved by HPLC analysis conducted on the Cbz-
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In conclusion an asymmetric aza-MIRC process for the synthesis of highly 
functionalised terminal aziridines bearing a quaternary stereogenic center 
employing the commercially available thiourea 73a/K2CO3 system was 
developed. By reacting easily available -acyl acrylates with tosyloxy 
carbamates, the aziridines were obtained in high yield and good 
enantioselectivity, up to 82% ee. The aziridines represent valuable 
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6. AN ORGANOCATALYTIC SYNTHESIS OF 
HELICENES 




6.1.1 The Fischer indolization 
The Fischer indolization is still one of the main routes to synthesize 
indoles. It was discovered more than 120 years ago that heating the 
hydrazone 81 (derived from N-methyl phenyl hydrazine  82 and piruvic 
acid) in hydrochloric acid a new compound was obtained with loss of 
ammonia (Scheme 6.1).151 
 
Scheme 6.1 Fischer indolization route to access indoles. 
 
Initially proposed mechanisms eventually were shown to be wrong and 
only in 1924 Robinson and Robinson proposed the mechanism that is still 
accepted today (Scheme 6.2). It involvs a [3,3]-sigmatropic rearrangement 
and the generated imine undergoes intramolecular attack. By loss of 
ammonia the energetically favoured indole ring is formed.152  
                                                          
151 a) E. Fischer, F. Jourdan, Ber. Dtsch. Chem. Ges. 1883, 16, 2241; b) E. Fischer, O. 
Hess, Ber. Dtsch. Chem. Ges. 1884, 17, 559.  
152 G. M. Robinson, R. Robinson, J. Chem. Soc., Trans. 1924, 125, 827. 
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Scheme 6.2 Accepted mechanism for the Fischer indolization.  
The Fischer indolization usually requires rather harsh conditions and a 
stoichiometric amount of acid to efficiently promote the reaction since 
ammonia is developed as by-product that can potentially quench the acid. 
Indole is a flat, achiral molecule but it is also possible to generate chiral 
products by means of Fischer indolization: enantioenriched indolenines 
and tetrahydrocarbazoles are only two of the possible examples. Recently, 
the List group reported the first catalytic asymmetric version of the 
Fischer indolization on 4-substituted cyclohexanone-derived 
phenylhydrazones. It was promoted by 5 mol % of a novel spirocyclic 
chiral phosphoric acid 83, with a weakly acidic cation-exchange polymer 
as ammonia scavenger (Amberlite® CG50) (Scheme 6.3).35 
 
Scheme 6.3 The first asymmetric catalytic Fischer indolization. 
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The mechanism proposed by the authors involves a dynamic kinetic 
resolution in which one of the two possible diastereoisomeric ion pairs 
hydrazone-catalyst undergoes the [3,3] sigmatropic rearrangement to give 
the product at a higher rate (Scheme 6.4). The two complexes hydrazone-
substrate are reversibly formed via protonation of the substrate by the 
chiral catalyst, followed by the irreversible pericyclic process thus leading 
to a quantitative yield of the highly enantioenriched product.  
 
Scheme 6.4 Proposed mechanism based on a kinetic dynamic resolution. 
 
Another possible application of the asymmetric Fisher indolization could 
involve the synthesis of helical chiral molecules containing an indole 
moiety (Scheme 6.5). 
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“Helicenes are polycyclic aromatic compounds with nonplanar screw-
shaped skeletons formed by ortho-fused benzene or other aromatic 
rings.”153 They are known to have interesting optical and electronic 
properties exploited in some applications (as ligands, chiral auxiliaries or 
catalysts, but also as molecular machines and dye material). The bottle 
neck to their wide diffusion still concerns their synthesis and/or 
resolution; the main strategies developed until now to obtain 
enantioenriched and functional helicenes involve the use of chiral starting 
materials154 or chiral auxiliaries155 (Scheme 6.6). 
 
                                                          
153 For a review see: Y. Shen, C. F. Chen, Chem. Rev. 2012, 112, 1463. 
154 a) K. Nakano, Y. Hidehira, K. Takahashi, T. Hiyama, K. Nozaki, Angew. Chem. Int. Ed. 
2005, 44, 7136; b) K. Yavari, S. Moussa, B. Ben Hassine, P. Retailleau, A. Voituriez, A. 
Marinetti, Angew. Chem., Int. Ed. 2012, 51, 6748; c) J. Žádný, A. Jančařík, A. Andronova, 
M. Šámal, J. Chocholoušová, J. Vacek, R. Pohl, D. Šaman, I. Císařová, I. Stará, I. Starý, 
Angew. Chem., Int. Ed. 2012, 51, 5959. 
155 M.C. Carreño, S. García-Cerrada, A. Urbano, J. Am. Chem. Soc. 2001, 123, 7929. 
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Scheme 6.6 Synthesis of optically active and functional helicenes. 
 
Only few examples of asymmetric catalytic synthesis of helicenes can be 
found in the literature, based on starting materials requiring multi-step 
synthesis and suffering from lack of a wide substrate scope. Tanaka in 
2007 and in 2012 proposed two Rh-catalyzed reactions to access helicenes 
and hetero-helicenes (Scheme 6.7).156 
                                                          
156 a) K. Tanaka, A. Kamisawa, T. Suda, K. Noguchi, M. Hirano, J. Am. Chem. Soc. 2007, 
129, 12078; b) Y. Sawada, S. Furumi, A. Takai, M. Takeuchi, K. Noguchi, K. Tanaka, J. 
Am. Chem. Soc. 2012, 134, 4080. 
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Scheme 6.7 Asymmetric Rh-catalyzed synthesis of helicenes. 
 
6.2 Results and Discussion 
 
6.2.1 Preliminary Studies 
On the basis of previous results obtained in the List group,35 mixing the 
hydrazine 84 and 2-tetralone in EtOH with a catalytic amount of acetic 
acid at 60 °C the hydrazone was expected to form. Instead, the only 
isolated compound was the Fisher indolization product (Scheme 6.8). 
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Scheme 6.8 Indole formation by reaction of hydrazine and tetralone. 
 
Performing the reaction with the polycyclic aromatic ketone 85 and 
stoichiometric amount of the diphenyl phosphoric acid (DPP), the 
dihydrohelicene 86a was obtained after few hours at room temperature 
(Scheme 6.9). 
 
Scheme 6.9 Synthesis of the dihydrohelicene 86a by means of Fischer 
indolization. 
 
The influence of Amberlite CG50 and MS on the rate of the process was 
investigated in the racemic reaction between dimethyl N-PIB protected 
hydrazine 84a and the polycyclic ketone 85 (Figure 6.1). 
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Figure 6.1 Influence of the CG50 and the molecular sieves on the rate of 
the process. 
 
Background reactions in the absence of the catalyst were not observed 
using either CG50 alone or molecular sieves alone (lines a and b). In the 
presence of 5 mol% of the diphenyl phosphoric acid (DPP) the reaction 
proceeded slowly, but seemed to have a certain extent of turnover, indeed 
after 24 hours the NMR yield was 34% (line c). The presence of molecular 
sieves did not improve the reactivity of the system (line d), while the 
reaction rate substantially increased with the addition of the weakly acidic 
polymer Amberlite CG50 (the NMR yield was more than 80 % in 5 hours) 
(line e). The presence of both molecular sieves and CG50 was detrimental 
for the NMR yield of the process (line f), even if it is important to consider 




















CG50 (a) MS (b) 
DPP (5 mol%) (c) DPP + MS (d) 
DPP + CG50 (e) DPP + CG50 + MS (f) 
*With trimethoxy 
benzene as the 
internal standard. 
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Among different BINOL and SPINOL-based phosphoric acids, the SPINOL-
pyrene derivative 87 proved to be the best catalyst and dichloromethane 
the best solvent to achieve the highest enantioselectivity (Scheme 6.10). 
 
Scheme 6.10 Catalyst 87 as the best promoter for the Fischer 
indolization reaction. 
 
Reaction conditions were optimized performing the reaction with 5 mol% 
of catalyst 87 at -6°C (Table 6.1). The amount of CG50 did not seem to 
affect the enantioselectivity up to 1g/mmol ratio of CG50 to substrate 
(entries 1-3) but with a ratio of 2g/mmol, the enantioselectivity dropped 
(entry 4). Decreasing the ratio of molecular sieves to substrate from 2 to 0 
g/mmol facilitated a slight increase in enantiocontrol up to 91% ee 
(entries 5-7). The selectivity of the reaction did not significantly improve 
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C (M) eeb 
1 0.1 0.5 0.1 88 
2 0.5 0.5 0.1 90 
3 1 0.5 0.1 88 
4 2 0.5 0.1 81 
5 0.5 2 0.1 81 
6 0.5 1 0.1 88 
7 0.5 / 0.1 91 
8 0.5 / 0.05 84 
9 c 0.5 / 0.2 87 
a reaction conditions: 84a (0.025 mmol) and 85 (0.025 mmol) 
in CH2Cl2 with 87 (1.25*10-3 mmol) and CG50 and/or MS. b 
determined by HPLC analysis on a chiral stationary phase. c 
20 h  
 
A brief screen of catalyst loading was then performed at room temperature 
(Table 6.2). The model reaction carried out at room temperature with 5 
mol% of catalyst afforded the product with 80% ee after 18h (entry 1). 
Decreasing or increasing the amount of the phosphoric acid 87 reduced 
and improved the yield, respectively, without affecting the enantiocontrol 
(entries 2 and 3).  
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Table 6.2 Catalyst loading study.a  
 
Entry 87 (mol%) NMR yieldb eec 
1 5 39 80 
2 2 27 79 
3 10 51 80 
a Reaction conditions: 84a (0.025 mmol) and 85 (0.025 
mmol) in CH2Cl2 in 250 L with 87 (1.25*10-3 mmol) and 
CG50 and/or MS. b Determined using trimethoxy benzene 
as the internal standard; c Determined by HPLC analysis on 
a chiral stationary phase. 
 
The reaction carried out with hydrazine 84a and ketone 85, under the 
optimized conditions, furnished the product 86a with 74% yield and 91% 
ee. The employment of the naphthyl hydrazine 88a with the same ketone 
led to the expected product 89a in 56% yield and 79% ee (Scheme 6.11). 
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Scheme 6.11 Synthesis of the helicenes 86a and 89a. 
 
6.2.2 Synthesis of the Starting Materials.  
 
6.2.2.1 Synthesis of the Hydrazines 
N-Protected hydrazines were synthesized following a literature 
procedure.157 The hydrazine hydrochloride salt was treated with NaHCO3 
and the appropriate benzyl bromide in H2O at 100°C to give the 
substitution product. Differently N-protected 3,5-dimethyl-phenyl 
hydrazine 84a-e were obtained reacting 3,5-dimethyl-hydrazine 
hydrochloride salt 90 with differently substituted benzyl bromides 
(Scheme 6.12).  
                                                          
157 R. B. Perni, G. W.  Gribble, Org. Prep. Proced. Int. 1982, 14, 343. 
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Scheme 6.12 Differently N-protected 3,5-dimethyl-phenyl hydrazines 
84a-e. 
 
Following the same procedure, naphthyl hydrazine hydrochloride salt 91 
and 2,5-dimethyl hydrochloride salt 92 were employed to synthesize the 
p-iodo and p-trifluoromethyl benzyl naphthylhydrazines 88a and 88b and 
the p-iodo benzyl 2,5-dimethyl-phenyl hydrazine 93, although the latter 
compound showed to be particularly unstable (Scheme 6.13). Yields of the 
desired products were only moderate because the reaction led to a mixture 
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Scheme 6.13 Synthesis of hydrazines 88a, b and 93. 
 
6.2.2.2 Synthesis of Ketones 
The ketones were synthesized following procedures reported in the 
literature.158 Refluxing methoxybenzylchloride 94 and triethylphosphite 
led to the methoxy benzylphosphonate 95 (Scheme 6.14 a). 95 was 
reacted with the aldehydes 96a-c in DMF and with tBuOK as the base to 
furnish the corresponding stilbenes 97a-c. Compounds 97a-c were then 
subjected to a photochemical rearrangement with a Rayonet apparatus at 
300 nm under acid conditions in CH3CN to afford the ketones in low yield 
(Scheme 6.14 b). 
 
                                                          
158 a) J.-H. Ho, T.-I. Ho, R. S. Liu, Org. Lett. 2001, 3, 409; b) A. S. Khartulyari, M. Kapur, 
M. E. Maier, Org. Lett. 2006, 8, 5834. 
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Scheme 6.14 Synthetic route to ketones 85, 98 and 99. 
 
The dibromo stilbene derivative 100, obtained from dibromobenzaldehyde 
and phosphonate 95, was subjected to the Suzuki coupling with naphthyl 
and phenyl boronic acids to give the corresponding products 101 and 102 
in high yield. Unfortunately, the naphthyl derivative 101 was not a 
suitable substrate for the cyclization reaction (Scheme 6.15 a), whereas 
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the diphenyl substituted stilbene 102 was successfully subjected to the 
cyclization reaction to give the polycyclic compound 103 (Scheme 6.15 b). 
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6.2.3 Study of the N-protecting Group 
Replacement of the p-iodo benzyl group with the simple benzyl group 
(hydrazine 84b) or the p-tert-butyl benzyl (hydrazine 84c) or the m,m-
trifluoromethylbenzyl (hydrazine 84d) significantly decreased the 
enantiocontrol. The p-trifluoromethyl benzyl hydrazine 84e furnished the 
product with a comparable level of enantioselectivity to the PIB protected 
compound (Scheme 6.16). 
 
 
Scheme 6.16 Screen of different N-protecting groups. 
 
The p-trifluoromethyl benzyl protecting group was tested on the naphthyl 
hydrazine (88b) leading to a result comparable to the reaction conducted 
on the PIB protected derivative (Scheme 6.17). 
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Scheme 6.17 Use of naphthyl hydrazine 88b in the reaction. 
 
The N-unprotected naphthyl hydrazine gave the desired product with only 
modest enantiocontrol (Scheme 6.18). 
 
Scheme 6.18 Fischer indolization with unprotected naphthyl hydrazine 
88c. 
 
6.2.4 Substrate Scope and Limitation of the Reaction 
The dimethyl phenyl hydrazine 84a (Table 6.3) and the naphthyl 
hydrazine 88a (Table 6.4) were reacted with different ketones under the 
optimized conditions. When reacting dimethyl phenyl hydrazine 84a with 
the phenanthrene containing ketone 98 and the thiophene derivative 99, 
respectively products 104 and 105 were obtained in good yield and high 
enantioselectivity. 
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Table 6.3 Scope of the reaction with the hydrazine 84a.  
 

















a Reaction conditions: 84a (0.05 mmol) and the ketone (0.05 mmol) in CH2Cl2 
(250 L) with 87 (1.25*10-3 mmol) and CG50 (500 mg/mmol). b Isolated yield 
after flash chromatography. c Determined by HPLC analysis on a chiral 
stationary phase.  d Racemization observed, in 5 hours the isolated product 
was found as a racemate. 
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Ketone 103 furnished a product whose enantiomeric excess decreased 
over time (from 67% ee to racemate in 5 hours). 
Table 6.4 scope of the reaction with the hydrazine 88a. 
 















a reaction conditions: 88a (0.05 mmol) and the ketone (0.05 mmol) in CH2Cl2 
(250 L) with 87 (1.25*10-3 mmol) and CG50 (500 mg/mmol). b isolated yield 
after flash chromatography. c determined by HPLC analysis on a chiral 
stationary phase.  d reaction performed at -2°C.  
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Naphthyl hydrazine 88a, reacted with ketones 85, 98, 99 and 103, 
afforded the products with up to 84% ee, showing a lower enantiocontrol 
with respect to the results presented in Table 6.3.  
Interestingly, diphenylketone 103 provided the product with 76% ee, 
which was found stable towards time-dependent racemization. 
Finally, the 2,5-dimethyl hydrazine 93 gave a poor result in terms of yield 
and enantioselectivity possibly due to its instability (Scheme 6.19). 
 
Scheme 6.19 Reaction performed starting from the 2,5-dimethylhydrazine 
93. 
 
6.2.5 Configuration of the Helicenes and their Reactivity 
A general correlation between the optical activity and stereochemistry 
(helicity) of helicenes has been established.159 The synthesized compounds 
were levorotatory (  D < 0) so it was possible to assign the M 
configuration, and this was also proved by X-ray crystallographic analysis 
of the compound 86a (Figure 6.2). 
                                                          
159 R. H. Martin, Angew. Chem., Int. Ed. 1974, 13, 649. 
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Figure 6.2 Crystallographic structure of the compound 86a  
 
The dihydrohelicenes are prone to oxidation to the aromatic derivatives, as 
it was observed in the case of compound 86e. The 1H-NMR analysis of a 
CDCl3 solution of compound 86e showed the formation, over time, of a by-
product corresponding to the oxidized compound 111 (Scheme 6.20). 
 
Scheme 6.20 Aromatic helicene found as by-product of 86e. 
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6.2.6 Preliminary Studies on the Double Indolization Process 
A diketone was then targeted in order to perform a double indolization on 
each of the ketone moieties leading longer helicene structures. Tetralone 
112 was first reacted with ethyl formate to give the 2-hydroxymethylene 
derivative 113, which was then reacted with methyl vinyl ketone to give 
the tricyclic compound 114. The ketone was protected with glycol as a 
ketal and the isomerization of the double bond concurrently occurred. The 
intermediate was then oxidized with DDQ to give compound 115. 
Dearomatization with Na in EtOH, followed by a strongly acidic work up 
furnished the desired product 116. On the contrary, ketal 117 was 
obtained under weakly acidic work up (Scheme 6.21).160 
 
Scheme 6.21 Synthesis of compound 116 and 117. 
                                                          
160 a) R. B. Turner, D. E. Nettleton, R. Ferebee, J. Am. Chem. Soc. 1956, 78, 22, 5923; b) 
M. C. Carreño, M. González-López, A. Urbano, Chem. Commun. 2005, 611. 
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Unfortunately, the reaction between naphthyl hydrazine 88a and diketone 
116 afforded only traces of the desired product 118 with 73% ee (Scheme 
6.22). 
 
Scheme 6.22 Synthetic attempt to a double Fischer indolization process.  
 
Reacting 1 equivalent of dimethyl phenylhydrazine 84a with diketone 116, 
the product of single Fisher indolization could be detected and isolated. 
This compound was then reacted with another equivalent of hydrazine 
84a but the reaction did not proceed to the desired product 120 and only 
unidentified by-products were formed (Scheme 6.23). 
 
Scheme 6.23 Synthetic attempt to a stepwise double Fischer indolization. 
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The double Fisher indolization between hydrazines 84a and 88a and bis-
ketone 116 to access structurally more extended helicenes will be subject 




In conclusion, preliminary interesting results have been achieved on the 
Fischer indolization between hydrazines and polycyclic ketones catalysed 
by SPINOL-based phosphoric acids. The challenging helical products were 
obtained in good yield and good to high enantiocontrol. An approach to 
extended helicenes via double indolization has been also designed. 
SUMMARY 
 




Chirality, often found in many natural products and in molecules of 
interest for pharmaceutical applications and for biological studies, is 
targeted in many synthetic strategies. In this PhD work, several 
methodologies were developed aimed to form C-C and C-heteroatom bonds 
in a stereoselective fashion, by employing easily accessible small organic 
molecules as promoters. The investigations focused on Michael type and 
MIRC (Michael Initiated Ring Closure) reactions by employing different 
Michael acceptors and donors, and testing several bifunctional 
organocatalysts. Our interest was directed towards those catalytic 
processes where the substrates were activated through a non-covalent 
activation mode by the organocatalyst.  
Since heteroatom-containing three-membered rings are among the most 
useful and important synthetic targets in organic chemistry, a significant 
part of the PhD work was spent to develop new methodologies to produce 
enantioenriched epoxides and aziridines. A new class of functionalised 
epoxides was synthesized via a diastereo- and enantioselective 
nucleophilic epoxidation of trisubstituted electron-poor olefins bearing a 
cyano group (Scheme 7.1). 
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A commercially available diaryl prolinol was employed and the desired 
epoxides were obtained in high yield, complete diastereoselectivity and 
good enantioselectivity. As an example of the synthetic utility of these 
compounds, reduction of the carbonyl compound was performed on model 
epoxide to generate the corresponding synthetically challenging electron-
poor epoxy alcohol with good diastereocontrol (Scheme 7.2). 
 
Scheme 7.2 Reduction of the carbonyl moiety to obtain the epoxy alcohol 
37. 
 
Diaryl prolinols were also found to be efficient catalysts in the asymmetric 
Michael addition of cyclic -ketoesters to nitroolefines. An unusual and 
impressive effect of hexafluorobenzene as solvent was disclosed, able to 
turn the process from scarcely to highly stereoselective. The desired 
products were obtained in excellent yield, almost as a single 
diastereoisomer and high enantioselectivity (Scheme 7.3). 
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A plausible explanation for reaction rate and stereoselectivity 
enhancement, was provided by DFT calculations. The development of 
stabilizing interactions, between hexafluorobenzene with the negatively 
charged reactive enolate were responsible for the observed selectivity. 
A double Michael type sequence was exploited to construct densely 
functionalized 6-membered rings starting from the easily available 
divinylketones 45 and malononitrile as the nucleophile. The process, 
promoted by low cost quinine, allowed to obtain compounds 46 in 
satisfactory overall yield, high diastereoselectivity and good enantiocontrol 
(Scheme 7.4). 
 
Scheme 7.4 Tandem double Michael reaction for the construction of 
cycloehexanones. 
 
An enantioselective aza-MIRC (Michael Initiated Ring Closure) reaction 
has been developed to access difficult targets such as terminal aziridines 
bearing a quaternary stereocenter. Electron-poor acrylates 65 were 
reacted with the ambiphilic reagent 63a in the presence of a 
substoichiometric amount of commercially available catalyst 73a and 
K2CO3 to furnish the desired aziridines 66 in high yield and good 
enantioselectivity (Scheme 7.5) 
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Scheme 7.5 Aziridination of acrylates 65 mediated by Takemoto catalyst 
73a. 
 
The synthetic potential of this class of aziridines has been demonstrated 
in the regioselective ring-opening of model aziridine 66a to obtain highly 
useful enantiomerically enriched ,-disubstituted -amino acid esters 
(Scheme 7.6). 
 
Scheme 7.6 Deprotection and regioselective ring-opening of the aziridine 
66a to obtain an -amino acid ester derivative. 
 
During the period spent at the Max Planck Institute für Kohlenforschung, 
an asymmetric version of the Fischer indolization for the synthesis of 
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helical molecules was developed. Phosphoric acid 87 was found to 
catalyse the process in the presence of an ammonia scavenger, the 
Amberlite CG50, providing the compounds in good yield and good to high 
stereocontrol (Scheme 7.7). 
 
Scheme 7.7 Asymmetric Fischer indolization catalysed by phosphoric 
acid 87 
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8. EXPERIMENTAL SECTION 
 
8.1 General experimental conditions 
 
General methods and materials 
All reactions requiring dry or inert conditions were conducted in flame 
dried glassware under a positive pressure of nitrogen. Reactions were 
monitored by thin layer chromatography (TLC) on Merck silica gel plates 
(0.25 mm) and visualised by UV light and/or different stain reagents: 
phosphomolybdic acid/ethanol spray test or I2 vapors. Flash 
chromatography was performed on Merck silica gel (60, particle size: 
0.040–0.063 mm). 1H NMR and 13C NMR spectra were recorded on 400 or 
500 MHz spectrometers at room temperature in CDCl3 or CD2Cl2 as 
solvent. Chemical shifts for protons are reported in ppm (δ) relative to 
tetramethylsilane with the solvent resonance employed as the internal 
standard (CD2Cl2 δ 5.32 ppm; CDCl3 δ 7.26 ppm). Data are reported as 
follows: chemical shift (multiplicity (s = singlet, d = doublet, t = triplet, dd 
= double doublet, sept = septet, m = multiplet, br = broad), coupling 
constants (Hz) and integration). 13C chemical shifts are reported in ppm (δ) 
from tetramethylsilane (TMS) with the solvent resonance as the internal 
standard (CD2Cl2, δ 53.8 ppm; CDCl3, δ 77.0 ppm). 
Optical rotations were determined with Jasco Dip-1000 digital polarimeter 
or Autopol IV polarimeter (Rudolph Research Analytical) at 582 nm 
(sodium D-line) using a 3.5 mm x 100 mm cell. Data are reported as 
follows:  temp , concentration (c in g/100 mL), and solvent. 
FTIR spectra were recorded as thin films on KBr plates using Bruker 
Vertex 70 spectrometer and absorption maxima are reported in 
wavenumber (cm-1). 
ESI-MS was performed using a Bio-Q triple quadrupole mass spectrometer 
(Micromass, Manchester, UK) equipped with an electrospray ion source. 
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High resolution mass spectra were determined on a Bruker APEX III FTMS 
(7 T magnet). All masses are given in atomic units/elementary charge 
(m/z) and reported in percentage relative to the basic peak. 
Melting points (uncorrected) were measured on a digital Electrothermal 
9100 apparatus. 
HPLC analyses were performed on a Waters-Breeze 2487 system, 
equipped with a dual absorbance detector and  a 1525 Binary HPLC Pump 
or on a Shimadzu LC-2010C system equipped with a spectrophotometric 
detector. The chiral stationary phase of the columns is specified in each 
experiment. 
The solvents were purified and dried by standard procedures prior to use. 
Anhydrous toluene and all starting materials (unless otherwise noted) 
were purchased from different commercial suppliers and used without 
further purification. Petroleum ether refers to light petroleum ether 
(boiling point 40-60°C).  
 
Catalysts 
Diaryl prolinol derivative catalysts not commercially available were 
synthetized according to a procedure reported by Mathre at al.161 
Peryhydroindolyl methanol derivative 36 was obtained following a 
procedure reported in the literature,162 and NOBIN-prolinamide 41 
synthesis was performed according a procedure by Lattanzi et al.163 
Cinchona alkaloid thioureas were synthetized according the procedure 
introduced by Soós and co-workers,164 and CPD 51 following a procedure 
by Deng.165 Thioureas 7 and 73b and the diphenylethane diamine 
                                                          
161 D. J. Mathre, T. K. Jones, L. C. Xavier, T. J. Blacklock, R. A. Reamer, J. J. Mohan, E. T. 
T. Jones, K. Hoogsteen, M. W. Baum, E. J. J. Grabowski, J. Org. Chem., 1991, 56, 751. 
162 a) R. S. Luo, J. Weng, H. B. Ai, G. Lu, A.S.C. Chan, Adv. Synth. Catal. 2009, 351, 2449; 
b) K. M. B. Gross, Y. M. Jun, P. Beak, J. Org. Chem. 1997, 62, 7679. 
163 A. Russo, G. Botta, A. Lattanzi, Synlett 2007, 5, 795. 
164 B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967. 
165 H. Li, Y. Wang, L. Tang, L. Deng, J. Am. Chem. Soc. 2004, 126, 9906. 
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derivative 74 were prepared following general procedures.166 The 
squaramide 75 was synthesized following the procedure of Rawal et al.167  
Sulfonimides 76 and 77 were obtained following a procedure reported by 
Liang, Ye and co-workers.168 For the synthesis of catalyst 87 a recently 
reported procedure was adapted.35 
 
  
                                                          
166 a) J. M. Mitchell, N. S. Finney, Tetrahedron Lett. 2000, 41, 8431; b) D. E. Fuerst, E. N. 
Jacobsen, J. Am. Chem. Soc., 2005, 127 , 8964; c) L. N. Jia, J. Huang, L. Peng, L. L. Wang, 
J. F. Bai, F. Tian, G. Y. He, X. Y. Xu, L. X. Wang, Org. Biomol. Chem. 2012, 10, 236. 
167 H. Konishi, T. Y. Lam, J. P. Malerich, V. H. Rawal, Org. Lett. 2010, 12, 2028. 
168 F. Yu, X. Sun, Z. Jin, S. Wen, X. Liang, J. Ye, Chem. Commun. 2010, 46, 4589. 
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8.2 Asymmetric Epoxidation 
 
8.2.1 Starting Materials 
Compounds 32 and 34a-m were prepared using general procedures 






Procedure A: to a solution of ethyl 2-cyanoacetate (9 mmol) and 
benzaldehyde (9 mmol) in 30 mL of dry CH2Cl2, Al2O3 (4.5 mmol) and 5 
drops of piperidine were added. The mixture is stirred at room 
temperature until completion, monitored by TLC (eluent: petroleum 
ether/EtOAc 8:2). A solid was formed and the precipitate was filtered and 
purified by flash chromatography (petroleum ether/EtOAc 9:1 as eluent) 
to give the product in 67% yield. 
                                                          
169 For the characterization of the compounds, see also: a) S. Fioravanti, A. Morreale, L. 
Pellacani, P. A. Tardella, Synlett 2004, 1083; b) P. K. Amancha, Y.-C. Lai, I-C. Chen, H.-J. 
Liu, J.-L. Zhu, Tetrahedron 2010, 66, 871; c) S. J. Deshpande, P. R. Leger, S. R. Sieck 
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Procedure B: in a round bottom flask equipped with a condenser to the 
opportune 3-oxo propanenitrile (3 mmol) and aryl aldehyde (3.9 mmol), 
PPh3 (0.6 mmol) was added and the mixture was heated to 80 °C. After 
completion, monitored by TLC (eluent: petroleum ether/Et2O 8:2) the 
mixture was allowed to cool at room temperature, diluted in EtOAc and 
washed with water. The organic phase was dried over Na2SO4  and the 
solvent was removed under reduced pressure. The product was isolated by 
flash chromatography (eluent: petroleum ether/Et2O 9:1) in 54-98% yield. 
Procedure C: to a suspension of NaH (12 mmol) in dry THF (20 mL) under 
a positive pressure of nitrogen acetonitrile (4 mmol) is added. After 30 
minutes under reflux, EtOAC (16 mmol) is added quickly. After 18 h the 
mixture is allowed to cool to room temperature, the solvent was 
evaporated and the mixture was neutralized with HCl 1N and extracted 
with CH2Cl2. The unified organic phases were dried over Na2SO4 and the 
solvent was removed under reduced pressure. The crude was dissolved in 
ethanol, benzaldehyde (4 mmol), a drop of piperidine, and L-Proline (0.8 
mmol) were added and the mixture was heated to reflux. The solution was 
stirred until completion, monitored by TLC (petroleum ether/EtOAc 9:1 as 
eluent), concentrated under reduced pressure and directly subjected to 
flash chromatography (eluent: mixtures of petroleum ether/Et2O 95:5 to 
petroleum ether /EtOAc 9:1) in 42% yield.       
 




1H NMR (CDCl3, 400 MHz) 8.06 (s, 1H), 8.03 (d, J = 
8.2 Hz, 2H), 7.94-7.86 (m, 2H), 7.65-7.62 (m, 1H), 
7.61-7.39 (m, 5H); 13C NMR (CDCl3, 100 MHz)  
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1H NMR (CDCl3, 400 MHz) 8.06 (s, 1H), 7.99 
(d, J = 8.5 Hz, 2H), 7.90-7.86 (m, 2H), 7.67-7.60 
(m, 1H), 7.56-7.49 (m, 4H), 1.36 (s, 9H); 13C 
NMR (CDCl3, 100 MHz)  189.2, 157.8, 155.6, 
136.0, 133.3, 131.2, 129.3, 129.2, 128.6, 126.4, 117.2, 109.0, 35.4, 31.0.   
 
(E)-2-benzoyl-3-(naphthalen-2-yl)acrylonitrile (34f) 
1H NMR (CDCl3, 400 MHz) 8.42 (s, 1H), 8.27-
8.21 (m, 2H), 7.94-7.87 (m, 5H), 7.68-7.62 (m, 
2H), 7.62-7.52 (m, 3H); 13C NMR (CDCl3, 100 
MHz) 189.1, 155.6, 135.9, 135.5, 134.3, 133.4, 132.9, 129.44, 129.40, 
129.34, 129.26, 129.20, 128.7, 127.9, 127.3, 125.3, 117.2, 109.9. 
 
(E)-2-(3-chlorobenzoyl)-3-phenylacrylonitrile (34i) 
1H NMR (CDCl3, 400 MHz) 8.07 (s, 1H), 8.04 (d, 
J = 7.52 Hz, 2H), 7.85 (apparent t, J = 1.8 Hz, 
1H), 7.78 (dd, J = 7.7, 1.1 Hz, 1H), 7.63-7.57 (m, 
2H), 7.55-7.51 (m, 2H), 7.47 (t, J = 7.8 Hz, 1H); 13C NMR (CDCl3, 100 
MHz)  187.6, 156.1, 137.3, 135.1, 133.7, 133.4, 131.6, 131.3, 129.9, 
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(E)-3-(4-bromophenyl)-2-(4-methoxybenzoyl)acrylonitrile (34k) 
1H NMR (CDCl3, 400 MHz) 7.96 (s, 1H), 
7.94 (d, J = 6.8 Hz, 2H), 7.88 (d, J = 8.6 
Hz, 2H), 7.65 (d, J = 8.6 Hz, 2H), 7.00 (d, J 
= 6.9 Hz, 2H), 3.90 (s, 3H); 13C NMR 
(CDCl3, 100 MHz)  186.6, 164.1, 153.3, 132.6, 132.1, 132.0, 130.8, 
128.1, 128.0, 117.1,  114.0, 110.7, 55.6.    
 
8.2.2 Experimental Procedures and Compounds Characterization 
 
General procedure for the synthesis of racemic epoxides 
 A sample vial was charged with the opportune alkene 34 (0.20 mmol), 2-
piperidinemethanol (9.2 mg, 0.080 mmol) and toluene  (1 mL). TBHP (5-6 
M decane solution, 44 L, 0.24 mmol) was added to the solution at room 
temperature. Stirring was maintained until the alkene was consumed as 
monitored by TLC. The crude reaction mixture was directly purified by 
flash chromatography on silica gel (eluent: petroleum ether/Et2O 80:20 ) 
affording the racemic epoxides in 51-99% yield. 
 
General procedure for the asymmetric epoxidation of trans-4-
carbonyl--substituted acrylonitrile 32 and 34a-m. 
A sample vial was charged with alkene (0.20 mmol), catalyst 29b (6.2 
mg, 0.020 mmol) and m-xylene (4.0 mL). TBHP (5-6 M decane solution, 
44 L, 0.24 mmol) was then added to the stirred solution at -20°C. The 
reaction was monitored by TLC (petroleum ether/diethyl ether 80:20 as 
eluent). The solvent was removed under reduced pressure and the 
crude reaction mixture was directly purified by flash chromatography 
on silica gel eluting with mixtures of petroleum ether/Et2O 80:20 to 
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provide the epoxide. Crystallization using n-hexane/iPrOH mixtures 
performed at room temperature gave prismatic crystals in an 
enantioenriched form. 
 
(2R,3S)-ethyl 2-cyano-3-phenyloxirane-2-carboxylate (33) 
White solid, m.p. 34.2-35.6;  24D  = -40.5 (c 0.58, 
CHCl3), 23% ee; FTIR max (KBr)/cm-1 1758, 1719, 
1271, 1053, 750, 724; 1H NMR (CDCl3, 400 MHz) 
7.49-7.41 (m, 5H), 4.52 (s, 1H), 4.46-4.35 (m, 2H), 
1.40 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz)  162.7, 130.4, 129.8, 
128.8, 126.8, 112.9, 64.2, 64.0, 53.3, 14.0;HPLC analysis with Chiralpak 
AS-H column, 95:5 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; 
minor enantiomer tR = 10.4 min, major enantiomer tR = 11.2 min. 
 
(2R,3S)-2-benzoyl-3-phenyloxirane-2-carbonitrile (35a) 
White solid, m.p. 93-95°C;  21D  = -163.4 (c 0.50, 
CHCl3), 94% ee; FTIRmax (KBr)/cm-1 3065, 1699, 
1449, 1256, 1156, 760, 696; 1H NMR (CDCl3, 400 
MHz 8.05 (dd, J  = 7.9, 1.2 Hz, 2H), 7.71-7.68 (m, 
1H), 7.57-7.51 (m, 7H), 4.41 (s, 1H); 13C NMR (CDCl3, 100 MHz)  186.8, 
135.0, 132.8, 130.5, 130.0, 129.3, 129.1, 129.0, 126.7, 114.1, 64.2, 58.6; 
Anal. Calcd. for C16H11NO2: C, 77.10; H, 4.45; N, 5.62; Found: C, 76.28; 
H, 4.46; N, 5.21; HPLC analysis with Chiralpak AS-H column, 95:5 n-
hexane/iPrOH, 1 mL/min, detection at 254 nm; minor enantiomer tR = 






- 150 - 
 
(2R,3S)-2-benzoyl-3-(4-tert-butylphenyl)oxirane-2-carbonitrile (35b) 
White solid, m.p. 75-76°C;  23D  = -93.3 (c 
0.42, CHCl3), 73% ee; FTIRmax (KBr)/cm-1 
2923, 1701, 1256, 764, 696. 1H NMR (CDCl3, 
400 MHz)  8.05 (dd, J = 7.8, 1.3 Hz, 2H) , 
7.71-7.67 (m, 1H), 7.56-7.50 (m, 4H), 7.45-7.43 (m, 2H), 4.37 (s, 1H), 1.36 
(s, 9H); 13C NMR (CDCl3, 100 MHz)  186.8, 153.7, 134.9, 132.8, 129.2, 
129.0, 126.9, 126.5, 125.9, 114.2, 64.4, 58.6, 34.8, 31.2; Anal. Calcd. for 
C20H19NO2: C, 78.66; H, 6.27; N, 4.59; Found: C, 77.88; H, 6.02; N, 4.85; 
HPLC analysis with Chiralpak AS-H column, 95:5 n-hexane/iPrOH, 1 
mL/min, detection at 254 nm; minor enantiomer tR = 11.4 min, major 
enantiomer tR = 8.1 min. 
 
(2R,3S)-2-benzoyl-3-o-tolyloxirane-2-carbonitrile (35c) 
White solid, m.p. 96-98°C;  21D  = -9.2 (c 0.49, 
CHCl3), 57% ee; FTIRmax (KBr)/cm-1 3064, 1700, 
1449, 1257, 758, 696; 1H NMR (CDCl3, 400 MHz)  
8.12 (dd, J = 8.4, 1.1 Hz, 2H) , 7.73-7.68 (m, 1H), 
7.58-7.54 (m, 2H), 7.45-7.43 (m, 1H), 7.40-7.31 (m, 2 H) , 7.28-7.26 ( m, 
1H), 4.52 (s, 1H), 2.42 (s, 3H); 13C NMR (CDCl3, 100 MHz)  187.0, 136.5, 
135.0, 132.7, 130.4, 129.9, 129.3, 129.1, 128.8, 126.4, 125.3, 114.1, 
62.8, 58.1, 18.8; Anal. Calcd. for C17H13NO2: C, 77.55; H, 4.98; N, 5.32; 
Found: C, 76.23; H, 5.08; N, 5.10; HPLC analysis with Chiralpak AS-H 
column, 98:2 n-hexane/iPrOH, 0.6 mL/min, detection at 254 nm; minor 
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(2R,3S)-2-benzoyl-3-(4-bromophenyl)oxirane-2-carbonitrile (35d) 
White solid, m.p. 132-134°C;  25D  = -156.1 (c 
0.55, CHCl3), 99% ee; FTIR max (KBr)/cm-1 
3064, 2359, 1699, 1596, 1257, 1071, 1012, 
898, 703; 1H NMR (CDCl3, 400 MHz)  8.04 
(dd, J = 8.2, 1.4 Hz, 2H) , 7.72-7.68 (m, 1H), 7.64 (dd, J  = 6.7, 1.8 Hz, 2H) , 
7.57-7.53 (m, 2H), 7.38 (d, J = 8.4 Hz, 2H), 4.38 (s, 1H); 13C NMR (CDCl3, 
100 MHz)  186.4, 135.0, 132.6, 132.2, 129.2, 129.1, 128.2, 124.8, 113.8, 
63.5, 58.4; Anal. Calcd. for C16H10BrNO2: C, 58.56; H, 3.07; N, 4.27; 
Found: C, 56.90; H, 3.79; N, 4.89; HPLC analysis with Chiralpak AS-H 
column, 90:10 n-hexane:2-propanol, 1 mL/min, detection at 254 nm; 
minor enantiomer tR = 18.7 min, major enantiomer tR = 12.1 min. 
 
(2R,3S)-2-benzoyl-3-(4-cyanophenyl)oxirane-2-carbonitrile (35e) 
Yellow solid, m.p. 166-167°C;  22D  = -80.1 (c 
0.53, CHCl3), 70% ee; FTIRmax (KBr)/cm-1 
2924, 2231, 1703, 1597, 1449, 1256, 1156, 
900, 696; 1H NMR (CDCl3, 400 MHz)  8.05 (d, 
J  7.5 Hz, 2H) , 7.80 (d, J = 8.2 Hz, 2H), 7.73-7.70 (m, 1H), 7.63 (d, J = 8.3 
Hz, 2H), 7.58-7.54 (m, 2H), 4.49 (s, 1H); 13C NMR (CDCl3, 100 MHz)  
185.9, 135.3, 132.7, 132.4, 129.3, 129.2, 127.9, 127.4, 117.9, 114.4, 
113.5, 62.8, 58.3; Anal. Calcd. for C17H10N2O2: C, 74.44; H, 3.67; N, 
10.21; Found: C, 73. 78; H, 4.03; N, 9.35; HPLC analysis with Chiralpak 
OD-H column, 70:30 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; 
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(2R,3S)-2-benzoyl-3-(naphthalen-2-yl)oxirane-2-carbonitrile (35f) 
White solid, m.p. 113-115°C;  19D = -116.0 (c 
0.58, CHCl3), 77% ee; FTIRmax (KBr)/cm-1 
3069, 1685, 1457, 1245, 764, 696; 1H-NMR 
(CDCl3, 400 MHz)  8.09-8.07 (m, 2H) , 8.01-
7.97 (m, 2H), 7.93-7.91 (m, 2H), 7.72.7.68 (m, 1H) , 7.60-7.54 (m, 5H), 
4.57 (s, 1H); 13C-NMR (CDCl3, 100 MHz)  186.7, 135.0, 134.1, 132.8, 
129.2, 129.1, 129.0, 128.2, 127.9, 127.4, 127.3, 127.1, 126.9, 114.1, 
64.5, 58.8. Anal. Calcd. for C20H13NO2: C, 80.25; H, 4.38; N, 4.68; Found: 
C, 73.93; H, 3.81; N, 4.03; HPLC analysis with Chiralpak AS-H column, 
95:5 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; minor enantiomer 
tR = 27.2 min, major enantiomer tR = 21.3 min. 
 
(2R,3S)-2-benzoyl-3-(furan-3-yl)oxirane-2-carbonitrile (35g) 
Yellow solid, m.p. 56-58°C;  25D  = -89.8 (c 0.68, 
CHCl3), 81% ee; FTIRmax (KBr)/cm-1 3139, 1701, 
1598, 1268, 1166, 1024, 876, 699; 1H NMR (CDCl3, 
400 MHz)  8.05 (dd, J  = 8.3, 1.2 Hz, 2H) , 7.76 (s, 
1H), 7.72-7.68 (m, 1H), 7.56-7.53 (m, 3H), 6.64-6.62 (m, 1H), 4.32 (s, 1H); 
13C NMR (CDCl3, 100 MHz) 186.8, 144.2, 143.6, 135.0, 132.7, 129.2, 
129.1, 117.1, 114.5, 108.4, 58.7, 57.9. Anal. Calcd. for C14H9NO3: C, 
70.29; H, 3.79; N, 5.86; Found: C, 70.60; H, 3.82; N, 5.46; HPLC analysis 
with Chiralpak AS-H column, 95:5 n-hexane/iPrOH, 1 mL/min, detection 
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(2R,3S)-2-benzoyl-3E-styryloxirane-2-carbonitrile (35h) 
Yellow oil;  23D  = -121.9 (c 0.81, CHCl3), 84% 
ee; FTIRmax (KBr)/cm-1 3065, 1703, 1245, 
1010, 760, 699; 1H-NMR (CDCl3, 400 MHz)  
8.05 (dd, J  =7.82, 1.24 Hz, 2H) , 7.71-7.67 (m, 
1H), 7.56-7.47 (m, 4H) , 7.42-7.36 (m, 3H) , 7.07 (d, J = 15.9, 1H), 6.20 
(dd, J = 15.9, 8.2 Hz, 1H), 4.01 (d, J  = 8.2 Hz, 1H); 13C NMR (CDCl3, 100 
MHz)  187.1, 141.2, 134.9, 134.6, 132.8, 129.6, 129.2, 129.1, 128.9, 
127.2, 118.9, 114.5, 64.2, 57.2. Anal. Calcd. for C18H13NO2: C, 78.53; H, 
4. 76; N, 5.09; Found: C, 77.40; H, 3.71; N, 5.78; HPLC analysis with 
Chiralpak AS-H column, 95:5 n-hexane/iPrOH, 1 mL/min, detection at 
254 nm; minor enantiomer tR = 22.1 min, major enantiomer tR = 15.2 min. 
 
(2R,3S)-2-(3-chlorobenzoyl)-3-phenyloxirane-2-carbonitrile (35i) 
Yellow solid, m.p. 86-90°C;  27D = -97.3 (c 0.68, 
CHCl3), 73% ee; FTIRmax (KBr)/cm-1 3068, 1685, 
1245, 1157, 1078, 900, 860, 696; 1H NMR 
(CDCl3, 400 MHz) 8.04 (s, 1H), 7.95 (d, J = 7.8 
Hz, 1H), 7.68-7.65 (m, 1H) , 7.50-7.47 (m, 6H), 4.42 (s, 1H); 13C NMR 
(CDCl3, 100 MHz)  186.0, 135.5, 134.8, 134.1, 130.6, 130.3, 129.7, 
129.1, 128.9, 127.3, 126.6, 113.6, 64.2, 58.9; Anal. Calcd. for 
C16H10ClNO2: C, 67.74; H, 3.55; N, 4.94; Found: C, 66.22; H, 3.61; N, 
4.60; HPLC analysis with Chiralpak AS-H column, 90:10 n-hexane/iPrOH, 
1 mL/min, detection at 254 nm; minor enantiomer tR = 12.0 min, major 
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(2R,3S)-2-(4-methoxybenzoyl)-3-phenyloxirane-2-carbonitrile (35j) 
White solid, m.p. 102-104°C;  24D  = -138.6 (c 
0.65, CHCl3), >99% ee; FTIRmax (KBr)/cm-1 
2845,  1661, 1600, 1261, 1154, 1025, 764, 
699; 1H NMR (CDCl3, 400 MHz) 8.07 (dd, J = 
8.5, 0.48 Hz, 2H) , 7.50 (bs, 5H), 7.00 (d, J = 8.5 Hz, 2H) , 4.39 (s, 1H), 
3.90 (s, 3H); 13C NMR (CDCl3, 100 MHz)   184.7, 165.0, 131.8, 130.3, 
130.2, 128.8, 126.6, 125.5, 114.4, 63.9, 58.5, 55.6; Anal. Calcd. for 
C17H13NO3: C, 73.11; H, 4.69; N, 5.02; Found: C, 71.38; H, 4.66; N, 4.85; 
HPLC analysis with Chiralpak AS-H column, 90:10 n-hexane/iPrOH, 1 
mL/min, detection at 254 nm; minor enantiomer tR = 30.2 min, major 




White solid, m.p. 98-101°C;  28D  = -81.6 
(c 0.58, CHCl3), 79% ee; FTIR max 
(KBr)/cm-1 3020, 1683, 1257, 764, 703; 
1H NMR (CDCl3, 400 MHz)  8.04 (d, J  = 
8.3 Hz, 2H), 7.62 (d, J  = 7.8 Hz, 2H), 7.36 (d, J = 8.0 Hz, 2H), 6.99 (d, J = 
8.4 Hz, 2H), 4.36 (s, 1H), 3.97 (s, 3H); 13C NMR (CDCl3, 100 MHz)  184.3, 
165.1, 132.1, 131.8, 129.3, 128.2, 125.4, 124.7, 114.4, 114.2, 63.3, 58.3, 
55.7; Anal. Calcd. for C17H12BrNO3: C, 57.00; H, 3.38; N, 3.91; Found: C, 
55.78; H, 3.09; N, 4.60; HPLC analysis with Chiralpak OD-H column, 
90:10 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; minor 
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(2R,3S)-2-benzoyl-3-cyclohexyloxirane-2-carbonitrile (35l) 
Colorless oil;  28D  = -15.2 (c 0.53, CHCl3), 48% ee; 
FTIRmax (KBr)/cm-1 3020, 1635, 1450, 1216, 750, 
669; 1H NMR (CDCl3, 400 MHz)  8.02 (d, J = 7.7 
Hz, 2H), 7.66 (t, J  = 7.7 Hz, 1H), 7.51 (t, J  = 7.7 
Hz, 2H) , 3.09 (d, J = 8.9 Hz, 1H), 1.98 (dd, J = 25.0, 12.4 Hz,  2H), 1.75-
1.66 (m, 2H) , 1.63-1.54 (m, 2H), 1.56-1.13 (m, 5H); 13C NMR (CDCl3, 100 
MHz)  187.7, 134.7, 132.9, 129.1, 128.9, 114.8, 67.9, 55.5, 39.2, 29.8, 
28.2, 25.7, 24.9; Anal. Calcd. for C16H17NO2: C, 75.27; H, 6.71; N, 5.49; 
Found: C, 73.58; H, 7.34; N, 4.78; HPLC analysis with Chiralpak AS-H 
column, 95:5 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; minor 
enantiomer tR = 7.9 min, major enantiomer tR = 6.7 min. 
 
(2R,3S)-2-acetyl-3-phenyloxirane-2-carbonitrile (35m) 
Pale yellow solid, m.p. 77.3-78.9°C;  24D  = -188.9 (c 
0.628, CHCl3), 83% ee; FTIRmax (KBr)/cm-1 3025, 2360, 
1457,1127, 864, 813, 606; 1H NMR (CDCl3, 400 MHz) 
7.47-7.41 (m, 5H), 4.42 (s, 1H), 2.38 (s, 3H); 13C NMR 
(CDCl3, 100 MHz)  195.5, 130.4, 129.8, 128.8, 126.6, 113.4, 64.1, 59.0, 
25.0; Anal. Calcd. for C11H9NO2: C, 70.58; H, 4.85; N, 7.48; Found: C, 
71.36; H, 4.98; N, 7.63; HPLC analysis with Chiralpak AS-H column, 
90:10 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; minor 
enantiomer tR = 20.6 min, major enantiomer tR = 14.1 min. 
 
Procedure for the reduction of 35a to epoxy alcohol 37 
L-selectride (200 L, 0.2 mmol, 1.0 M in THF) was added to a stirred 
solution of 35a (50 mg, 0.2 mmol) in anhydrous THF (4 mL) at -78°C. 
After the consumption of the reagent, monitored by TLC (petroleum 
ether/Et2O 70:30 as eluent) the mixture was diluted with water and 
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extracted with EtOAc. The organic layers were dried over Na2SO4 and 
concentrated in vacuo. The crude mixture was analysed via 1H-NMR to 
determine the diastereoisomeric ratio (dr 5.5/1) then purified by flash 
chromatography on silica gel (petroleum ether/Et2O 70:30 as eluent) 
providing the mixture of the two diasteroisomers in 93% yield. Further 
flash chromatography on silica gel (petroleum ether/Et2O 90:10 as 




Colorless oil;  28D  = -225.8 (c 0.67, CHCl3), 99% ee; 
FTIRmax (KBr)/cm-1 3066, 3035, 1498, 1455, 760, 
698; major diastereoisomer: 1H NMR (CDCl3, 400 
MHz)  7.40-7.54 (m, 10 H), 4.92 (s, 1H), 4.40 (s, 1H), 2.68 (bs, 1H); 13C 
NMR (CDCl3, 100 MHz)  136.9, 131.2, 129.6, 129.4, 129.0, 128.6, 126.6, 
126.3, 114.8, 74.0, 61.4, 61.1; Anal. Calcd for C16H13NO2: C, 76.48; H, 
5.21; N, 5.57; found: C, 74.27, H, 6.40; N, 4.08; HPLC analysis with 
Chiralpak AS-H column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 
220 nm; minor diasteroisomer: minor enantiomer tR = 27.7 min, major 
enantiomer tR = 16.1 min; major diasteroisomer: minor enantiomer tR = 
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8.3 Asymmetric Michael Addition to Nitrostyrene 
 
Trans-nitrostyrene 38a, maleimide 43 and the cyclic -ketoesters 39a-e 
were commercially available and employed without further purification. 
Trans-nitroalkenes 38b-j were prepared using general procedures reported 
in the literature.170 All Michael adducts 40a-m and 44 are known 
compounds. 97,171 
 
General procedure for the synthesis of racemic Michael adducts 40b, 
d, e, i, k. 
In a sample vial, -ketoester 39 (0.2 mmol) was added to a solution of the 
appropriate trans-nitroolefin (0.2 mmol) and the piperidinemethanol ( 11.5 
mg, 0.1 mmol) in toluene ( 200 L) at room temperature. The mixture was 
stirred until completion (monitored by TLC, petroleum ether/Et2O 8:2 as 
eluent), then it was directly loaded onto silica gel and purified by flash 
chromatography, eluting with petroleum ether/Et2O (8:2 to 7:3) to give 
racemic adducts (yields from 76 to 97 %). 
 
General procedure for the asymmetric conjugate addition 
In a sample vial -ketoester 39 (0.2 mmol) was added to a solution of 
appropriate trans-nitroolefin (0.2 mmol) and catalyst 29e (10.6 mg, 0.03 
mmol) in hexafluorobenzene (500 L) at room temperature. The mixture 
was stirred until completion (monitored by TLC, petroleum ether/Et2O 8:2 
                                                          
170 a) O. Andrey, A. Alexakis, G. Belardinelli, Org. Lett. 2003, 5, 2559; b) A. Côté, V. N. G. 
Lindsay, A. B. Charette Org. Lett. 2007, 9, 85. 
171 a) For data of compound 40a, 40l and 40m, see: R. Manzano, J. M.  Andrés, M. 
Muruzábal, R. Pedrosa, R. Adv. Synth. Cat. 2010, 352, 3364; b) For data of compounds 
40b-f, see: 97c; c) For data of compounds 40g-h, see: 97d; d) For data of compounds 40i-l, 
see: 97b; e) For data of compound 40m, see: T. Okino, Y. Hoashi, T. Furukawa, X. Xu, Y. 
Takemoto J. Am. Chem. Soc. 2005, 127, 119 ; f) For data of compound 44, see: G. Bartoli, 
M. Bosco, A. Carlone, A. Cavalli, M. Locatelli, A. Mazzanti, P. Ricci, L. Sambri, P. 
Melchiorre Angew. Chem. Int. Ed.  2006, 45, 4966.  
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as eluent), then it was directly loaded onto silica gel and purified by flash 
chromatography, eluting with petroleum ether/Et2O (8:2 to 7:3) to give the 
pure adducts 40a-m and 44. 
 
(2R, 3S)-Ethyl 1-(2-nitro-1-phenylethyl)-2-oxocyclopentane 
carboxylate (40a) 
Pale yellow oil;  20D  = -68.1 (c 0.63, CHCl3), 90% ee; 1H 
NMR (CDCl3, 400 MHz) 7.33-7.24 (m, 5H), 5.18 (dd, J 
= 13.6, 4.0 Hz, 1H), 5.01 (dd, J = 13.6, 10.8 Hz, 1H), 
4.21 (q, J = 7.2 Hz, 2H), 4.08 (dd, J = 10.8, 4.0 Hz, 1H), 
2.41-2.31 (m, 2H), 2.08-1.79 (m, 4H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz)  212.4, 169.3, 135.3, 129.3, 128.8, 128.3, 76.5, 62.4, 
62.2, 46.2, 37.9, 31.2, 19.4, 14.0; HPLC analysis with Chiralcel OD-H 
column, 90:10 n-hexane/iPrOH, 0.5 mL/min, detection at 210 nm; minor 
enantiomer tR = 26.1 min, major enantiomer tR = 36.7 min. 
 
(2R, 3S)-Ethyl 1-(1-(naphthalen-2-yl)-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40b) 
Yellow oil;  18D  = -32.8 (c 1.01, CHCl3), 88% ee; 
1H NMR 
(CDCl3, 400 MHz) 7.81-7.78 (m, 3H), 7.73-7.72 (m, 1H), 
7.49-7.38 (m, 3H), 5.26 (dd, J = 13.6, 3.8 Hz, 1H), 5.15 
(dd, J = 13.6, 10.9 Hz, 1H), 4.27-4.19 (m, 3H), 2.42-2.31 
(m, 2H), 2.08-1.96 (m, 2H), 1.94-1.77 (m, 2H), 1.27 (t, J 
= 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz)  212.3, 169.4, 133.1, 132.91, 
132.87, 128.9, 128.7, 128.0, 127.6, 126.7, 126.5, 126.4, 76.6, 62.5, 62.3, 
46.3, 37.9, 31.4, 19.4, 14.0; HPLC analysis with Chiralpak IC column, 
90:10 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 
enantiomer tR = 23.8 min, major enantiomer tR = 31.6 min. 
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(2R, 3S)-Ethyl 1-(1-(3-bromophenyl)-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40c) 
Pale yellow oil;  18D  = -15.9 (c 1.03, CHCl3), 90% ee; 1H 
NMR (CDCl3, 400 MHz) 7.45-7.42 (m, 2H), 7.28-7.17 
(m, 2H), 5.20 (dd, J = 13.6, 3.6 Hz, 1H), 5.00 (dd, J = 
14.0, 11.2 Hz, 1H), 4.21 (q, J =  7.2 Hz, 2H), 3.97 (dd, J 
=  10.8, 3.2 Hz, 1H), 2.46-2.32 (m, 2H), 2.17-2.09 (m, 
1H), 1.97-1.67 (m, 3H), 1.28 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 
MHz)  212.1, 169.1, 138.0, 132.3, 131.5, 130.3, 128.1, 122.8, 76.2, 62.3, 
62.2, 45.8, 37.8, 31.8, 19.3, 14.0; HPLC analysis with Chiralcel OD-H 
column, 90:10 n-hexane/iPrOH, 0.7 mL/min, detection at 210 nm; minor 
enantiomer tR = 22.9 min, major enantiomer tR = 28.6 min. 
 
(2R, 3S)-Ethyl 1-(1-(4-fluorophenyl)-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40d) 
Pale yellow oil;  19D  = -18.6 (c 1.02, CHCl3), 88% ee; 1H 
NMR (CDCl3, 400 MHz) 7.29-7.27 (m, 2H), 7.03-6.98 
(m, 2H), 5.15 (dd, J = 13.5, 3.8 Hz, 1H), 4.97 (dd, J = 
13.5, 11.1  Hz, 1H), 4.20 (q, J =  7.2 Hz, 2H), 4.05 (dd , 
J = 11.1, 3.6 Hz, 1H), 2.43–2.32 (m, 2H), 2.08-1.82 (m, 
4H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz)  212.3, 169.3, 
162.4 (d, J = 46.5 Hz), 131.1 (d, J = 10 Hz), 115.9, 115.7, 76.5, 62.4, 62.3, 
45.5, 37.9, 31.4, 19.4, 14.0; HPLC analysis with Chiralpak IC column, 
80:20 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 
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(2R, 3S)-Ethyl 1-(1-(2-chlorophenyl)-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40e)  
Yellow oil;  23D  = 17.8 (c 0.92, CHCl3), 90% ee; 1H NMR 
(CDCl3, 400 MHz) 7.58-7.55 (m, 1H), 7.40-7.37 (m, 
1H), 7.26-7.22 (m, 2H), 5.48 (dd, J = 14.1, 3.6 Hz, 1H), 
5.10 (dd, J = 13.8, 10.5 Hz, 1H), 4.52 (dd, J = 10.8, 3.6 
Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 2.49 (t, J = 7.5 Hz, 2H), 2.27-1.88 (m, 
4H), 1.27 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz)  212.6, 169.3, 
135.5, 134.7, 130.1, 129.3, 129.0, 127.6, 76.8, 62.1, 37.8, 33.0, 29.7, 
19.3, 14.0; HPLC analysis with Chiralpak IC column, 90:10 n-
hexane/iPrOH, 1 mL/min, detection at 220 nm; minor enantiomer tR = 
19.3 min, major enantiomer tR = 24.5 min. 
 
(2R, 3S)-Ethyl 1-(1-furan-2-yl)-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40f) 
Pale yellow oil;  23D  = -31.4 (c 0.58, CHCl3), 72% ee; 1H 
NMR (CDCl3, 400 MHz) 7.33 (d, J = 1.2 Hz, 1H), 6.30 
(dd, J = 3.3, 1.8 Hz, 1H), 6.18 (d, J = 3.2 Hz, 1H), 4.95-
4.91 (m, 2H), 4.44 (dd, J = 9.8, 4.6 Hz, 1H), 4.21 (q, J = 
7.2 Hz, 2H), 2.51-2.30 (m, 2H), 2.15-1.95 (m, 3H), 1.80-1.72 (m, 1H), 1.28 
(t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz)  212.1, 168.9, 149.1, 
142.7, 110.8, 110.1, 74.5, 62.3, 61.9, 40.4, 37.9, 30.2, 19.5, 14.0; HPLC 
analysis with Chiralcel OD-H column, 90:10 n-hexane/iPrOH, 1 mL/min, 
detection at 220 nm; minor enantiomer tR = 10.3 min, major enantiomer tR 
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(2R, 3S)-Methyl 1-(2-nitro-1-(2-thienyl)ethyl)-2-oxocyclopentane 
carboxylate (40g) 
Yellow wax;  24D  = -32.3  (c 0.88, CHCl3), 84% ee; 1H 
NMR (CDCl3, 400 MHz) 7.24-7.23 (m, 1H), 6.96-6.92 
(m, 2H), 5.12 (dd, J = 13.8, 3.7 Hz, 1H), 4.92 (dd, J = 
13.8, 10.1 Hz, 1H), 4.41 (dd, J = 10.1, 3.7 Hz, 1H), 3.77 
(s, 3H), 2.45-2.37 (m, 2H), 2.16-1.91 (m, 4H); 13C NMR (CDCl3, 100 MHz)  
212.3, 169.8, 137.4, 128.6, 126.8, 126.1, 77.5, 62.4, 53.1, 42.1, 38.0, 
31.5, 19.4; HPLC analysis with Chiralcel OD-H column, 88:12 n-
hexane:EtOH, 0.5 mL/min, detection at 233 nm; minor enantiomer tR = 
24.9 min, major enantiomer tR = 42.1 min. 
 
(2R, 3S)-Methyl 1-(2-nitro-1-phenylethyl)-2-oxocyclopentane 
carboxylate (40h) 
White wax;  20D  = -24.3 (c 1.00, CHCl3), 88% ee; 1H NMR 
(CDCl3, 400 MHz) 7.32-7.22 (m, 5H), 5.20-5.14 (dd, J = 
13.8, 4.2 Hz, 1H), 5.07-4.98 (dd, J = 13.5, 10.8 Hz, 1H), 
4.08 (dd, J = 10.8, 3.9 Hz, 1H), 3.76 (s, 3H), 2.30–2.43 
(m, 2H), 1.77–2.09 (m, 4H); 13C NMR (CDCl3, 100 MHz)  212.2, 169.8, 
135.2, 129.3, 128.8, 128.3, 76.4, 62.4, 53.1, 46.2, 37.9, 31.1, 19.3; HPLC 
analysis with Chiralcel OD-H column, 90:10 n-hexane: /iPrOH, 1 mL/min, 
detection at 220 nm; minor enantiomer tR = 17.0 min, major enantiomer tR 
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(2R, 3S)-Methyl 1-(2-nitro-1-p-tolyethyl)-2-oxocyclopentane 
carboxylate (40i) 
Pale yellow oil;  24D  = -24.2 (c 0.97, CHCl3), 66% ee; 1H 
NMR (CDCl3, 400 MHz)7.14-7.08 (m, 4H) , 5.13 (dd, J 
= 13.2, 4.5 Hz, 1H), 4.99 (dd, J = 13.2, 11.1 Hz, 1H), 4.07 
(dd, J = 10.8, 3.6 Hz, 1H), 3.76 (s, 3H), 2.52-2.34 (m, 
2H), 2.30 (s, 3H), 2.07-1.77 (m, 4H); 13C NMR (CDCl3, 
100 MHz)  212.64, 170.07, 138.36, 132.20, 129.78, 129.35, 76.7, 62.7, 
53.3, 46.0, 38.3, 31.2, 21.3, 19.6; HPLC analysis with Chiralpak IC 
column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 
enantiomer tR = 22.5 min, major enantiomer tR = 33.6 min. 
 
(2R, 3S)-Methyl 1-(1-(4-methoxyphenyl)-2-nitroethyl)-2-oxo 
cyclopentanecarboxylate (40j) 
 Pale yellow oil; 58% ee; 1H NMR (CDCl3, 400 MHz) 
7.18-7.15 (m, 2H), 6.84-6.82 (m, 2H), 5.11 (dd, J = 
13.3, 4.1 Hz, 1H), 5.01-4.89 (dd, J = 13.3, 11 Hz, 1H), 
4.04 (dd, J = 11.0, 4.1 Hz, 1H), 3.78 (s, 3H), 3.75(s, 3H), 
2.44-2.30 (m, 2H), 2.06-1.80 (m, 4H);13C NMR (CDCl3, 
100 MHz)  212.3, 169.8, 159.3, 130.4, 126.9, 114.1, 
76.5, 62.6, 55.1, 53.0, 45.4, 37.9, 30.9, 19.3; HPLC analysis with 
Chiralpak ASH column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 
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(2R, 3S)-Methyl 1-(1-cyclohexyl-2-nitroethyl)-2-oxocyclopentane 
carboxylate (40k) 
Pale yellow oil;  24D  = -34.1 (c 0.33, CHCl3), 62% ee; 1H 
NMR (CDCl3, 400 MHz) 5.06 (dd, J = 15.6, 3.9 Hz, 1H) , 
4.53 (dd, J = 14.7, 5.7 Hz, 1H), 3.66 (s, 3H), 2.73-2.64 
(m, 2H) , 2.42-2.37 (m, 2H), 2.01-2.00 (m, 3H), 1.70-
1.47 (m, 5H), 1.20-0.98 (m, 6H); 13C NMR (CDCl3, 100 MHz) 213.2, 
170.2, 74.0, 62.3, 53.0, 45.3, 39.5, 38.1, 33.0, 32.4, 28.8, 27.0, 26.7, 
26.1, 19.5; HPLC analysis with Chiralpak IC column, 97:3 n-
hexane/iPrOH, 1 mL/min, detection at 220 nm; minor enantiomer tR = 




White solid; 1H NMR (CDCl3, 400 MHz) 8.05 (d, J 
= 8.1 Hz, 1H), 7.52 (t, J = 7.2 Hz, 1H), 7.38-7.28 (m, 
6H), 7.20 (d, J = 7.5 Hz, 1H), 5.16 (dd, J = 13.8, 4.5 
Hz, 1H), 5.06 (dd, J = 13.2, 10.2 Hz, 1H), 4.21 (dd, J 
= 10.2, 3.6 Hz, 1H), 3.65 (s, 3H), 2.99-2.95 (m, 2H), 
2.46-2.32 (m, 1H), 2.08-1.99 (m, 1H); 13C NMR (CDCl3, 100 MHz) 194.4, 
170.5, 142.7, 136.1, 134.3, 130.1, 129.6, 129.0, 128.9, 128.7, 128.5, 
127.3, 78.1, 60.0, 53.0, 47.4, 31.0, 25.8; HPLC analysis with Chiralcel OD 
column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; major 
diastereoisomer tR = 35.6 min (minor enantiomer), tR = 19.4  min (major 
enantiomer); minor diastereosiomer tR = 24.5 min (minor enantiomer), tR = 
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(2R, 3S)- Methyl 1-(2-nitro-1-phenylethyl)-2-oxocycloheptane 
carboxylate (40m) 
Colorless oil; major diastereoisomer: 1H NMR (CDCl3, 
400 MHz) 7.35-7.25 (m, 3H), 7.21-7.10 (m, 2H), 5.00-
4.89 (m, 2H), 4.07 (dd, J = 10.1, 4.3 Hz, 1H), 3.78 (s, 
3H), 2.66-2.49 (m, 2H), 2.53 (ddd, J = 12.7, 8.9, 4.3 
Hz, 1H), 1.94-1.40 (m, 8H); 13C NMR (CDCl3, 100 
MHz)208.3, 171.3, 135.5, 129.4, 128.7, 128.3, 77.8, 65.4, 52.4, 48.4, 
41.3, 32.8, 28.9, 25.0, 24.4; HPLC analysis with Chiralcel OD-H column, 
95:5 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; major 
diastereoisomer: tR = 14.3 min (minor enantiomer), tR = 31.3 min (major 
enantiomer), minor diastereosiomer tR = 13.1 min (minor enantiomer), tR = 




White solid; the diastereoisomers (1:1) could not be 
separated. 1H NMR (CDCl3, 400 MHz) 7.72-7.69 
(m, 1H), 7.66-7.61 (m, 1.85H), 7.50-7.32 (m, 3.7H), 
7.30-7.25 (m, 9.3H), 4.60 (m, 3.8H), 4.06 (dd, J = 
9.2, 6.0 Hz, 1H), 4.05-3.95 (m, 0.9H), 3.75 (s, 
2.5H), 3.28-3.02 (m, 1.85H), 3.0-2.78 (m, 1.9H), 2.38 (dd, J = 18.4, 6.0 
Hz, 1H), 2.35-2.19 (m, 0.85H); 13C NMR (CDCl3, 100 MHz) 200.2, 199.5, 
176.9, 176.6, 175.6, 174.9, 170.2, 169.2, 152.8, 152.4, 136.1, 135.8, 
135.4, 134.7, 134.6, 128.7, 128.6, 128.5, 128.2, 127.9, 127.8, 126.4, 
124.9, 60.7, 60.5, 53.4, 53.0, 43.9, 43.1, 42.5, 37.1, 34.0, 32.3, 31.4, 
26.3; HPLC analysis with Chiralpak AD-H column, 75:25 n-
hexane/iPrOH, 0.75 mL/min, detection at 254  nm; major diastereoisomer 
tR = 27.0 min (minor enantiomer), tR = 34.8 min (major enantiomer), minor 
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8.4 Asymmetric Double Michael Addition 
  
Malononitrile and ethyl cyano acetate were commercially available 
reagents and employed as purchased without further purification. 




In a round-bottom flask 18 mmol of NaOH were dissolved in H2O (5.5 mL), 
3 mmol of the opportune ketone and 6 mmol of the correct aldehyde (3 
mmol for the synthesis of the asymmetric dienones) were dissolved in 
EtOH (3.7 mL) and the solution was added dropwise at 0 °C. The mixture 
was stirred at room temperature until full conversion of the starting 
materials monitored by TLC eluent petroleum ether/Et2O 7:3). The formed 
yellow solid is filtered and washed with H2O until neutrality, dissolved in 




                                                          
172 a) W. M. Weber, L. A. Hunsaker, S. F. Abcouwer, L. M. Deck, D. L. Vander Jagt, Bioorg. 
Med. Chem. 2005,  13, 3811;  b) N. G. Rule, M. R. Detty, J. E. Kaeding, J. A. Sinicropi, J. 
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General procedure for the synthesis of racemic diaryl cyclohexanones  
A solution of 45 (0.2 mmol), malononitrile (13.2 mg, 0.2 mmol) and 2-
piperidinemethanol (23.0 mg, 0.2 mmol) in toluene (5 mL) was stirred at 
room temperature until the dienone was consumed as monitored by TLC 
(petroleum ether/Et2O 6:4 as eluent). The crude reaction mixture was 
directly purified by flash chromatography on silica gel eluting with 
mixtures of petroleum ether/Et2O (9:1 to 7:3) affording cyclohexanones in 
30-50% yield. 
 
General procedure for the asymmetric synthesis of trans-4-oxo-2,6-
diaryl-cyclohexane-1,1-dicarbonitriles 47a-g. 
A solution of the opportune divinylketone 45 (0.2 mmol), malononitrile 
(13.2 mg, 0.2 mmol) and quinine (19.4 mg, 0.06 mmol) in toluene (10 mL) 
was stirred at room temperature until the starting materials were 
consumed as monitored by TLC (petroleum ether/Et2O 6:4 as eluent). The 
crude reaction mixture was directly purified by flash chromatography on 
silica gel eluting with mixtures of petroleum ether/Et2O (9:1 to 7:3) 
affording the pure cyclohexanones. 
 
Procedure for the asymmetric synthesis of 46 
Ethyl 2-cyanoacetate (22 L, 0.2 mmol) was added to a solution of 45a 
(56.2 mg, 0.24 mmol) and quinine (19.4 mg, 0.06 mmol) in toluene (666 
L) at room temperature. Stirring was maintained until 45a was 
consumed as monitored by TLC (petroleum ether/Et2O 6:4 as eluent). The 
crude reaction mixture was directly purified by flash chromatography on 
silica gel eluting with mixtures of petroleum ether/Et2O (9:1 to 7:3) 
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Procedure for the kinetic resolution of 48 
A solution of 48 (60.1 mg, 0.2 mmol) and quinine (19.5 mg, 0.06 mmol) in 
toluene (5 mL) was stirred for 15 h at room temperature. The compound 
48a and the cyclized product 47a were recovered by flash chromatography 
on silica gel (eluent: petroleum ether/ Et2O 9:1 to 6:4).    
 
(2R,6R)-ethyl 1-cyano-4-oxo-2,6-diphenyl cyclohexane carboxylate 
(46)111 
white solid,  20D  = 34.7 (c 0.70, CHCl3), ee 60%; 
1H NMR (CDCl3, 400 MHz) 7.41-7.27 (m, 8H), 
7.22-7.14 (m, 2H), 4.02-3.93 (m, 2H), 3.86-3.74 
(m, 2H), 3.23-3.12 (m, 2H), 3.04 (dd, J = 16.6, 5.5 
Hz, 1H), 2.81 (ddd, J = 16.7, 3.9, 1.0 Hz, 1H), 0.88 (t, J = 7.2 Hz, 3H); 13C 
NMR (CDCl3, 100 MHz)  207.2, 166.2, 137.3, 136.7, 128.7, 128.6, 128.5, 
128.4, 128.3, 118.4, 62.7, 55.7, 48.0, 42.9, 42.4, 41.6, 13.3. HPLC 
analysis with Chiralpak AD-H column, 90:10 n-hexane/iPrOH, 0.75 
mL/min, detection at 220 nm; minor enantiomer tR = 25.4 min, major 
enantiomer tR = 20.0 min. 
 
(2R,6R)-4-oxo-2,6-diphenylcyclohexane-1,1-dicabonitrile (47a) 
White solid, mp 68-70 °C;  23D  = -2.71 (c 1.14, 
CHCl3), ee 86%; FTIRmax (KBr)/cm-1 3034, 2252, 
1720, 1500, 1219, 700; 1H NMR (CDCl3, 400 MHz)  
7.44-7.41 (m, 6H) , 7.33–7.29 (m, 4H), 3.82 (dd, J = 
7.3, 6.1 Hz, 2H), 3.18-3.05 (m, 4H); 13C NMR (CDCl3, 100 MHz)  204.5, 
135.0, 129.6, 129.2, 128.9, 113.8, 45.6, 45.0, 42.4; MS (ESI) m/z 299.33 
[(M-H)-]. HPLC analysis with Chiralpak OD-H column, 70:30 n-
hexane/iPrOH, 1 mL/min, detection at 220 nm; minor enantiomer tR = 
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(2R,6R)-4-oxo-2,6-di-p-tolylcyclohexane-1,1-dicabonitrile (47b) 
Yellow solid, mp 168-170 °C;  17D  = 22.2 (c 
0.43, CHCl3), ee 85%; FTIRmax (KBr)/cm-1 
3024, 2256, 1719, 1516, 1216, 758; 1H NMR 
(CDCl3, 400 MHz)  7.22-7.16 (m, 8H) , 3.80-
3.76 (m, 2H), 3.14-3.01 (m, 4H), 2.37 (s, 6H); 13C NMR (CDCl3, 100 MHz)  
204.9, 139.5, 132.0, 129.8, 128.7, 114.0, 45.2, 42.4, 21.1; MS (ESI-) m/z 
327.54 [(M-H)-]. HPLC analysis with Chiralpak AD-H column, 90:10 n-
hexane/iPrOH, 1 mL/min, detection at 220 nm; minor enantiomer tR = 




White solid, mp 159-160 °C;  18D  = 4.70 
(c 0.85, CHCl3), ee 83%; FTIRmax 
(KBr)/cm-1 2925, 2249, 1728, 1424, 
1327, 759; 1H NMR (CDCl3, 400 MHz)  
7.72-7.70 (m, 2H), 7.48-7.44 (m, 2H), 
3.89-3.84 (m, 2H), 3.21-3.09 (m, 4H); 13C NMR (CDCl3, 100 MHz)  203.2, 
138.4, 132.0 (q, J = 33.0 Hz) , 129.4, 126.3 (q, J = 3.6 Hz), 123.5 (q, J = 
272.3 Hz), 113.1, 45.4, 44.3, 42.0; MS (ESI-) m/z 435.45 [(M-H)-]. HPLC 
analysis with Chiralpak AD-H column, 75:25 n-hexane/iPrOH, 1 mL/min, 
detection at 220 nm; minor enantiomer tR = 8.5 min, major enantiomer tR 







- 170 - 
 
(2R,6R)-4-oxo-2-phenyl-6-p-tolylcyclohexane-1,1-dicabonitrile (47d) 
White solid, mp 56-58 °C;  16D  = 4.8 (c 0.46, 
CHCl3), ee 82%; FTIRmax (KBr)/cm-1 3031, 2923, 
2253,1721, 1516, 1218, 762, 701; 1H NMR 
(CDCl3, 400 MHz)  7.43-7.41 (m, 3H), 7.32-7.29 
(m, 2H), 7.23-7.17 (m, 4H), 3.83-3.79 (m, 2H), 3.17-3.03 (m, 4H), 2.37 (s, 
3H); 13C NMR (CDCl3, 100 MHz)  204.8, 139.6, 135.0, 131.9, 129.8, 
129.5, 129.1, 128.9, 128.8, 113.9, 113.8, 45.41, 45.36, 45.1, 42.4, 21.1; 
MS (ESI) m/z 313.61 [(M-H)-]. HPLC analysis with Chiralpak AD-H 
column,95:5 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 




Pale yellow solid, mp 55-57 °C;  22D  = 14.7 (c 
0.28, CHCl3), ee 85%; FTIRmax (KBr)/cm-1 
2965, 2226, 1722, 1516, 1258, 756; 1H NMR 
(CDCl3, 400 MHz)  7.44-7.40 (m, 3H), 7.32-
7.28 (m, 2H), 7.25-7.20 (m, 2H) , 6.95-6.90 (m, 
2H), 3.84-3.76 (m, 5H), 3.17-3.01 (m, 4H); 13C NMR (CDCl3, 100 MHz)  
204.8, 160.3, 135.0, 130.1, 129.5, 129.2, 128.8, 126.8, 114.4, 113.92, 
113.87, 55.3, 45.3, 45.1, 42.5, 42.4, 29.7; MS (ESI-) m/z 329.52 [(M-H)-]. 
HPLC analysis with Chiralpak AD-H column, 90:10 n-hexane/iPrOH, 1 
mL/min, detection at 220 nm; minor enantiomer tR = 19.0 min, major 









White solid, mp 92-94 °C;  19D  = 14.0 (c 0.90, 
CHCl3), ee 80%; FTIRmax (KBr)/cm-1 2925, 
2252, 1722, 1495, 1218, 762; 1H NMR (CDCl3, 
400 MHz)  7.48-7.40 (m, 5H) 7.34-7.27 (m, 4H), 
3.86–3.82 (m, 1H), 3.80 (dd, J = 8.2, 5.8 Hz, 
1H), 3.19-3.04 (m, 4H); 13C NMR (CDCl3, 100 MHz)  204.2, 135.8, 134.8, 
133.4, 130.2, 129.7, 129.4, 129.2, 128.9, 113.6, 113.5, 45.8, 44.84, 
44.78, 42.3, 42.2; MS (ESI-) m/z 333.45 [(M-H)-]. HPLC analysis with 
Chiralpak OD column, 50:50 n-hexane/iPrOH, 1 mL/min, detection at 




Yellow solid, mp 117-119 °C;  22D  = -2.17 (c 0.69, 
CHCl3), ee 86%; FTIR max (KBr)/cm-1 2973, 2227, 
1722, 1634, 1216, 701; 1H NMR (CDCl3, 400 MHz)  
7.44-7.39 (m, 4H) , 7.34-7.31 (m, 2H), 7.14-7.12 (m, 
1H) , 7.09-7.06 (m, 1H), 4.23-4.19 (m, 1H) , 3.84 (dd, J = 9.3, 5.2 Hz, 1H), 
3.25-2.98 (m, 4H); 13C NMR (CDCl3, 100 MHz) 203.4, 137.0, 134.8, 
129.6, 129.2, 128.8, 128.7, 127.5, 127.0, 113.6, 45.4, 43.8, 43.6, 42.4, 
42.3; MS (ESI) m/z 305.49 [(M-H)-]. HPLC analysis with Chiralpak AD-H 
column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 
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(S, E)-2-(3-oxo-1,5-diphenylpent-4-enyl)malononitrile (48) 
White wax,  19D  = 2.2 (c 1.21, CHCl3), ee 69%; 
FTIRmax (KBr)/cm-1 3032, 2256, 1688, 1610, 
1180, 701; 1H NMR (CDCl3, 400 MHz)  7.63 (d, 
J = 16.2 Hz, 1H) , 7.58-7.37 (m, 10H), 6.76 (d, J 
= 16.2 Hz, 1H) , 4.63 (d, J = 5.1 Hz, 1H), 3.90-3.85 (m, 1H), 3.47-3.30 (m, 
2H); 13C NMR (CDCl3, 100 MHz)  196.3, 144.6, 136.4, 133.7, 131.2, 
129.3, 129.13, 129.08, 128.5, 127.9, 125.0, 111.8, 111.7, 42.0, 41.1, 
28.7; MS (ESI) m/z 299.52 [(M-H)-]. HPLC analysis with Chiralpak AD-H 
column, 70:30 n-hexane/iPrOH, 1 mL/min, detection at 220 nm; minor 
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8.5 Asymmetric Aziridination Reaction. 
 
Experimental Procedures and Compounds Characterization 
-ketoesters, precursors of the required acrylate substrates, that were not 
commercially available, were synthetized according literature 
procedures.148 Differently substituted methyl ketones 67 were reacted 
with the opportune carbonate (methyl or ethyl) with NaH as base, to give 




NaH (60% w/w, 856 mg, 21.4 mmol) was suspended in dry toluene (3 mL) 
under a positive pressure of nitrogen, the opportune carbonate was added, 
followed by a solution of the ketone 67 in dry toluene (3 mL). The mixture 
was stirred under reflux for 1-3 hours and afterwards neutralized with a 
saturated solution of NH4Cl and extracted with diethyl ether. The 
combined organic layers were dried over Na2SO4 and the solvent was 
evaporated under reduced pressure. The product was purified by flash 
chromatography (eluent: petroleum ether/ Et2O 95:5 to 9:1)   
This procedure could not be extended to the tbutyl and benzyl ketoesters 
to obtain the desired products 68m and n so a different approach was 
employed: the acyl halide 69 was reacted with the corresponding ester 70 








In a two-necked round bottom flask under a positive pressure of nitrogen, 
dry THF (18 mL) was added to the diisopropylamine  (3.9 mL, 27.9 mmol). 
The solution is cooled to -78°C and butyllithium was added quickly but 
keeping low the temperature. The system was allowed to warm to -10 °C 
and after 15 minutes it is again cooled to -78 °C. The opportune ester ( 27 
mmol)) is slowly added and finally the acyl chloride (1 mL, 9 mmol) as a 
THF solution. The mixture is allowed to warm to room temperature until 
completion monitored by TLC (eluent petroleum ether/Et2O 9:1). After 1h 
the reaction is quenched with a diluted HCl solution and extracted with / 
Et2O three times. The unified organic phases were dried over Na2SO4 and 
the solvent was removed under reduced pressure. The product was 
purified by flash chromatography (eluent: petroleum ether/Et2O 100:5). 
The -amidoester was synthetized by means of a condensation between 
diethyl malonate and benzylamine in the presence of molecular sieves. 
 
 
The ethyl diester (10 mmol) and the benzyl amine (10 mmol) in dry toluene 
over molecular sieves were refluxed under nitrogen for the necessary time 
(3-5 days monitoring by TLC, petroleum ether/EtOAc 8:2 as eluent). Then 
molecular sieves were filtered off, and the solution extracted with 
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EtOAc/HCl (1N) two times. The organic layer was collected, dried over 
Na2SO4 and the solvent removed under vacuum. The residue was purified 
by flash chromatography, eluent petroleum ether /Et2O 8:2 to Petroleum 
ether/EtOAc 6:4). 
The dicarbonyl compounds were subjected to a methylenation reaction, 
according a procedure reported in the literature,149 in which formaldehyde 
and diisopropylammonium trifluoroacetate were employed. 
 
 
In a screw capped vial containing freshly distilled THF (40 mL), β-
ketoesters (4.0 mmol), p-formaldehyde (360 mg, 12 mmol) and 
CF3COONH2iPr2 salt (861 mg, 4 mmol) were added. CF3COOH (31 L, 0.40 
mmol) was added and the mixture was warmed to 60°C and stirred 
overnight. The reaction mixture was then extracted with EtOAc/water and 
the organic layer dried over Na2SO4. The solvent was then removed under 
vacuum. The residue was loaded onto silica gel and purified by flash 
chromatography (petroleum ether/EtOAc 9:1 as eluent) to obtain the 
alkenes.173 
Starting amines 63a-e were synthesized according to the literature.150 As 
an example, the Boc-protected amine is prepared as follows: to a solution 
of the Boc-hydroxylamine (1 mmol) in dry CH2Cl2 (2 mL), pyridine was 
added (2.4 mmol). The solution was cooled at -20°C followed by a portion-
wise addition of TsCl (1 mmol). The mixture is allowed to warm to room 
                                                          
173 Alkenes 65a-o need to be used freshly prepared, because they are prone to 
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temperature and after completion, monitored by TLC (eluent petroleum 
ether/EtOAc 6:4), diluted with CHCl3 and washed with water. The organic 
layers were concentrated under vacuum and the product was isolated by 
flash chromatography. 
 
Ethyl 2-benzoylacrylate (65a) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 2982, 1728, 1665, 1241, 772. 1H NMR 
(CDCl3, 400 MHz) δ 7.84-7.82 (m, 2H), 7.56 (t, J = 7.3 
Hz, 1H), 7.44 (t, J = 7.8 Hz, 2H), 6.66 (s, 1H), 6.04 (s, 1H), 4.19 (q, J = 7.1 
Hz, 2H), 1.16 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 193.0, 
164.2, 141.3, 136.1, 133.5, 131.2, 129.3, 128.4, 61.4, 13.8. MS (ESI m/z) 
205.10 [MH+, 100%], 227.09 [MNa+, 35%]. 
 
Ethyl 2-(4-methylbenzoyl)acrylate (65b) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm-1 2983, 1727, 1671, 1237, 771. 1H 
NMR (CDCl3, 400 MHz) δ 7.76 (d, J = 8.2 Hz, 2H), 
7.26 (d, J = 8.1 Hz, 2H), 6.67 (s, 1H), 6.03 (s, 1H), 4.22 (q, J = 7.1 Hz, 2H), 
2.42 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 192.9, 
164.4, 144.6, 141.5, 133.7, 131.0, 129.6, 129.2, 61.5, 21.7, 14.0. MS (ESI 
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Ethyl 2-(3-methylbenzoyl)acrylate (65c) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 2982, 1728, 1675, 1251, 763. 1H NMR 
(CDCl3, 400 MHz) δ 7.65 (s, 1H), 763-7.58 (m, 1H), 
7.58-7.27 (m, 2H), 6.64 (s, 1H), 6.01 (s, 1H), 4.19 (q, J = 7.1 H, 2H z), 2.36 
(s, 3H), 1.16 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 193.2, 
164.2, 141.3, 138.3, 136.1, 134.3, 131.0, 129.6, 128.3, 126.6, 61.3, 21.1, 
13.8. MS (ESI m/z) 219.37 [MH+, 10%], 256.41 [MK+, 70%]. 
 
Ethyl 2-(2-methylbenzoyl)acrylate (65d) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 2867, 1718, 1636, 1219, 771.  1H NMR 
(CDCl3, 400 MHz) δ 7.51-7.42 (m, 1H), 7.41-7.35 (m, 
1H), 7.28-7.19 (m 2H), 6.63 (s, 1H), 6.12 (s, 1H), 4.19 (q, J = 7.2 Hz, 2H), 
2.51 (s, 3H), 1.17 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 195.2, 
164.6, 143.0, 138.6, 136.7, 132.4, 131.7, 129.8, 125.4, 61.4, 20.7, 13.9. 
MS (ESI m/z) 219.44 [MH+, 15%], 256.39 [MK+, 90%]. 
 
Ethyl 2-(4-methoxybenzoyl)acrylate (65e) 
Purified by flash chromatography (petroleum 
ether/EtOAc 97:3 as eluent). Pale yellow oil. 
FTIR max (KBr)/cm-1 2982, 1725, 1666, 1600, 
1263, 772. 1H NMR (CDCl3, 400 MHz) δ 7.85 (d, 
2H, J = 8.8 Hz), 6.94 (d, 2H, J = 8.8 Hz), 6.66 (s, 1H), 6.00 (s, 1H), 4.23 (q, 
2H, J = 7.1 Hz), 3.88 (s, 3H), 1.22 (t, 3H, J = 7.1 Hz); 13C NMR (CDCl3, 100 
MHz) δ 191.8, 164.5, 164.0, 141.5, 131.9, 130.5, 129.2, 113.8, 61.5, 55.5, 
14.0. MS (ESI m/z) 235.24 [MH+, 5%], 257.19 [MNa+, 100%]. 
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Ethyl 2-(4-chlorobenzoyl)acrylate (65f) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm-1 2984, 1732, 1683, 1588, 1220, 
772. 1H NMR (CDCl3, 400 MHz) δ 7.79 (d, J = 8.6 
Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 6.70 (s, 1H), 6.07 (s, 1H), 4.22 (q, J = 7.1 
Hz, 2H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 192.0, 
164.1, 141.0, 140.1, 134.6, 131.7, 130.7, 128.9, 61.6, 13.9. MS (ESI m/z) 
239.34 [MH+, 55%], 261.37 [MNa+, 85%], 268.38 [MK+, 45%]. 
 
Ethyl 2-(3-bromobenzoyl)acrylate (65g) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 2984, 1733, 1687, 1565, 1233, 772. 1H 
NMR (CDCl3, 400 MHz) δ 7.98 (s, 1H), 7.77-7.53 (m, 
2H), 7.34 (t, J = 7.8 Hz, 1H), 6.71 (d, J = 0.7 Hz, 1H), 6.09 (d, J = 0.6 Hz, 
1H), 4.26-4.18 (m, 2H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 
MHz) δ 191.7, 164.0, 140.8, 138.0, 136.4, 132.14, 132.09, 130.1, 127.9, 
122.8, 61.6, 13.9.  MS (ESI m/z) 305.19 [MNa+, 100%]  
 
Ethyl 2-(2-naphthoyl)acrylate (65h) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm-1 2981, 1727, 1673, 1222, 771. 1H 
NMR (CDCl3, 400 MHz) δ 8.33 (s, 1H), 8.01-7.89 
(m, 4H), 7.65-7.53 (m, 2H), 6.77 (d, J = 0.6 Hz, 1H), 6.12 (d, J = 0.6 Hz, 
1H), 4.24 (q, J = 7.1 Hz, 2H), 1.19 (t, J = 7.1 Hz, 3H): 13C NMR (CDCl3, 100 
MHz) δ 193.2, 164.4, 141.4, 135.8, 133.6, 132.3, 131.9, 131.4, 129.6, 
128.8, 128.6, 127.8, 126.9, 124.4, 61.6, 14.0. MS (ESI m/z) 255.47 [MH+, 
10%], 277.37 [MNa+, 100%]. 
EXPERIMENTAL SECTION 
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Ethyl 2-(furan-2-carbonyl)acrylate (65i) 
Purified by flash chromatography (petroleum 
ether/EtOAc 95:5 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 3134, 2984, 1726, 1661, 1465, 1255, 771. 
1H NMR (CDCl3, 400 MHz) δ 7.64-7.61 (m, 1H), 7.17-7.15 (m, 1H), 6.62 (s, 
1H), 6.54 (dd, J = 3.6, 1.7 Hz, 1H), 6.17 (s, 1H), 4.23 (q, J = 7.1 Hz, 2H), 
1.23 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 179.8, 164.0, 151.8, 
147.5, 140.5, 131.7, 120.1, 112.4, 61.5, 13.9. MS (ESI m/z) 195.26 [MH+, 
15%], 217.26 [MNa+, 100%], 233.19 [MK+, 10%]. 
 
Ethyl 2-(cyclohex-1-enecarbonyl)acrylate (65j) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR max 
(KBr)/cm-1 2941, 1724, 1658, 1634, 1220, 772. 1H 
NMR (CDCl3, 400 MHz) δ 6.76 (t, J = 3.9 Hz, 1H), 6.49 
(s, 1H), 5.81 (s, 1H), 4.23 (q, J = 7.2 Hz, 2H), 2.35-2.19 (m, 4H), 1.70-1.56 
(m, 4H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 194.6, 
164.5, 145.4, 141.2, 139.2, 129.2, 61.3, 26.3, 22.8, 21.7, 21.5, 14.0. MS 
(ESI m/z) 231.31 [MNa*, 100%] . 
 
Methyl 2-benzoylacrylate (65k) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm-1 2980, 1725, 1673, 1223,  772. 1H 
NMR (CDCl3, 400 MHz) δ 7.85 (dd, 2H, J1 = 7.1 Hz, J2 
= 1.1 Hz), 7.61-7.57 (m, 1H), 7.48-7.44 (m, 2H), 6.71 (s, 1H), 6.05 (s, 1H), 
3.75 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ 193.0, 164.7, 140.8, 136.0, 
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tert-Butyl 2-benzoylacrylate (65l) 
Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm-1 2979, 1725, 1678, 1248, 1148, 772. 
1H NMR (CDCl3, 400 MHz) δ 7.83 (d, J = 7.3 Hz, 2H), 7.60-7.55 (m, 1H), 
7.48-7.42 (m, 2H), 6.58 (s, 1H), 6.05 (s, 1H), 1.34 (s, 9H); 13C NMR (CDCl3, 
100 MHz δ 193.7, 163.4, 143.3, 136.7, 133.3, 130.7, 129.0, 128.4, 82.3, 
27.7. MS (ESI m/z) 234.50 [MH+, 40%], 255.46 [MNa+, 100%]. 
 
Benzyl 2-benzoylacrylate (65m) 
Purified by flash chromatography (petroleum 
ether/EtOAc 95:5 as eluent). Pale yellow oil. 
FTIR max (KBr)/cm-1 3033, 1729, 1674, 1221, 
772. 1H NMR (CDCl3, 400 MHz) δ 7.85-7.82 (m, 
2H), 7.62-7.55 (m, 1H), 7.47-7.41 (m, 2H), 7.31-7.27 (m, 3H), 7.21-7.16 
(m, 2H), 6.73 (s, 1H), 6.12 (s, 1H), 5.20 (s, 2H); 13C NMR (CDCl3, 100 MHz) 
δ 192.9, 164.1, 141.2, 136.2, 135.1, 133.5, 132.0, 129.3, 128.5, 128.4, 
128.2, 127.9, 67.0. MS (ESI m/z) 289.42 [MNa+, 100%] 
 
Diethyl 3-oxo-3-phenylprop-1-en-2-ylphosphonate (65n) 
Purified by flash chromatography (petroleum 
ether/EtOAc 1:1 as eluent). Colourless oil, FTIR max 
(KBr)/cm-1 2985, 1667, 1251, 1023, 772. 1H NMR 
(CDCl3, 400 MHz) δ 7.85 (d, 2H, J = 7.4 Hz), 7.62-7.53 (m, 1H), 7.49-7.43 
(m, 2H), 6.81 (d, 1H, J = 23.5 Hz), 6.28 (d, 1H, J = 45.0 Hz), 4.22-4.13 (m, 
4H), 1.31 (t, 6H, J = 7.1 Hz); 13C NMR (CDCl3, 100 MHz) δ 193.9, 139.6, 
138.3, 136.1, 133.5, 129.8, 128.5, 62.8 (d, J = 5 Hz), 16.2 (d, J = 6 Hz). 
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Ethyl 2-(benzylcarbamoyl)acrylate (65o) 
Purified by flash chromatography (petroleum 
ether/EtOAc 9:1 as eluent). Pale yellow oil. FTIR 
max (KBr)/cm- 2982, 1714, 1663, 1534, 1143, 
772. 1H NMR (CDCl3, 400 MHz) δ 8.79 (bs, 1H), 
7.34-7.17 (m, 5H), 7.17 (s, 1H), 6.79 (s, 1H), 4.57 (d, J = 5.7 Hz, 2H), 4.26 
(q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
166.2, 162.1, 138.4, 137.9, 132.4, 128.6, 127.6, 127.3, 61.7, 43.6. MS 
(ESI m/z) 256.13 [MNa+, 100%]. 
 
Catalyst 76 was synthesized according to literature procedure.174 
4-methyl-N-((1R, 2R)-2-(pyrrolidin-1-yl)cyclohexyl) benzene 
sulfonamide (76) 
Yellow oil,  
19
D  = -64.0 (c 0.98, CHCl3). FTIR 
max (KBr)/cm-1 2933, 1219, 1164, 772. 1H NMR 
(CDCl3, 400 MHz) δ 7.74 (d, J = 8.1 Hz, 2H), 
7.29 (d, J = 8.0 Hz, 2H), 2.69-2.58 (m, 1H), 
2.51-2.34 (m, 7H), 2.19-2.05 (m, 2H), 1.80-1.72 (m, 2H), 1.64-1.52 (m, 
5H), 1.28-1.04 (m, 6H), 0.93-0.79 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 
143.1, 137.0, 129.4, 127.2, 61.4, 55.2, 46.6, 32.7, 24.9, 24.2, 23.4, 21.8, 
21.5. MS (ESI m/z) 323.14 [MH+, 100%]. 
 
General procedure for the synthesis of racemic aziridines 66 
A sample vial was charged with compound 65 (0.20 mmol) and amine 63 
(0.20 mmol) in anhydrous toluene (4.0 mL). Triethylamine (0.20 mmol) 
was added and the solution was stirred at room temperature until 
completion (1-3 hours), monitored by TLC (eluent petroleum ether/CHCl3 
                                                          
174 F. Yu, X. Sun, Z. Jin, S. Wen, X. Liang, J. Ye, Chem. Commun. 2010, 46, 4589. 
EXPERIMENTAL SECTION 
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3:7) Flash chromatography (petroleum ether/Et2O 95:5 as eluent) gave 
racemic aziridines 63. 
 
Procedure for the asymmetric aziridination of compounds 65 
To a sample vial charged with the appropriate catalyst (0.02 mmol), K2CO3 
(0.1 mmol) and the amine (0.1 mmol) a solution of the alkene (0.1 mmol) 
in anhydrous toluene (2 mL), cooled at 0°C for 10 minutes, was added and 
the reaction mixture stirred at 0°C. After completion, monitored by TLC 
(eluent petroleum ether/CHCl3 3:7), the reaction mixture was directly 
loaded onto silica gel and purified by flash chromatography (eluting with 
petroleum ether/Et2O 95:5) to give the corresponding chiral aziridines 
65a-o. 
 
(R)-1-tert-butyl 2-ethyl 2-benzoylaziridine-1,2-dicarboxylate (66aa) 
Colourless oil.  13D  = -79.2 (c 0.88, CHCl3), 78% ee. 
FTIR max (KBr)/cm-1 2981, 1747, 1733, 1688, 1369, 
1249, 1156, 772. 1H NMR (CDCl3, 400 MHz) δ 8.24 (d, 
J = 8.2 Hz, 2H), 7.63-7.58 (m, 1H), 7.52-7.43 (m, 2H), 
4.31-4.20 (m, 1H), 4.19-4.11 (m, 1H), 2.95 (s, 1H), 2.70 (s, 1H), 1.52 (s, 
9H), 1.11 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 190.7, 166.6, 
158.0, 134.7, 133.7, 129.6, 128.4, 82.9, 62.8, 48.6, 36.4, 27.9, 13.9. MS 
(ESI m/z) 342.40 [MNa+, 80%]. HPLC analysis with Chiralpak AS-H 
column, 95:5 n-hexane/iPrOH, 0.6 mL/min, detection at 254 nm; minor 
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1-Benzyl 2-ethyl 2-benzoylaziridine-1,2-dicarboxylate (66ab) 
Colourless oil.  20D  = -57.4 (c 0.70, CHCl3), ee 70%. 
FTIR max (KBr)/cm-1 2923, 1744, 1730, 1685, 1219, 
772. 1H NMR (CDCl3, 400 MHz) δ 8.22-8.16 (m, 2H), 
7.62-7.52 (m, 2H), 7.48-7.36 (m, 6H), 5.25 (s, 2H), 
4.24-4.04 (m, 2H), 3.04 (d, J = 1.28 Hz, 1 H), 2.77 (d, 
J = 1.28 Hz, 1 H), 1.06 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
190.3, 166.4, 159.4, 135.0, 134.5, 133.8, 129.5, 128.6, 128.5, 69.0, 63.0, 
48.5, 36.5, 13.8. MS (ESI m/z) 376.41 [MNa+, 100%]. HPLC analysis with 
Chiralpak AS-H column, 80:20 n-hexane/iPrOH, 1 mL/min, detection at 
220 nm; minor enantiomer tR = 13.8 min, major enantiomer tR = 10.7 min. 
 
Ethyl 2-benzoyl-1-tosylaziridine-2-carboxylate (66ac) 
Colourless oil.  18D  = 8.6 (c 0.92, CHCl3), 36% ee. 
FTIR max (KBr)/cm-1 2977, 1751, 1733, 1691, 1220, 
1166, 772. 1H NMR (CDCl3, 400 MHz) δ 8.10 (d, 2H, J 
= 8.2 Hz), 7.89-7.68 (m, 2H), 7.63-7.55 (m, 1H), 7.51-
7.41 (m, 2H), 7.33-7.27 (m, 2H), 4.34-4.16 (m, 2H), 
3.37 (s, 1H), 2.94 (s, 1H), 2.42 (s, 3H), 1.17 (t, 3H, J = 
7.1 Hz); 13C NMR (CDCl3, 100 MHz) δ 188.9, 164.9, 144.8, 136.2, 134.3, 
134.0, 129.7, 129.6, 128.5, 127.8, 63.2, 53.6, 37.3, 21.6, 13.6. MS (ESI 
m/z) 396.36 [MNa+, 100%]. HPLC analysis with Chiralpak AS-H column, 
70:30 n-hexane/iPrOH, 0.8 mL/min, detection at 220 nm; minor 
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(R)-1-tert-butyl 2-ethyl 2-(4-methylbenzoyl)aziridine-1,2-dicarboxylate 
(66b) 
Colourless oil.  22D  = -73.6 (c 0.48, CHCl3), 78% ee. 
FTIR max (KBr)/cm-1 2979, 1746, 1685, 1249, 1156, 
772. 1H NMR (CDCl3, 400 MHz) δ 8.14 (d, 2H, J = 
8.1 Hz), 7.27 (d, 2H, J = 8.2 Hz), 4.30-4.21 (m, 1H), 
4.20-4.09 (m, 1H), 2.94 (s, 1H), 2.68 (s, 1H), 2.42 (s, 
3H), 1.52 (s, 9H), 1.13 (t, 3H, J = 7.1 Hz); 13C NMR (CDCl3, 100 MHz) δ 
190.3, 166.7, 158.0, 144.8, 132.2, 129.8, 129.1, 82.8, 62.7, 48.6, 36.4, 
27.9, 21.8, 13.9. MS (ESI m/z) 356.37 [MNa+, 100%]. HPLC analysis with 
Chiralpak AS-H column,95:5 n-hexane:2-propanol, 0.6 mL/min, detection 
at 254 nm; minor enantiomer tR = 14.0 min, major enantiomer tR = 11.2 
min. 
 
(R)-1-tert-butyl 2-ethyl 2-(3-methylbenzoyl)aziridine-1,2-dicarboxylate 
(66c) 
Colourless oil.  22D  = -69.7 (c 0.47, CHCl3), 82% ee. 
FTIR max (KBr)/cm-1 2981, 1747, 1732, 1686, 1250, 
1156, 772. 1H NMR (CDCl3, 400 MHz) δ 8.07 (d, J = 
7.5 Hz, 1H), 7.98 (s, 1H), 7.42-7.32 (m, 2H), 4.31-4.09 
(m, 2H), 2.94 (d, J = 1.4 Hz, 1H), 2.68 (d, J = 1.4 Hz, 
1H), 2.42 (s, 3H), 1.52 (s, 9H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 
100 MHz) δ 191.0, 166.6, 158.0, 138.3, 134.7, 134.6, 129.7, 128.3, 127.1, 
82.8, 62.7, 48.7, 36.5, 27.9, 21.3, 13.9. MS (ESI m/z) 334.28 [MH+, 10%], 
356.43 [MNa+, 100%]. HPLC analysis with Chiralpak AS-H column, 95:5 
n-hexane/iPrOH, 0.6 mL/min, detection at 254 nm; minor enantiomer tR = 
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(R)-1-tert-butyl 2-ethyl 2-(2-methylbenzoyl)aziridine-1,2-dicarboxylate 
(66d) 
Colourless oil.  23D  = -24.0 (c 0.60, CHCl3), 50% ee. 
FTIR max (KBr)/cm-1 2979, 1746, 1688, 1248, 1156, 
772. 1H NMR (CDCl3, 400 MHz) δ 8.19-8.11 (m, 1H), 
7.45-7.38 (m, 1H), 7.29- 7.27 (m, 2H), 4.25-4.13 (m, 
1H), 4.12-4.05 (m, 1H), 2.90 (d, J = 1.6 Hz, 1H), 2.77 
(d, J = 1.6 Hz, 1H), 2.54 (s, 3H), 1.49 (s, 9H), 1.06 (t, J = 7.1 Hz, 3H); 13C 
NMR (CDCl3, 100 MHz) δ 193.1, 166.7, 157.9, 139.8, 134.8, 132.2, 131.8, 
130.5, 125.4, 82.8, 62.5, 49.8, 36.6, 27.9, 21.2, 13.7. MS (ESI m/z) 
334.34 [MH+, 10%], 356.45 [MNa+, 100%]. HPLC analysis with Chiralpak 
IC column, 90:10 n-hexane/iPrOH, 1 mL/min, detection at 254 nm; minor 




Colourless oil.  23D  = -56.6 (c 0.82, CHCl3), 80% 
ee. FTIR max (KBr)/cm-1 2982, 1746, 1678, 
1251, 1156, 772. 1H NMR (CDCl3, 400 MHz) δ 
8.24 (d, J = 8.8 Hz, 2H), 6.95 (d, J = 8.8 Hz, 2H), 
4.29-4.25 (m, 1H), 4.24-4.11 (m, 1H), 3.88 (s, 
3H), 2.93 (d, J = 1.0 Hz, 1H), 2.66 (d, J = 1.0 Hz, 1H); 13C NMR (CDCl3, 
100 MHz) δ 189.2, 166.8, 164.0, 158.1, 132.2, 127.8, 113.7, 82.8, 62.7, 
55.5, 48.6, 36.5, 27.9, 13.9. MS (ESI m/z) 372.18 [MNa+, 100%]. HPLC 
analysis with Chiralpak AS-H column, 80:20 n-hexane/iPrOH, 0.6 
mL/min, detection at 254 nm; minor enantiomer tR = 12.5 min, major 
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(R)-1-tert-butyl 2-ethyl 2-(4-chlorobenzoyl)aziridine-1,2-dicarboxylate 
(66f) 
Colourless oil.  19D  = -59.0 (c 0.61, CHCl3), 78% 
ee. FTIR max (KBr)/cm-1 2981, 1749, 1735, 1690, 
1250, 1156, 772. 1H NMR (CDCl3, 400 MHz) δ 
8.22 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.5 Hz, 2H), 
4.32-4.21 (m, 1H), 4.20-4.07 (m, 1H), 2.95 (s, 1H), 
2.68 (s, 1H), 1.53 (s, 9H), 1.14 (t, J = 7.1 Hz, 3H);  13C NMR (CDCl3, 100 
MHz) δ 189.7, 166.3, 157.8, 140.3, 133.0, 131.0, 128.8, 83.1, 62.9, 48.4, 
36.5, 27.9, 13.9. MS (ESI m/z) 376.19 [MNa+, 100%]. HPLC analysis with 
Chiralpak AS-H column, 98:2 n-hexane/iPrOH, 0.6 mL/min, detection at 
254 nm; minor enantiomer tR = 13.5 min, major enantiomer tR = 11.5 min. 
 
(R)-1-tert-butyl 2-ethyl 2-(3-bromobenzoyl)aziridine-1,2-dicarboxylate 
(66g) 
Colourless oil.  24D  = -52.1 (c 0.62, CHCl3), 70% ee. 
FTIR max (KBr)/cm-1 2978, 1749, 1733, 1693, 1567, 
1370, 1248, 1155,772. 1H NMR (CDCl3, 400 MHz) δ 
8.35 (s, 1H), 8.22 (d, J = 7.8 Hz, 1H), 7.72 (dd, J  = 
7.9, 0.84 Hz, 1H), 7.36 (t, J = 7.9 Hz, 1H), 4.35-4.22 
(m, 1H), 4.21-4.09 (m, 1H), 2.97 (d, J = 0.6 Hz, 1H), 2.67 (d, J = 0.6 Hz, 
1H), 1.54 (s, 9H), 1.15 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
189.7, 166.2, 157.8, 136.6, 136.5, 132.3, 130.0, 128.4, 122.8, 83.3, 62.9, 
48.4, 36.5, 28.0, 13.9. MS (ESI m/z) 422.10 [MNa+, 100%]. HPLC analysis 
HPLC with Chiralpak AS-H column, 90:10 n-hexane/iPrOH, 0.8 mL/min, 
detection at 254 nm; minor enantiomer tR = 7.5 min, major enantiomer tR 
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(R)-1-tert-butyl 2-ethyl 2-(2-naphthoyl)aziridine-1,2-dicarboxylate 
(66h) 
White solid. Mp 72.5-74.0 °C.  22D  = -55.23 (c 
0.67, CHCl3), 74% ee. FTIR max (KBr)/cm-1 2980, 
1746, 1733, 1683, 1250, 1156, 772. 1H NMR 
(CDCl3, 400 MHz) δ 8.90 (s, 1H), 8.23-8.18 (m, 
1H), 8.01 (d, J = 8.0 Hz, 1H), 7.93-7.85 (m, 2H), 
7.63-7.57 (m, 1H), 7.56-7.49 (m, 1H), 4.30-4.05 (m, 2H), 3.02 (s, 1H), 2.75 
(s, 1H), 1.57 (s, 9H), 1.10 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
190.8, 166.7, 158.1, 135.8, 132.4, 132.2, 132.0, 129.9, 128.9, 128.2, 
127.8, 126.7, 124.6, 83.0, 62.8, 48.8, 36.7, 28.0, 13.9. MS (ESI m/z) 
392.16 [MNa+, 100%], 408.11 [MK+, 20%]. HPLC analysis with Chiralpak 
AS-H column, 95:5 n-hexane/iPrOH, 0.6 mL/min, detection at 254 nm; 
minor enantiomer tR = 15.0 min, major enantiomer tR = 12.3 min. 
 
(R)-1-tert-butyl 2-ethyl 2-(furan-2-carbonyl)aziridine-1,2-dicarboxylate 
(66i) 
Colourless oil.  20D  = -94.4 (c 0.56, CHCl3), 74% ee. 
FTIR max (KBr)/cm-1 2983, 1748, 1733, 1678, 1252, 
1219, 772. 1H NMR (CDCl3, 400 MHz) δ 7.76 (d, J = 
3.2 Hz, 1H), 7.66 (s, 1H), 6.59-6.54, (m, 1H), 4.32-4.11 
(m, 2H), 2.94 (s, 1H), 2.64 (s, 1H), 1.49 (s, 9H), 1.21-1.11 (m, 3H); 13C 
NMR (CDCl3, 100 MHz) δ 178.6, 166.0, 157.8, 150.6, 147.7, 121.7, 112.5, 
82.9, 62.8, 48.1, 36.1, 27.9, 14.0. MS (ESI m/z) 332.18 [MNa+, 100%], 
348.14 [MK+, 20%]. HPLC analysis with Chiralpak AS-H column, 90:10 n-
hexane/iPrOH, 1 mL/min, detection at 254 nm; minor enantiomer tR = 8.9 








Colourless oil.  22D  = -57.14 (c 0.42, CHCl3), 72% ee. 
FTIR max (KBr)/cm-12938, 1746, 1673, 1369, 1220, 
1158, 772. 1H NMR (CDCl3, 400 MHz) δ 7.52-7.47 (m, 
1H), 4.36-4.23 (m, 1H), 4.21-4.09 (m, 1H), 2.79 (d, J 
= 1.4 Hz, 1H), 2.54 (d, J = 1.4 Hz, 1H), 2.38-2.12 (m, 4H), 1.73-1.58 (m, 
4H), 1.49 (s, 9H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
191.3, 167.0, 158.1, 145.6, 137.1, 82.5, 62.5, 48.2, 36.2, 27.9, 26.3, 
22.9, 21.7, 21.4, 14.0. MS (ESI m/z) 346.20 [MNa+, 100%], 362.18 [MK+, 
25%]. HPLC analysis with Chiralpak AD-H column, 98:2 n-hexane/iPrOH, 
0.6 mL/min, detection at 220 nm; minor enantiomer tR = 14.9 min, major 
enantiomer tR = 13.4 min. 
 
(R)-1-tert-butyl 2-methyl 2-benzoylaziridine-1,2-dicarboxylate (66k) 
Colourless oil.  13D  = -65.8 (c 0.90, CHCl3), 78% ee. 
FTIR max (KBr)/cm-1 2979, 1751, 1733, 1688, 1370, 
1251, 1156, 802. 1H NMR (CDCl3, 400 MHz) δ 8.27-
8.21 (m, 2H), 7.63-7.58 (m, 1H), 7.51-7.46 (m, 2H), 
3.74 (s, 3H), 2.97 (d, J = 1.4 Hz, 1H), 2.70 (d, J = 1.4 
Hz, 1H), 1.53 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 190.6, 167.1, 157.9, 
134.5, 133.9, 129.7, 128.5, 83.0, 53.4, 48.4, 36.6, 27.9. MS (ESI m/z) 
328.30 [MNa+, 100%], 344.15 [MK+, 5%]. HPLC analysis with Chiralpak 
AS-H column, 95:5 n-hexane/iPrOH, 0.6 mL/min, detection at 254 nm; 
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(R)-di-tert-butyl 2-benzoylaziridine-1,2-dicarboxylate (66l) 
 Colourless oil.  22D  = -55.1 (c 0.56, CHCl3), 76% ee. 
FTIR max (KBr)/cm-1 2979, 2933, 1725, 1678, 1248, 
1148, 772.  1H NMR (CDCl3, 400 MHz) δ 8.24 (d, J = 
7.4 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.49-7.42 (m, 
2H), 2.89 (d, J = 1.0 Hz, 1H), 2.68 (d, J = 1.0 Hz, 1H), 1.54 (s, 9H), 1.30 (s, 
9H); 13C NMR (CDCl3, 100 MHz) δ 191.0, 165.3, 158.3, 135.1, 133.4, 
129.4, 128.2, 84.4, 82.7, 49.3, 35.8, 27.9, 27.6 . MS (ESI m/z) 370.42 
[MNa+, 100%]. HPLC analysis with Chiralpak AS-H column, 95:5 n-
hexane/iPrOH, 0.6 mL/min, detection at 254 nm; minor enantiomer tR = 
9.1 min, major enantiomer tR = 8.3 min. 
 
(R)-2-benzyl 1-tert-butyl 2-benzoylaziridine-1,2-dicarboxylate (66m) 
Colourless oil.  20D  = -73.2 (c 0.45, CHCl3), 72% 
ee. FTIR max (KBr)/cm-1 3032, 2347, 1735, 
1685, 1220, 772. 1H NMR (CDCl3, 400 MHz) δ 
8.19 (d, J = 1.2 Hz, 2H), 7.61-7.53 (m, 1H), 
7.46-7.38 (m, 2H), 7.32-7.18 (m, 3H), 7.07-7.01 (m, 2H), 5.26 (d, J = 12.3 
Hz, 1H), 5.05 (d, J = 12.3 Hz, 1H), 2.96 (d, J = 1.5 Hz, 1H), 2.75 (d, J = 1.4 
Hz, 1H), 1.45 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 190.4, 166.5, 157.9, 
134.7, 134.4, 133.7, 129.6, 128.4, 128.1, 82.9, 68.1, 48.6, 36.4, 27.8. MS 
(ESI m/z) 404.27 [MNa+, 100%]. HPLC analysis with Phenomenex Lux 
column, 90:10 n-hexane/iPrOH, 1.0 mL/min, detection at 254 nm; minor 










Colourless oil.  24D  = 46.3 (c 0.48, CHCl3), 50% ee. 
FTIR max (KBr)/cm-1 2982, 1729, 1679, 1271, 1159, 
1023, 772. 1H NMR (CDCl3, 400 MHz) δ 8.41-8.34 (m, 
2H), 7.62-7.54 (m, 1H), 7.49-7.42 (m, 2H), 4.28-4.10 
(m, 4H), 3.02 (dd, J = 9.4, 0.9 Hz, 1H), 2.50 (dd, J = 
3.9, 1.0 Hz, 1H), 1.56 (s, 9H), 1.33 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 Hz, 
3H); 13C NMR (CDCl3, 100 MHz) δ 192.4 (d, J = 11 Hz), 158.3 (d, J = 9 Hz), 
134.6, 133.8, 130.5, 128.1, 82.8, 63.9 (d, J = 7 Hz), 63.5 (d, J = 6 Hz), 
45.8, 44.1, 33.7, 27.9, 16.1. MS (ESI m/z) 406. 25 [MNa+, 100%]. HPLC 
analysis with Chiralpak AS-H column, 95:5 n-hexane/iPrOH, 0.6 mL/min, 
detection at 254 nm; minor enantiomer tR = 9.3 min, major enantiomer tR 
= 12.2 min. 
 
1-tert-butyl 2-ethyl 2-(benzylcarbamoyl)aziridine-1,2-dicarboxylate 
(66o) 
Colourless oil.  20D  = -20.8 (c 0.87, CHCl3), 72% 
ee. FTIR max (KBr)/cm-1 2981, 1734, 1676, 1531, 
1370, 1249, 1157, 772. 1H NMR (CDCl3, 400 
MHz) δ 7.68 (bs, 1H), 7.40-7.19 (m, 5H), 4.51 (d, 
J = 5.8 Hz, 2H), 4.38-4.15 (m, 2H), 2.94 (d, J = 1.1 Hz, 1H), 2.72 (d, J = 
1.1 Hz, 1H), 1.43 (s, 9H), 1.31 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 100 
MHz) δ 167.0, 164.0, 157.5, 137.6, 128.7, 127.6, 82.7, 62.8, 44.7, 43.5, 
37.6, 27.8, 13.9. MS (ESI m/z) 371.25 [MNa+, 100%]. HPLC analysis with 
Chiralpak AD-H column, 95:5 n-hexane/iPrOH, 1 mL/min, detection at 
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Procedure for synthesis of compound 80 
 
 
Enantiomerically enriched aziridine 66a (0.2 mmol, 77% ee) dissolved in 
dry THF (1 mL) was treated with tetrabutylammonium fluoride (0.2 mmol, 
1 M solution in THF) at 60°C. After completion of reaction, monitored by 
TLC (eluent petroleum ether/EtOAc 6:4), the reaction was quenched with 
saturated NaHCO3 aqueous solution and extracted with EtOAc (3 x 50 
mL). Combined organic phases were evaporated under reduced pressure. 
The residue was purified by flash chromatography and isolated in 98% 
yield. 
Deprotected aziridine 78 was dissolved in dry THF (4 mL) and at 0°C a 
solution of HCl·Et2O (0.2 mmol) diluted in THF (0.14 M) was added 
dropwise. After 2 hours the reaction mixture was treated with 5% aqueous 
NaHCO3 and extracted with CH2Cl2 (3 x 50 mL), combined organic phases 
were evaporated under reduced pressure. The residue was directly treated 
with a solution of benzyl dicarbonate (1.4 equivalents) in dry THF (800 L) 
at 0°C. After 2 hours the mixture was diluted with EtOAc and washed with 
water. Aqueous phase was extracted with EtOAc (2 x 50 mL). Combined 
organic layers were evaporated and after purification by flash 
chromatography (eluent petroleum ether/EtOAc 98:2) compound 80 was 
obtained in 38% yield (77% ee). 
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(R)-Ethyl 2-benzoylaziridine-2-dicarboxylate (78) 
Purified by flash chromatography (petroleum 
ether/Et2O 8:2 as eluent). Colourless oil.  20D  = -12.3 
(c 0.52, CHCl3). FTIR max (KBr)/cm- 2924, 2854, 1733, 
1688, 1220, 772. 1H NMR (CDCl3, 400 MHz) δ 7.94 (d, J = 7.7 Hz, 2H), 
7.88 (d, J = 7.7 Hz, 1H), 7.58-7.52 (m, 2H), 7.50-7.32 (m, 3H), 4.30-3.98 
(m, 3.6H), 2.64 (d, J = 9.2 Hz, 1H), 2.47 (t, J = 9.6 Hz, 1H), 2.39 (d, J = 
10.9 Hz, 1H), 2.33 (d, J = 9.0 Hz, 1H), 2.12 (d, J = 10.0 Hz, 1H), 2.06 (t, J 
= 9.5 Hz, 1H), 1.05 (t, J = 7.1 Hz, 3H), 0.99 (t, J = 7.0 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz) δ 194.3, 191.9, 170.9, 168.9, 135.6, 135.3, 133.6, 
133.5, 128.8, 128.6, 128.5, 128.3, 62.7, 62.0, 44.7, 43.1, 33.4, 32.7, 
13.8,13.6 MS (ESI m/z) 220.45 [MH+, 25%], 242.44 [MNa+, 100%].  
 
(R)-Ethyl 2-amino-2-(chloromethyl)-3-oxo-3-phenylpropanoate (79) 
Colourless oil.  22D  = +15.1 (c 0.50, CHCl3). FTIR max 
(KBr)/cm-1 2360, 1729, 1692, 1219, 772 1H NMR 
(CDCl3, 400 MHz) δ 7.98 (d, J = 8.1 Hz, 2H), 7.62-7.52 
(m, 1H), 7.49-7.37 (m, 2H), 4.45-4.15 (m, 3H), 4.11 (d, 
J = 11.6 Hz, 1H), 1.15 (t, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 100 MHz) δ 
193.4, 169.4, 134.2, 133.5, 129.0, 128.6, 69.4, 63.0, 49.2, 13.7. MS (ESI 




Purified by flash chromatography (petroleum 
ether/EtOAc 98:2 as eluent). Colourless oil.  22D  = 
+8.8 (c 0.50, CHCl3), 77% ee. FTIR max (KBr)/cm-1 
1724, 1694, 1497, 1289, 1219, 1038, 772. 1H NMR 
(CDCl3, 400 MHz) δ 7.91 (d, J = 8.0 Hz, 2H), 7.59-7.49 (m, 1H), 7.47-7.41 
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(m, 2H), 7.32-7.21 (m, 3H), 7.12-7.03 (m, 2H), 6.64 (s, 1H), 5.01 (d, J = 
12.4 Hz, 1H), 4.91 (d, J = 12.4 Hz, 1H), 4.53 (d, J = 11.6 Hz, 1H), 4.43 (d, 
J = 11.7 Hz, 1H), 4.38-4.18 (m, 2H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR 
(CDCl3, 100 MHz) δ 190.5, 166.9, 153.9, 135.8, 134.2, 133.4, 128.5, 
128.4, 128.1, 127.7, 70.5, 67.0, 63.8, 46.6, 13.8. HPLC analysis with 
Chiralpak IC column, 95:05 n-hexane/iPrOH, 0.8 mL/min, detection at 
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8.6 Asymmetric Synthesis of Helicenes 
 
Synthesis and Characterization of Hydrazines 
N-protected hydrazines were synthesized following a procedure reported in 
the literature.157 The hydrazine or its hydrochloride salt (4.0 mmol) was 
treated with NaHCO3 (1 equivalent for the free hydrazine, 2 for the 
hydrochloride salt) and the appropriate benzyl bromide in H2O at 100°C 
under vigorous stirring. After 3 hours the mixture was allowed to cool to 
room temperature, diluted with MTBE  (30 mL) and the organic layer was 
separated, dried over MgSO4 and concentrated under reduced pressure. 





Purified by flash chromatography (pentane/MTBE 
8:2), pale brown solid. 1H‐NMR (500 MHz, CDCl3) 
δ 7.67 (d, J = 8.2 Hz, 2H), 7.07 (d, J = 8.2 Hz, 2H), 
6.68 (s, 2H), 6.51 (s, 1H), 4.51 (s, 2H), 3.56 (bs, 
2H), 2.29 (s, 6H); 13C‐NMR (125 MHz, CDCl3) δ 
152.1, 139.1, 138.1, 138.0, 130.1, 121.2, 111.7, 92.9, 60.2, 22.0. MS (EI) 
m/z (%): 352 (24), 217 (9), 135 (100). HRMS (EI) m/z calculated for 
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1-benzyl-1-(3,5-dimethylphenyl) hydrazine (84b) 
The reaction was conducted on a 2.0 mmol scale. 
Purified by flash chromatography (hexane/MTBE 
9:1), yellow oil. 1H-NMR (500 MHz, CDCl3) δ 7.40-
7.28 (m, 5H), 6.77 (s, 2H), 6.52 (s, 1H), 4.58 (s, 2H), 
3.53 (bs, 2H), 2.32 (s, 6H); 13C‐NMR (125 MHz, CDCl3) δ 151.9, 138.7, 
137.8, 128.6, 127.9, 127.3, 120.6, 111.5, 60.4, 21.7. MS (EI) m/z (%): 226 
(37), 135 (83), 91 (100). HRMS (EI) m/z calculated for C15H18N2Na (M+Na+) 
249.136214, found 249.136000. 
 
1-(3,5-dimethylphenyl)-1-(4-(trifluoromethyl)benzyl) hydrazine (84c) 
Purified by flash chromatography 
(hexane/MTBE 8:2), dark yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 7.60 (d, J = 8.1 Hz, 2H), 
7.42 (d, J = 8.1 Hz, 2H), 6.67 (s, 2H), 6.52 (s, 
1H), 4.63 (s, 2H), 3.62 (s, 2H), 2.29 (s, 6H). 
13C‐NMR (125 MHz, CDCl3) δ 151.7, 142.4, 138.9, 129.5 (q, J = 32.6 Hz), 
127.9, 125.5 (sept, J = 4.2 Hz), 124.2 (q, J = 272.0 Hz), 120.9, 111.2, 
60.0, 21.7. MS (EI) m/z (%): 294 (30), 159 (50), 135 (100), 105 (40). HRMS 




Purified by flash chromatography 
(hexane/MTBE 8:2), dark yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 7.81 (s, 3H), 6.65 (s, 2H), 
6.57 (s, 1H), 4.64 (s, 2H), 3.69 (bs, 2H), 2.31 (s, 
6H). 13C‐NMR (125 MHz, CDCl3) δ 151.8, 141.6, 
139.1, 131.8 (q, J = 33.0 Hz), 127,8 (d, J = 3.6 Hz), 123.3 (q, J = 271.2 
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Hz), 121.6, 121.2 (sep, J = 3.7 Hz), 111.4, 60.0, 21.7. MS (EI) m/z (%): 362 
(35), 227 (16), 135 (100). HRMS (EI) m/z calculated for C17H16F6N2Na 
(M+Na+) 385.110988, found 385.111507. 
 
1-(4-(tert-butyl)benzyl)-1-(3,5-dimethylphenyl) hydrazine (84e) 
 Purified by flash chromatography 
(hexane/MTBE 9:1), white solid. 1H NMR (500 
MHz, CDCl3) δ 7.37 (d, J = 8.25 Hz, 2H), 7.25 (d, 
J = 8.25 Hz, 2H), 6.76 (s, 2H), 6.50 (s, 1H), 4.53 
(s, 2H), 3.50 (bs, 2H), 2.30 (s, 6H), 1.33 (s, 9H). 
13C‐NMR (125 MHz, CDCl3) δ 152.0, 150.2, 138.7, 134.6, 127.7, 125.6, 
120.6, 111.6, 60.1, 34.5, 31.3, 21.7. MS (EI) m/z (%): 282 (35), 147 (41), 




Purified by flash chromatography 
(pentane/MTBE 8:2), red solid. 1H NMR (500 
MHz, CDCl3) δ 7.75-7.71 (m, 2H), 7.68-7.64 (m, 
3H), 7.44-7.37 (m, 2H), 7.30-7.25 (m, 2H), 7.08 
(d, J = 8.3 Hz, 2H), 4.64 (s, 2H), 3.66 (bs, 2H). 13C‐NMR (125 MHz, CDCl3) 
δ 149.2, 137.8, 137.0, 134.5, 130.0, 128.9, 128.0, 127.4, 126.6, 126.4, 
123.1, 117.1, 107.8, 92.9, 59.9. MS (EI) m/z (%): 374 (29), 217 (8), 157 
(100), 128 (51). HRMS (EI) m/z calculated for C17H15N2INa (M+Na+) 
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1-(naphthalen-2-yl)-1-(4-trifluoromethyl)benzyl)hydrazine (88b) 
The reaction was conducted on a 2.0 mmol 
scale. Purified by flash chromatography 
(hexane/MTBE 100:2), yellow solid. 1H NMR 
(500 MHz, CD2Cl2) δ 7.71 (t, J = 9.4 Hz, 2H), 
7.64 (d, J = 8.6 Hz, 1H), 7.59 (d, J = 7.8 Hz, 2H), 7.46 (d, J = 7.8 Hz, 2H), 
7.42-7.39 (m, 1H), 7.38-7.33 (m, 1H), 7.26-7.21 (m, 2H), 4.76 (s, 2H), 3.75 
(bs, 2H).  
 
1-(2,5-dimethylphenyl)-1-(4-iodobenzyl)hydrazine (93) 
The reaction was conducted on a 2.0 mmol scale. 
Purified by flash chromatography (pentane/MTBE 
8:2), orange oil. 1H NMR (500 MHz, CD2Cl2) δ 7.66 
(d, J = 7.3 Hz, 2H), 7.16 (d, J = 7.4 Hz, 2H), 7.03 (d, 
J = 7.6 Hz, 1H), 7.00 (s, 1H), 6.80 (d, J = 7.6 Hz, 1H), 4.01 (s, 2H), 2.31 (s, 
3H), 2.27 (s, 3H). 
  
Synthesis and Characterization of Ketones 
The ketones were synthesized from the corresponding stilbenes according 
a known literature procedure.158a  
The stilbenes were obtained following a Wittig-Horner procedure: to a 
suspension of tBuOK  (15 mmol) in DMF, a 0.2 M solution of the 4-
methoxybenzylphosphonate (9 mmol) was added. After ten minutes a 
solution of the corresponding aldehyde (6 mmol) was added and the 
mixture is kept under vigorous stirring until completion (monitored by 
TLC, eluent: hexane/EtOAc 20:1). Water was added and the mixture is 
extracted with MTBE, the organic layers were washed three times with 
brine, dried over MgSO4 and concentrated under reduced pressure. The 
product is purified by crystallization from EtOAc.  
EXPERIMENTAL SECTION 
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The stilbene (500 mg) is added to a 0.5 M solution of HCl in 500 mL of 
degassed acetonitrile. After consumption of the starting material 
(monitored by TLC, eluent hexane/EtOAc 7:3) the mixture is neutralized 
with Na2CO3 (aq) and the organic layer is separated, dried over MgSO4 and 
concentrated under reduced pression. The product is purified by column 
chromatography on SiO2. 
     
8,9-dihydrophenanthro[3,4-b]tiophene-10(11H)-one (99)  
Purified by flash chromatography with hexane/CH2Cl2 
8:2 as eluent, yellow solid. 1H NMR (500 MHz, CDCl3) δ 
8.21 (d, J = 5.9 Hz, 1H), 7.92 (d, J = 8.6 Hz, 1H), 7.84 (d, 
J = 8.2 Hz, 1H), 7.75 (d, J = 8.2 Hz, 1H), 7.62 (d, J = 5.6 
Hz, 1H), 7.40 (d, J = 8.2 Hz, 1H), 4.36 (s, 2H), 3.35 (t, J = 
6.9 Hz, 2H), 2.77 (t, J = 6.9 Hz, 2H). 13C‐NMR (125 MHz, CDCl3) δ 210.0, 
140.2, 134.3, 133.9, 133.4, 131.3, 128.8, 128.7, 128.0, 126.1, 126.0, 
124.8, 120.7, 45.3, 38.5, 30.2. MS (EI) m/z (%): 252 (100), 210 (61). 




Purified by flash chromatography with hexane/EtOAc 
9:1 as eluent. 1H NMR (500 MHz, CDCl3) δ 8.06 (s, 
1H), 7.86 (d, J = 8.2 Hz, 1H), 7.75 (d, J = 8.2 Hz, 2H), 
7.65 (s, 1H), 7.51-7.42 (m, 5H), 7.42-7.35 (m, 4H), 
3.25-3.17 (m, 4H), 2.49 (t, J = 6.7 Hz, 2H). 13C‐NMR 
(125 MHz, CDCl3) δ 210.5, 144.4, 140.1, 139.8, 138.7, 135.9, 134.4, 
130.0, 129.42, 129.37, 129.1, 128.9, 128.4, 128.3, 127.5, 127.4, 127.2, 
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General procedure for the asymmetric Fisher indolization: 
A reaction vial was charged with catalyst 87 (1.79 mg, 0.0025 mmol), 
Amberlite® CG50 (25 mg), the corresponding hydrazine (0.05 mmol) and 
the opportune ketone (0.05 mmol). CH2Cl2 was added and the mixture was 
stirred for 3 days at -5°C. The crude reaction mixture was directly 
submitted to column chromatography. 
The racemates were prepared using a stoichiometric amount of diphenyl 
phosphate in respect to the hydrazine and the ketone. The reaction was 
performed at rt for 4 hours. The crude reaction mixture was directly 




Purified by flash chromatography with 
hexane/MTBE 19:1 as eluent.   25D -454.21 
(C = 0.38, CH2Cl2, 91% ee). 1H NMR (500 MHz, 
CD2Cl2) δ 8.32 (d, J =  8.4 Hz, 1H), 7.74 (d, J = 
7.8 Hz, 1H), 7.77-7.56 (m, 5H), 7.48 (d, J = 7.6 
Hz, 1H), 7.38-7.33 (m, 1H), 6.91-6.83 (m, 4H), 
6.35 (s, 1H), 5.41 (d, J = 17.1 Hz, 1H), 5.36 (d, J = 17.3 Hz, 1H), 2.98-2.82 
(m, 4H), 2.29 (s, 3H), 1.14 (s, 3H). 13C‐NMR (125 MHz, CD2Cl2) δ 139.9, 
138.0, 137.84, 137.81, 136.8, 132.6, 132.3, 131.5, 131.11, 131.06, 128.3, 
128.1, 127.32, 127.30, 126.9, 126.6, 126.13, 126.11, 125.7, 124.9, 124.2, 
123.81, 123.75, 114.4, 106.9, 92.5, 46.3, 31.7, 21.24, 21.17, 19.4. MS 
(EI) m/z (%): 561 (100), 344 (17), 217 (4). HRMS (EI) m/z calculated for 
C33H25NINa (M+Na+) 584.084562, found 584.084112. HPLC analysis with 
Chiralcel OD‐RH column, 80:20 MeCN/H2O, 1.0 mL/min, detection at  








Purified by flash chromatography with 
hexane/MTBE 19:1 as eluent. 1H NMR (500 
MHz, CD2Cl2) δ 8.35 (d, J = 8.5 Hz, 1H), 7.74 (dd, 
J = 7.8, 1.0 Hz, 1H), 7.63 (d, J = 8.8 Hz, 1H), 7.60 
(d, J = 8.7 Hz, 1H), 7.57 (d, J = 7.7 Hz, 1H), 7.48 
(d, J = 7.7 Hz, 1H), 7.38-7.29 (m, 3H), 7.28-7.23 
(m, 1H), 7.11 (d, 7.3 Hz, 2H), 6.92-6.88 (m, 2H), 6.35 (s, 1H), 5.47 (d, J = 
17.0 Hz, 1H), 5.42 (d, J = 17.0 Hz, 1H), 2.99-2.86 (m, 4H), 2.29 (s, 3H), 
1.15 (s, 3H). 13C‐NMR (125 MHz, CD2Cl2) δ 140.2, 138.0, 137.9, 136.9, 
132.6, 132.34, 132.30, 131.6, 131.0, 130.9, 128.9, 128.3, 127.4, 127.3, 
126.9, 126.6, 126.1, 126.07, 126.01, 125.6, 124.8, 124.2, 123.73, 123.67, 
114.2, 107.0, 46.7, 31.7, 21.25, 21.20, 19.5. MS (EI) m/z (%): 437 (100), 
346 (29), 91 (7). HRMS (EI) m/z calculated for C33H27NNa (M+Na+) 
460.203570, found 460.203745. HPLC analysis with Chiralcel OD‐3R 
column, 80:20 MeCN/H2O, 1.0 mL/min, detection at 237 nm; minor 




Reaction conducted on 0.02 mmol scale. 
Isolated by preparative TLC with 
hexane/EtOAc 7:3 as eluent. 1H NMR (500 
MHz, CDCl3) δ 8.34 (d, J = 8.4 Hz, 1H), 7.75 
(d, J = 8.4 Hz, 1H), 7.66-7.56 (m, 5H), 7.48 
(d, J = 7.4 Hz, 1H), 7.36 (t, J = 7.3 Hz, 1H), 
7.22 (d, J = 8.3 Hz, 2H), 6.93-6.87 (m, 1H), 6.87 (s, 1H), 5.52 (d, J = 17.4 
Hz, 1H), 5.47 (d, J = 17.4 Hz, 1H), 2.99-2.82 (m, 4H), 2.29 (s, 3H), 1.16 (s, 
3H). HPLC analysis with Chiralcel OD‐RH column, 85:15 MeCN/H2O, 1.0 
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mL/min,  detection at 235 nm; minor enantiomer tR = 7.5 min, major 




Reaction conducted on 0.02 mmol scale. 
Isolated by preparative TLC with 
hexane/EtOAc 7:3 as eluent. 1H NMR (500 
MHz, CDCl3) δ = 8.41 (d, J = 8.6 Hz, 1H), 
7.74 (d, J = 7.1 Hz, 1H), 7.64 (d, J = 8.8 Hz, 
1H), 7.61 (d, J = 8.7 Hz, 1H), 7.57 (d, 7.7 Hz, 
1H), 7.46 (d, J = 7.7 Hz, 1H), 7.39-7.33 (m, 3H), 7.06 (d, J = 8.3 Hz, 1H), 
6.99-6.84 (m, 1H), 6.93 (s, 1H), 6.39 (s, 1H), 5.45 (d, J = 17.0 Hz, 1H), 
5.39 (d, J = 16.9 Hz, 1H), 2.98-2.86 (m, 4H), 2.33 (s, 3H), 1.26 (s, 9H), 
1.22 (s, 3H). HPLC analysis with Chiralcel OD3 column, 99:1 
heptane/iPrOH, 1.0 mL/min, detection at 235 nm; minor enantiomer tR = 




Purified by flash chromatography with 
hexane/MTBE 19:1 as eluent.   25D -536.67 
(C = 0.36, CH2Cl2, 79% ee). 1H NMR (500 
MHz, CD2Cl2) δ 8.27 (d, J =  8.5 Hz, 1H), 7.75-
7.53 (m, 8H), 7.47 (d, J = 8.9 Hz, 1H), 7.44 (d, 
J = 8.8 Hz, 1H), 7.06 (t, J = 7.4 Hz, 1H), 6.96 (t, J = 7.4 Hz, 1H), 6.90 (d, J 
= 8.4 Hz, 1H), 6.83 (d, J = 8.2 Hz, 2H), 6.47-6.41 (m, 2H), 5.59-5.50 (m, 
2H), 3.08-2.92 (m, 4H). 13C‐NMR (125 MHz, CD2Cl2) δ 138.9, 138.0, 137.6, 
137.5, 133.2, 132.6, 132.4, 131.8, 131.2, 129.4, 128.5, 128.0, 127.8, 
127.4, 127.2, 127.0, 126.5, 126.4, 125.82, 125.77, 125.6, 124.4, 123.8, 
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123.6, 122.65, 122.59, 119.9, 116.0, 110.9, 92.7, 46.6, 31.9, 21.2.  MS 
(EI) m/z (%): 585 (100), 368 (63), 217 (9). HRMS (EI) m/z calculated for 
C35H24NINa (M+Na+) 608.084564, found 608.084892. HPLC analysis with 
Chiralcel OD‐RH column, 80:20 MeCN/H2O, 1.0 mL/min, detection at 237 




Isolated by preparative TLC with 
hexane/EtOAc 7:3 as eluent. 1H NMR (500 
MHz, CD2Cl2) δ 8.28 (d, J = 8.4 Hz, 1H), 
7.75-7.66 (m, 3H), 7.65 (d, J = 7.6 Hz, 1H), 
7.61 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 8.0 Hz, 
3H), 7.49-7.42 (m, 2H), 7.20 (d, J = 7.9 Hz, 2H), 7.06 (t, J = 7.4 Hz, 1H), 
6.96 (t, J = 7.4 Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 6.47-6.42 (m, 2H), 5.73-
5.63 (m, 2H), 3.1-2.9 (m, 4H). HPLC analysis with Chiralcel OD‐RH 
column, 85:15 MeCN/H2O, 1.0 mL/min, detection at 237 nm; minor 
enantiomer tR = 8.0 min, major enantiomer tR = 7.0 min. 
 
9-(4-iodobenzyl)-11,13-dimethyl-8,9-dihydro-7H-triphenyleno[2,1-
c]carbazole (104)  
Purified by flash chromatography with 
hexane/MTBE 19:1 as eluent.   25D -
574.40.21 (C = 0.50, CH2Cl2, 92% ee). 1H 
NMR (500 MHz, CD2Cl2) δ 8.46 (d, J = 7.5 
Hz, 1H), 8.43 (d, J = 7.8 Hz, 1H), 8.34 (d, J 
= 8.1 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 8.07 
(d, J, = 8.3 Hz, 1H), 7.57-7.49 (m, 4H), 7.42 
(d, J = 7.9 Hz, 1H), 7.29 (t, J = 7.5 Hz, 1H), 6.79-6.71 (m, 4H), 6.25 (s, 
1H), 5.30 (d, J = 17.3 Hz, 1H), 5.25 (d, J = 17.3 Hz, 1H), 2.93-2.73 (m, 
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4H), 2.18 (s, 3H), 1.21 (s, 3H). 13C‐NMR (125 MHz, CD2Cl2) δ 139.9, 138.0, 
137.9, 137.8, 137.3, 132.2, 131.7, 131.2, 131.1, 130.5, 130.2, 130.0, 
129.7, 128.0, 128.0, 127.4, 127.2, 126.8, 126.4, 126.3, 125.1, 123.8, 
123.6, 123.4, 123.2, 122.8, 119.2, 114.6, 106.9, 92.6, 46.3, 31.4, 21.25, 
21.19, 19.4. MS (EI) m/z (%): 613 (100), 396 (27), 217 (4). HRMS (EI) m/z 
calculated for C37H28NINa (MNa+) 636.115865, found 636.115964. HPLC 
analysis with Chiralcel OD‐RH column, 95:5 MeCN:H2O, 1.0 mL/min, 
detection at 235 nm; minor enantiomer tR = 29.4 min, major enantiomer tR 




Purified by flash chromatography with 
hexane/CH2Cl2 9:1 as eluent.   25D -528.54 
(C = 0.41, CH2Cl2, 93% ee). 1H NMR (500 
MHz, CD2Cl2) δ 7.80 (d, J  = 8.8 Hz, 1H), 7.69-
7.62 (m, 4H), 7.53 (d, J = 5.3 Hz, 1H), 7.44 (d, 
J = 8.0 Hz, 1H), 7.08 (d, J = 5.6 Hz, 1H), 6.90 
(s, 1H), 6.85 (d, J = 8.3 Hz, 2H), 6.49 (s, 1H), 5.39 (d, J = 17.2 Hz, 1H), 
5.34 (d, J = 17.2 Hz, 1H), 2.97-2.89 (m, 2H), 2.87-2.77 (m, 2H), 2.33 (s, 
3H), 1.43 (s, 3H). 13C‐NMR (125 MHz, CD2Cl2) δ 140.4, 138.0, 137.8, 
137.6, 137.4, 136.5, 136.1, 131.9, 131.05, 130.94, 130.7, 128.1, 128.0, 
126.1, 125.2, 125.1, 124.7, 124.1, 122.6, 119.9, 113.5, 107.0, 92.6, 46.3, 
32.0, 21.3, 21.2, 19.6. MS (EI) m/z (%): 569 (100), 352 (20), 217 (6). 
HRMS (EI) m/z calculated for C31H24NISNa (MNa+) 592.056638, found 
592.056951. HPLC analysis with Chiralpak AD3R column, 60:40 
MeCN:H2O, 1 mL/min, detection at 235 nm; minor enantiomer tR = 49.6 








Purified by flash chromatography with 
hexane/EtOAc 19:1 as eluent. 1H NMR 
(500 MHz, CDCl3) δ 8.00 (s, 1H), 7.81 (d, J = 
7.8 Hz, 2H), 7.74 (d, J = 7.9 Hz, 1H), 7.70 
(d, J = 7.9 Hz, 2H), 7.62 (s, 1H), 7.52-7.44 
(m, 4H), 7.41-7.35 (m, 1H), 6.86 (d, J = 7.8 
Hz, 2H), 6.78-6.71 (m, 2H), 6.62 (s, 1H), 6.49 (s, 2H), 6.42 (s, 1H), 5.17 (d, 
J = 17.1 Hz, 1H), 5.06 (d, J = 16.1 Hz, 1H), 2.96-2.62 (m, 4H), 2.28 (s, 3H), 
1.20 (s, 3H). MS (EI) m/z (%): 665 (100), 448 (17), 217 (7). HRMS (EI) m/z 
calculated for C41H32INNa (MNa+) 688.147167, found 688.147838. HPLC 
analysis with Chiralcel OD3R column, 90:10 MeCN:H2O, 1 mL/min, 
detection at 235 nm; minor enantiomer tR = 10.8 min, major enantiomer tR 




Purified by flash chromatography with 
hexane/ CH2Cl2 19:1 as eluent.   25D -
789.89 (C = 0.44, CH2Cl2, 84% ee). 1H NMR 
(500 MHz, CD2Cl2) δ 8.63-8.57 (m, 2H), 8.40 
(d, J = 8.1 Hz, 1H), 8.31 (d, J = 8.1 Hz, 1H), 
8.13 (dd, J = 8.4, 0.9 Hz, 1H), 7.70-7.57 (m, 
6H), 7.46 (d, J = 9.1 Hz, 1H), 7.43 (d, J = 8.8 Hz, 1H), 7.13 (d, J = 8.5 Hz, 
1H), 7.11-7.06 (m, 1H), 6.99-6.95 (m, 1H), 6.83 (d, J = 8.7 Hz, 2H), 6.50-
6.43 (m, 2H), 5.58 (d, J = 17.4 Hz, 1H), 5.54 (d, J = 17.3 Hz, 1H), 3.13-
2.96 (m, 4H). 13C‐NMR (125 MHz, CD2Cl2) δ 138.8, 138.0, 137.8, 137.6, 
133.4, 131.7, 131.5, 130.6, 130.3, 130.2, 129.9, 129.3, 128.4, 128.0, 
127.9, 127.8, 127.3, 127.0, 126.7, 126.4, 126.2, 124.5, 124.1, 123.8, 
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123.5, 123.3, 122.8, 122.64, 122.60, 119.6, 119.5, 116.1, 110.8, 92.7, 
46.6, 31.4, 21.3. MS (EI) m/z (%): 635 (100), 418 (43), 217 (5). HRMS (EI) 
m/z calculated for C39H26INNa (MNa+) 658.100216, found 658.100460. 
HPLC analysis with Amycoat column, 80:20 MeCN/H2O, 1.0 mL/min, 
detection at 257 nm; minor enantiomer tR = 9.2 min, major enantiomer tR 




Purified by flash chromatography with 
hexane/CH2Cl2 9:1 as eluent.   25D -546.67 
(C = 0.28, CH2Cl2, 75% ee). 1H NMR (500 
MHz, CD2Cl2) δ 7.87 (d, J = 8.7 Hz, 1H), 7.81-
7.76 (m, 2H), 7.70 (d, J = 8.1 Hz, 1H), 7.64 
(d, 8.3 Hz, 2H), 7.55-7.47 (m, 3H), 7.35 (d, J = 5.5 Hz, 1H), 7.12 (d, J = 8.5 
Hz, 1H), 7.10-7.05 (m, 1H), 6.85 (d, J = 8.3 Hz, 2H), 6.64-6.56 (m, 2H), 
5.58 (d, J = 17.2 Hz, 1H), 5.53 (d, J = 17.2 Hz, 1H), 3.06-2.99 (m, 2H), 
2.99-2.87 (m, 2H). 13C‐NMR (125 MHz, CD2Cl2) δ 139.4, 138.1, 138.0, 
137.6, 136.9, 135.8, 133.0, 131.9, 130.5, 129.6, 128.6, 128.1, 127.6, 
127.3, 126.2, 126.0, 125.41, 125.37, 124.5, 123.7, 122.9, 122.5, 122.1, 
120.9, 120.3, 115.1, 111.0, 92.8, 46.7, 32.2, 21.2. MS (EI) m/z (%): 591 
(100), 374 (56), 217 (9). HRMS (EI) m/z calculated for C33H22NISNa (MNa+) 
614.040986, found 614.041543. HPLC analysis with chiralpak AD3R 
column, 70:30 MeCN:H2O, 1 mL/min, detection at 235 nm; minor 










Purified by flash chromatography with 
hexane/EtOAc 19:1 as eluent. 1H NMR (500 MHz, 
CDCl3) δ 8.09 (d, J  = 1.7 Hz, 1H), 7.84 (d, J = 7.9 
Hz, 1H), 7.80 (d, J = 7.4 Hz, 2H), 7.71 (d, J = 7.9 
Hz, 1H), 7.68 (d, J = 8.5 Hz, 2H), 7.55 (d, J = 7.9 
Hz, 1H), 7.53-7.48 (m, 2H), 7.44 (d, J = 1.6 Hz, 1H), 
7.41-7.37 (m, 1H)7.30 (d, J = 8.8 Hz, 1H), 7.28-
7.22 (m, 2H), 7.04 (d, J = 9.2 Hz, 1H), 6.98-6.93 (m, 
1H), 6.82 (d, J = 8.1 Hz, 2H), 6.64-6.56 (m, 2H), 6.46-6.31 (m, 2H), 6.18-
6.19 (m, 1H), 5.36 (d, J = 16.8 Hz, 1H), 5.23 (d, J = 17.1 Hz, 1H), 3.1-2.7 
(m, 4H). MS (EI) m/z (%): 687 (100), 470 (18), 217 (5). HRMS (EI) m/z 
calculated for C43H30INNa (MNa+) 710.131514, found 710.130804. HPLC 
analysis with Chiralcel OD3R column, 75:25 MeCN/H2O, 1 mL/min, 
detection at 235 nm; minor enantiomer tR = 70.9 min, major enantiomer tR 




Isolated by preparative TLC with 
hxane/EtOAc 6:4 as eluent. 1H NMR (500 
MHz, CD2Cl2) δ 8.09 (d, J = 8.8 Hz, 1H), 7.98-
7.92 (m, 3H), 7.80-7.75 (m, 3H), 7.55 (d, J = 
8.4 Hz, 1H), 7.47-7.42 (m, 1H), 7.31 (d, J = 
8.5 H, 2H), 7.14-7.10 (m, 3H), 7.01-7.66 (m, 
1H), 6.48 (s, 1H), 5.70 (d, J = 17.0 Hz, 1H), 5.65 (d, J = 17.0 Hz, 1H), 2.41 
(s, 3H), 1.25 (s, 9H), 1.04 (s, 3H). MS (EI) m/z (%): 491 (100), 147 (11). 








Purified by flash chromatography with 
hexane/EtOAc 19:1 as eluent. 1H NMR (500 MHz, 
CD2Cl2) δ 7.62-7.57 (m, 2H), 7.14 (d, J = 7.3 Hz, 
1H), 7.00 (d, J = 7.3 Hz, 1H), 6.87 (s, 1H), 6.80-
6.75 (m, 3H), 5.28 (d, J = 17.1 Hz, 1H), 5.21 (d, J 
= 17.0 Hz, 1H), 3.97 (d, J = 18.9 Hz, 1H), 3.23 (d, 
J = 18.4 Hz, 1H), 3.15-3.08 (m, 1H), 3.01-2.93 (m, 
1H), 2.81-2.75 (m, 2H), 2.73-2.64 (m, 1H), 2.53-2.40 (m, 3H), 2.37 (s, 3H), 
2.32 (s, 3H). 
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8.7 Computational Details 
 
The DFT geometry optimizations were performed at the GGA level with the 
Gaussian09 package,175 using the BP86 functional of Becke and 
Perdew.176 The electronic configuration of the molecular systems was 
described with the standard split-valence plus basis set with a 
polarization function of Ahlrichs and co-workers (SVP keyword in 
Gaussian09).177 The geometry optimizations were performed without 
symmetry constraints, and the characterization of the located stationary 
points was performed by analytical frequency calculations. The energies 
discussed in the text have been obtained through single point energy 
calculations on the BP86/SVP optimized geometries using the M06 
functional178 in connection with the TZVP basis set.179 Solvent effects 
including contributions of non electrostatic terms have been estimated in 
single point calculations on the gas phase optimized structures, based on 
the polarizable continuous solvation model PCM, using toluene or C6F6 as 
the solvent.180 Zero point energy and thermal corrections were included 
from gas-phase vibrational analysis at the BP86 level on the SVP 
optimized geometries.  
                                                          
175 Gaussian 09, Revision A.1, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, 
M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. 
Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. 
Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. 
Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr., J. E. Peralta, F. 
Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Kobayashi, 
J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyengar, J. Tomasi, M. Cossi, 
N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. Bakken, C. Adamo, J. 
Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. 
W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. 
Dannenberg, S. Dapprich, A. D. Daniels, Ö. Farkas, J. B. Foresman, J. V. Ortiz, J. 
Cioslowski and D. J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
176 a) A. D. Becke, Phys. Rev. A, 1988, 38, 3098; b) J. P. Perdew, Phys. Rev. B, 1986, 33, 
8822; c) J. P. Perdew, Phys. Rev. B, 1986, 34, 7406. 
177 A. Schaefer, H. Horn and R. Ahlrichs, J. Chem. Phys., 1992, 97, 2571. 
178 Y. Zhao; D. G. Truhlar, Theor Chem Acc., 2008, 120, 215. 
179 A. Schaefer; C. Huber; R. Ahlrichs, J. Chem. Phys., 1994, 100, 5829. 
180 V. Barone and M. Cossi, J. Phys. Chem. A, 1998, 102, 1995. 
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Gas-phase BP86/TZVP energy of the calculated transition states 
Table 8.1. Relative free energy, in kcal/mol, of the four possible transition 
states for the reaction of 37a and 38a promoted by 29a. Geometries have 
been optimized in the gas-phase with the BP86 functional and the SVP 
basis set. The energy of the structures in bold has been further refined 
through single point energy calculations in solvent with the M06 
functional and the TZVP basis set. 






Pro-S,R +C6F6 0.0 
Pro-R,S +C6F6 1.3 
  
Pro-S,R +2C6F6 0.0 
Pro-R,S +2C6F6 1.3 
 
BP86 and M06 interaction energy between the C6F6 molecule and the 
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The interaction energy between the reacting system and the C6F6 molecule 
in transition state pro-S,R + C6F6 is calculated as follows:  
 
E(interaction) = –[E(pro-S,R +C6F6) –E(pro-S,R) –E(C6F6)] 
 
With this approach, E(interaction) is calculated to be 4.8 kcal/mol in the 
gas-phase at the BP86/SVP level, and 14.6 kcal/mol in solvent at the 
M06/TZVP level. Although the BP86 value can be affected by the BSSE, 
the strong interaction at the M06 level indicates a rather strong 
interaction more driven by electrostatic interaction rather than dispersion. 
This strong interaction is more typical of a well defined minimum on the 
potential energy surface, rather than of a rather floppy potential energy 
surface. 
 
Steric profiles in transition states pro-R,S and pro-S,R 
The closer proximity between C6F6 and the enolate in TS pro-R,S can be 
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Figure 8.1 Steric profile of the pro-R,S and pro-S,R TS. The optimized 
geometry of C6F6, in white, is plotted on top of the steric profiles. 
 
In case of TS pro-R,S, steric hindrance by one of the Ph rings of the 
catalyst and the ethoxy group of 38a is higher on the right side, as 
evidenced by the red isocontour lines. On the left side, instead, the orange 
isocontour lines indicates reduced steric hindrance, so that C6F6 can be 
accommodated comfortably above the enolate. Differently, in TS pro-S,R 
the ethoxy group is placed on the left of the catalyst so that the ethoxy 
group and one of the Ph rings of the catalyst shape a narrow groove 
preventing optimal stacking of C6F6 on top of the enolate. The steric 
profiles of Figure 8.1 have been calculated using the geometry of 
transition states pro-R,S and pro-S,R in presence of a C6F6 molecule. The 
points in space defining the steric profile were located with the SambVca 
package developed by Cavallo’s group.181  
 
                                                          
181 A. Poater, B. Cosenza, A. Correa, S. Giudice, F. Ragone, V. Scarano, L. Cavallo, Eur. J. 
Inorg. Chem. 2009, 1759. 
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Figure 8.2. Structure of the pro-S,S and pro-R,R transition states and 
their relative energy with respect to the pro-S,R transition state. 
Structures are oriented along the forming C2-C3 bond. C atoms of 38a 
and 39a are coloured in pale green and pink, respectively. 
 
 
Figure 8.3. Structure of the pro-S,R and pro-R,S transition states in 
presence of a C6F6 molecule. Structures are oriented along the forming 
C2-C3 bond. C atoms of 38a and 39a are colored in pale green and pink, 









Figure 8.4. Structure of the pro-S,R and pro-R,S transition states in 
presence of 2 C6F6 molecules. Structures are oriented along the forming 
C2-C3 bond. C atoms of 38a and 39a are coloured in pale green and pink, 
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X-Ray molecular structure of epoxide 35d. Thermal ellipsoids are drawn 
at 20% probability level. 
X-ray diffraction quality single crystals of 35d were obtained by slow 
evaporation of a solution of 35d in hexane/iPrOH/CHCl3. 
A suitable crystal of 35d was selected and glued on a glass fiber and 
measured at room temperature with a Rigaku AFC11K diffractometer 
equipped with a Saturn944 CCD detector using CuK radiation. Data 
reduction was performed with the crystallographic package 
CrystalClear.182 Data have been corrected for Lorentz, polarization and 
absorption. The structures were solved by direct methods using the 
program IL MILIONE183  and refined by means of full matrix least-squares 
based on F2 using the program SHELXL97.184 
All non-hydrogen atoms were refined anisotropically, hydrogen atoms were 
positioned geometrically and included in structure factors calculations but 
not refined. 
                                                          
182 CrystalClear, Crystal Structure Analysis Package, Rigaku-Molecular Structure Corp. 
183 Burla, M. C.; Caliandro, R.; Camalli, M.; Carrozzini, B.; Cascarano, G. L.; De Caro, L.; 
Giacovazzo, C.; Polidori, G.; Siliqi, D.; Spagna, R. J. Appl. Cryst. 2007, 40, 609. 
184 Sheldrick, G. M. Acta Cryst. 2008, A64, 112. 
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A total of 181 refinable parameters were finally considered, final 
disagreement indices are R1= 0.0638 (1211 reflections F2>2F2), wR2= 
0.2247 (all 1771 independent. reflections).  
Flack parameter is -0.06(7). 
ORTEP plot is obtained by means of the program ORTEP32.185 
Crystal data: C16H10BrNO2, monoclinic, space group P2, Z= 2, a= 8.132(4) 
Å, b= 8.188(4) Å, c=10.529(5) Å, = 91.449(14)°, V=700.8(6) Å3, Dx = 1.555 




                                                          
185 Farrugia, L. J. J. Appl. Cryst. 1997, 30, 565. 
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ORTEP plot of (66h) with 30% probability ellipsoids (for seek of brevity H 
atoms are not shown). 
Single crystal diffraction data were collected on a Oxford Xcalibur CCD 
area detector diffractometer, using graphite monochromatic Mo Kα (λ = 
0.71069Å) radiation. Data reduction and absorption correction were 
performed using CrysAlisPRO 171.34.44 (Oxford Diffraction). The 
structure was solved by direct methods using SIR2011186 and refined by 
full-matrix least squares using SHELX-97187. Hydrogen atoms were 
generated in calculated position using SHELX-97. The absolute structure 
of the title compound was determined on the basis of the Flack x 
parameter188 and Bayesian statistics on Bijvoet differences.189 




                                                          
186 M. C. Burla, R. Caliandro, M. Camalli, B. Carrozzini, G. L. Cascarano, L. De Caro, C. 
Giacovazzo, G. Polidori, D. Siliqi, R. Spagna, J. Appl. Cryst. 2007, 40, 609. 
187 G. M. Sheldrick, Acta Cryst. A 2007, 64, 12. 
188 H. D. Flack, Acta Cryst. 1983, A39, 876. 
189 R. W. W. Hooft, L. H. Straver, A. L. Spek, J. Appl. Cryst. 2008, 41, 96. 
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Crystal data for 66h 
Empirical formula  C21 N1 O5 H23 
Formula weight  369.40 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 5.852(5) Å           = 90°. 
 b = 11.039(5) Å         = 96.987(5)°. 
 c = 15.374(5) Å           = 90°. 
Volume 985.8(10) Å 3 
Z 2 
Density (calculated) 1.245 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 392 
Crystal size 0.8 x 0.6 x 0.3 mm3 
Theta range for data collection 4.14 to 28.20°. 
Index ranges -7<=h<=7, -14<=k<=14, -
20<=l<=20 
Reflections collected 19850 
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Independent reflections 4481 [R(int) = 0.0522] 
Completeness to theta = 25.00∞ 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.86524 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4481 / 1 / 249 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0703, wR2 = 0.1737 
R indices (all data) R1 = 0.1207, wR2 = 0.1962 
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Compound 86a 
    
Crystal data and structure refinement. 
Identification code  7859sadabs 
Empirical formula  C33 H26 I N 
Color  orange 
Formula weight  563.45  g · mol-1  
Temperature  100 K 
Wavelength  1.54184 Å 
Crystal system  MONOCLINIC 
Space group  p 21 ,  (no. 4)  
Unit cell dimensions a = 11.595(3) Å       = 90°. 
 b = 8.301(2) Å         = 104.403(6)°. 
 c = 13.141(3) Å        = 90°. 
Volume 1225.1(5) Å3 
Z 2 
Density (calculated) 1.527  Mg · m-3 
EXPERIMENTAL SECTION 
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Absorption coefficient 10.425 mm-1 
F(000) 568 e 
Crystal size 0.57 x 0.34 x 0.13 mm3 
 range for data collection 3.47 to 65.08°. 
Index ranges -12  h  13, -9 k  8, -13  l  15 
Reflections collected 41725 
Independent reflections 3529 [Rint = 0.0594] 
Reflections with I>2(I) 3527 
Completeness to = 65.08° 94.2 %  
Absorption correction Gaussian 
Max. and min. transmission 0.33497 and 0.02099 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3529 / 1 / 318 
Goodness-of-fit on F2 1.078 
Final R indices [I>2(I)] R1 = 0.0318             wR
2 = 0.0827 
R indices (all data) R1 = 0.0318             wR
2 = 0.0827 
Absolute structure parameter 0.005(5) 
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